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Abstract 
While modern-day healthcare continues to improve in terms of available treatments 
and life expectancy in many countries, increasing costs of providing medical services 
to aging populations place these systems under increasingly severe pressure. With 
continuing increases in chronic afflictions and ailments related to old age, more cost-
efficient and long-term solutions are needed to meet these challenges. 
Regenerative medicine offers the potential for more effective long-term treatments, 
but is hindered by the high cost of the desired treatments in terms of development 
and implementation, owing to the complexity of the living materials used for such 
therapies. 
The work described in this thesis focuses on improving the level of control over the 
local cellular environment in order to reduce the need for costly materials (especially 
growth factors). Both surface topology and immobilization of growth factors have 
previously been shown to have an impact, and this research investigates potential 
interaction between these aspects. Patterning and immobilization of bio-active 
compounds are combined for the culture of human mesenchymal stem cells on 
surfaces with differently scaled patterns and concentrations of immobilized TGF-β1. 
Initial work focused on the creation of patterned surfaces with feature sizes ranging 
from 1 to 50 µm. Patterns were successfully produced in Poly (Ethylene Glycol), 
Polystyrene and Polycaprolactone surfaces using a microparticle-based moulding 
process. 
Further work resulted in the successful immobilization of TGF-β1 onto chemically 
modified surfaces, chiefly Polycaprolactone. Proteins were successfully immobilized 
onto Polycaprolactone surfaces at concentrations up to 4 pmol/cm2, with exact 
concentrations dependent on the parameters of the immobilization process. 
Finally, the developed methods were combined in a hybrid experiment using both 
patterned surfaces and growth factor immobilization. Results demonstrated a 
probable link between surface patterning and the effectiveness of immobilized 
growth factors, although further work is needed to more accurately describe any 
underlying processes. 
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1.1. Introduction 
The modern-day population of Earth is perhaps the healthiest it has ever been, 
owing to widespread improvements in numerous aspects of society, from food 
production to environmental safety to both preventative and treatment-based 
healthcare. However, as the average age steadily increases due to higher life 
expectancies, healthcare systems are increasingly burdened by the need to care for 
these aging populations, especially in more developed countries. For most 
individuals, the majority of all medical expenses occurred over a person’s lifetime will 
take place in the later years of life. Consequently, extended life expectancies have a 
major impact on total healthcare costs1–3. 
For example, NHS expenses in the UK have steadily risen both in total and per 
capita, with costs going up by an average of 3.8% per year compared to an average 
economic growth of 2.2% per year. Similar trends are seen in numerous other 
countries, as shown in Figure 1. 
 
Figure 1: Annual average growth rate in per capita health expenditure, real terms, 2005 to 2015 (or 
nearest year). Reproduced from Health At A Glance: Europe 2016: State of Health in the EU Cycle4. 
In 2015, numerous western nations spent over 10% of total GDP on healthcare and 
related services4. Further pressure is put on healthcare providers by the problem that 
a large number of medical needs in older populations are of a chronic or recurring 
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nature, including Alzheimer’s, diabetes, various types of cancer, and degenerative 
ailments such osteoporosis and arthritis5. Long-term care is the fastest-growing 
source of healthcare expenses, as shown in Figure 2. 
 
Figure 2: Growth of health spending for selected functions per capita, EU average, 2005-14. Reproduced 
from Health At A Glance: Europe 2016: State of Health in the EU Cycle4. 
Consequently, the current need for better treatment options is a major priority in 
healthcare research and development. Reducing costs and increasing efficacy and 
efficiency of existing treatments has been a long-time focus area in medical 
research, but does not address the underlying problem where continuing treatment is 
required for chronic conditions. Regenerative medicine offers a different approach, 
seeking to provide more effective treatments by actively restoring the damaged or 
weakened tissues of the patient, restoring long-term function through the use of 
living materials6. 
1.2. Advantages of Regenerative Medicine 
The field of regenerative medicine primarily deals with the use of living materials, 
including induced or naturally derived stem cells and cell-derived compounds such 
as extracellular matrix. The main purpose of treatments based on regenerative 
medicine is to create long-lasting solutions to a patient’s problems by creating or re-
creating healthy tissues. Examples of regenerative medicine include both cell-based 
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treatments and the use of artificial materials designed to enhance the body’s natural 
capacity for tissue restoration. 
Regenerative medicine is especially promising for the treatment of chronic ailments 
caused by old age or congenital defects. Theoretically, such therapies need no long-
term support like more standard methods; replacing a new-born’s faulty aortic valve 
with a plastic or metallic heart valve will eventually see it wear out, making repeat 
surgical intervention inevitable. In contrast, a tissue engineered heart valve made of 
living tissue will grow with the rest of the body while maintaining its function, 
potentially eliminating the need for further treatment. 
Restoration of damaged tissues can be accomplished by the introduction of 
artificially induced or natural stem cells, such as restoring cardiac function following 
myocardial infarction7,8. Further modification of patient-derived (stem) cells prior to 
delivery, such as by genetic modification, can provide a means of treatment for 
ailments such as diabetes, which are not caused by damaged tissue so much as 
non-functional cells or cellular processes9. Artificial degradable scaffolds can be 
implanted or formed in-situ to provide support for a patient’s own healing, in 
particular for tissues with rapid access to existing stem cells such as blood vessels 
or heart tissue10,11. Finally, some tissues may be re-created ex vivo and implanted 
whole, allowing for complete replacement of damaged materials and restoring 
function with only a minimal recovery time, which is especially important for tissues 
that are required in every-day life such as cartilage and bone. 
In summary, stem cells and tissue engineering are a promising source of new 
treatments for varying illnesses and injuries. However, the development of 
successful treatments in this area has been hindered by the complexity of the 
cellular environment and the resulting costs associated with both the use of 
biological materials and the degree of control necessary to meet regulatory 
demands12–16. Ex vivo culturing of (stem) cells for treatments often requires large 
amounts of growth factor-enriched medium, suitable surface or scaffold materials 
with strictly defined properties, or co-culture with different cell types. Creating 
effective therapies therefore requires that the functional parameters of the culturing 
system are well understood and precisely controlled, while simultaneously 
minimizing total costs and use of resources. 
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1.2.1. Role of the cellular environment 
It has previously been established that surface properties can have substantial 
effects on cellular differentiation, in particular with cell types that are only found in 
very specific environments such as osteoblasts or nerve cells17. For cells to thrive in 
culture, the local material properties must logically be comparable to that found in 
their natural environment. The mechanical aspects of the environment, such as the 
Young’s Modulus of the material or (dynamic) loading, are of particular interest for 
stimulating extracellular matrix production18. Similarly, the immobilization of 
biochemical factors onto solid particles (for suspension culture) or surfaces (for 
adherent culture) is shown to potentially alter the effectiveness of the factors 
involved, including increasing the effective dose, preventing negative effects found 
with equivalent higher doses in solution, reducing the total amounts of factors 
needed during cell culture and enabling long-term drug effects in tissue engineered 
scaffolds19–24. More broadly, chemical properties such as hydrophobicity and the 
presence of specific amino acid groups found in extracellular matrix can have a 
profound effect. 
Likewise, the chemical composition of cell culture media has been under continuous 
investigation for years. While some research focuses on how to better mimic the in-
vivo environment through the inclusion of, for example, sera and metabolic by-
products from other cultures, the most work takes place in selecting the most 
effective combination(s) of growth factors, amino acids, and other compounds for 
particular cell culture methods25–29. 
1.2.2. Challenges in the creation of tissue engineered cartilage 
Cartilage is a major focus for regenerative medicine due to the great difficulty of 
restoring damaged or lost cartilage to full functionality. While cartilage can regrow to 
some extent, the complexity of its physical structure makes full recovery very difficult. 
Because the function of cartilage relies on the interplay between osmotic pressure, 
lubrication and a complex fibrous matrix of arched collagen fibres, even minor 
defects can create steadily worsening damage. Likewise, this means that most 
replacements do not have the correct mechanical or structural properties, and further 
wear and damage are common after medical intervention. 
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Currently, the main methods to treat damaged cartilage, be it due to trauma such as 
sports injuries or degenerative ailments such as arthritis, are unable to restore the 
original cartilage structure. The most straightforward treatment is to remove 
damaged tissue to create a new, smooth surface within a joint using underlying 
cartilage. However, this process often leads to complications after further use of the 
joint, since the new cartilage surface will not have the same mechanical properties 
due to the reduced thickness and different fibre structures within the tissue. 
Artificially inducing micro-fractures in the bone underneath damaged cartilage can 
release stem cells from the underlying bone marrow to induce natural healing, but 
has shown a lack of reliable long-term effectiveness30. Injection of autologous stem 
cells, either with or without a suitable scaffold, can promote healing in a similar 
manner31. Finally, damaged cartilage may be replaced by autografts, allografts or 
artificial ex vivo created tissue. 
The difficulties inherent in attempting to restore cartilage to its original structure and 
function make this medical need an important area of research. While artificial 
cartilage can already be created from various sources of stem cells, challenges 
remain in creating the correct structure and mechanical properties suitable for long-
term use32,33. Consequently, insights into how to better control the cellular 
environment and more effectively direct cells used for the creation of artificial 
cartilage, such as mesenchymal stem cells and chondrocytes, could lead to 
immediate advantages in both current research and future treatments. 
This project is intended primarily as a proof of concept, and the effects, if any, that 
are found from combining immobilized growth factors and surface topology may be 
relevant for multiple different cell or tissue types. The use of chondrocytes for the 
creation of artificial cartilage will be the initial starting point for further work during this 
project, but other cell or tissue types may be considered if appropriate. 
1.3. Research novelty 
A large amount of research is underway to improve various parts of cell-based 
therapies, but despite the fact this issue has been recognized as a potential factor, 
limited information is available regarding how the physical environment influences 
biochemical factors34. While some research has been performed that combines 
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material topology and the immobilization of growth factors35–37 these studies typically 
focus on the inclusion of only a small number of environments or growth factor levels.  
Because of the inherent complexity of cell-environment interaction and the influence 
on cellular signalling pathways, looking at a single type of environment may not 
provide sufficient detail to fully describe the interaction process. Using different types 
of cellular environments or growth factor concentrations may have different effects 
on the affected cells. This project will investigate this relationship by focusing on the 
effect of the topological properties of the substrate and the effective concentration of 
immobilized growth factors both separately and when combined, using a number of 
different surface topologies. This should provide novel insights into how these 
different factors influence each other. 
1.4. Project hypothesis 
The hypothesis that directs this research is outlined as follows: 
- Topological features of cell culture surfaces will influence the effective 
concentration of growth factors when immobilized on these surfaces. Smaller 
feature sizes are expected to result in a higher effective concentration. 
This project aims to gain additional knowledge regarding the manipulation of cellular 
pathways through altering cytokine presentation on patterned surfaces. Any positive 
or negative influences found during this research could allow researchers and 
industry to enhance their control of cellular proliferation and differentiation processes 
for use in clinical research and therapies. 
Possible benefits that may be revealed by this project include: 
- Improved process output due to a reduction in cell loss during culturing (such 
as those caused by cell death or cells that have to be removed because of 
faulty differentiation) 
- Reduced process costs in existing techniques due to more efficient resource 
use (particularly growth factors) 
- Access to potential new treatment options due to improved or different 
manipulation of cellular signalling pathways and differentiation 
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- Potential improvements in bio-active surfaces for both bioreactor culture 
systems and implant-based treatment designs (both short term degradable 
scaffolds and longer term semi-permanent implants) 
1.5. Review of existing literature 
The increasing need for more cost-effective medical treatments indicates that 
research should not only attempt to develop new treatments, but also improve 
existing ones for greater efficacy, improved efficiency and reliability, and/or reduced 
cost. Improving these types of treatments by enhancing control over the process or 
reducing the required amounts of (costly) resources is then a potentially effective 
method to reduce or eliminate these therapies’ main downsides. This project does 
not focus on treating a single, specific medical challenge; rather, it is intended to 
serve as a proof-of-concept, and if beneficial effects are found during the course of 
this project it is hoped these will be applicable to a broad range of processes in 
biomedical treatments and research.  
However, researching a combination of multiple different aspects of the cellular 
environment does provide a more complex challenge than more focused research. 
Consequently, before any actual experimental work can commence it is necessary to 
identify potential paths forward. For example, it is only feasible to investigate a single 
cell type during this project. Different cells or tissues have different requirements, 
and the cell type selection therefore informs most every other decision made during 
the rest of the project. 
Likewise, once a suitable cell type is chosen, numerous different methods of 
influencing cultured cells are available. The various aspects of interest in the cellular 
environment need to be matched to different materials, modification strategies and 
cell culture regimens.  
Therefore, a literature review is performed to determine the best choices of cell type, 
materials and processing techniques for the project, primarily focusing on ease-of-
use, adaptation to the currently available infrastructure and research novelty. 
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1.5.1. Cell types and differentiation mechanisms 
1.5.1.1. General requirements 
Primarily, all cells used in this project must be capable of short term proliferation and 
differentiation. While long-term viability is less important for the specifics of this 
project, cell-lines that remain viable after extended culturing will be more clinically 
relevant. 
Furthermore, the cell line must be clinically relevant (for example, human cell lines 
are preferable over animal models), and if possible should have a minimum in ethical 
and procedural considerations associated with it (for example, iPSCs are preferable 
over embryonic cell lines). Should the cell line be used in the clinic, it may not cause 
significant adverse effects (such as chronic inflammation or cancer) in any exposed 
patients. 
The growth factors used must create a response in specified cell lines, either 
individually or when used in combination. At least one growth factor used for a 
culture situation must be critical for creating the desired response, and this growth 
factor must be suitable for linking to the polymer construct without experiencing a 
loss of function. Additional growth factors may be used in suspension as needed. 
While a number of growth factors are commercially available and usage can be 
scaled to fit the needs of the experiment, production costs are still a limiting factor. 
Any clinically relevant treatment must minimize both use and waste of materials. 
Finally, there need to be significant safety procedures in place as accidental 
exposure of the patient to traces of the protein in the product may result in adverse 
side effects, further limiting the suitability of large-scale use of (multiple) growth 
factors in therapeutic therapies. 
Possible cellular differentiation pathways are provided as combinations of cell types, 
growth factors and relevant cellular markers for analysis, since the effect of these 
materials will be highly interdependent and the effects of individual components 
cannot be translated to different situations. 
1.5.1.2. Mesenchymal stem cells 
Mesenchymal stem cells are potentially applicable in the creation of material such as 
cartilage38,39, bone40 and fat tissues41, and are commonly cultured in an adherent 
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situation due to the similarities with the relevant tissues in vivo and the dependence 
of these cells on the physical/mechanical environment42,43, although hydrogels and 
similar 3D scaffolds are becoming increasingly common. These cells are 
commercially available in a number of well-defined cell lines. However, if these cells 
are used in a clinical setting additional safety processes may be necessary to ensure 
the patient is not exposed to flawed cells in the product, such as cells with 
tumorigenic potential. 
1.5.1.2.1. Implementation 
Mesenchymal stem cells are primarily suited for adherent culturing to create tissue 
engineered 2D and 3D constructs. If a 3D construct is used, care must be taken to 
ensure medium (including nutrients and biological factors) can reach the entire 
construct through sufficient porosity or the use of artificial blood vessel-like structures. 
MSCs have been cultured in non-adherent/suspension situations as well, but this 
process is relatively less well defined and understood, compared to adherent 
culturing techniques44–46.  
Analysis of cellular differentiation is typically performed using fluorescent staining, 
flow cytometry, PCR analysis or by microscopy to quantify the cell morphology and 
visual characteristics. 
Mesenchymal stem cells are frequently used in clinical research; using this type of 
cells for biological research is relatively easy since several different MSC cell lines 
are commercially available in addition to primary cell sources. Like all cell culturing 
methods, MSCs must be cultured in sterile conditions to prevent contamination from 
bacteria, fungi, and other biological materials.  
The use of mesenchymal stem cells is scalable; however, since this cell type is 
primarily used for adherent cell culturing on surfaces or in scaffolds, the culturing 
technique may impose limits to the amount of material that can be manufactured at a 
single time due to effects such as diffusion and cross-tissue variability. Mesenchymal 
stem cells have the same clinical considerations that apply to every (foreign) cell 
type that is used for clinical purposes, and strict safety regulations must be in place 
during every step of the process. 
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1.5.1.2.2. Growth factors suitable for use with mesenchymal stem 
cells 1.5.1.2.2.1. TGF-β 
In mesenchymal stem cells, TGF-β influences cellular proliferation and differentiation, 
primarily into chondrogenic cell types23,24,47–50. TGF-β is suitable for presentation in 
solution or controlled release51 and for immobilization on the culturing surface 
through various methods, including UV-copolymerization after binding with a photo-
reactive linker20,23,24, the use of streptavidin-biotin linking methods, or non-covalent 
adsorption onto a surface22. 
TGF-β can be controlled by adjusting its (effective) concentration, either in solution 
or bound to a substrate. It may also be possible to modify its effect through covalent 
bonding with other proteins or molecules, or by combining it with other growth 
factors52 but this may also risk a loss of function and unknown side effects; thereby 
limiting clinical applicability. 
Implementation 
The effectiveness of this method will depend in part on the methods used to 
immobilize this protein and culture cells on the polymer construct, as not all 
modification strategies may be suitable. TGF-β can influence cells both through 
exterior contact and following phagocytosis, allowing for strategies involving both 
(non-) covalent binding and proteins in solution 53–56. This not only allows for 
strategies involving both (non-) covalent binding and proteins in solution, but may 
introduce additional differences in effectiveness between these approaches. 1.5.1.2.2.2. FGF-2 
Fibroblast Growth Factor 2 influences cellular proliferation and differentiation by 
promoting pluripotent lineages. FGF-2 on its own has a limited effect on 
differentiation in affected cells; rather it maintains proliferation and differentiation 
potential by keeping cells in an undifferentiated state for longer periods of time 57–59. 
However, FGF-2 has also shown enhanced chondrogenic differentiation in cultured 
cells, especially if compared with TGF-β60,61. FGF-2 can stimulate both 
chondrogenesis and osteogenesis62, and can be used to support cell proliferation on 
otherwise suboptimal surfaces22. 
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However, the complexity of the FGF-2 induced effects also leads to significant 
challenges during experiments. The broad impact of FGF-2 can lead to off-target 
effects and make interpretation of experimental data more difficult than when using 
biochemical factors with more limited effects. 
Implementation 
The addition of FGF-2 during cell culture has multiple simultaneous effects; 
consequently experiments with FGF-2 should analyse proliferation, cellular 
differentiation, and extracellular matrix production over time to gain a complete 
picture of differences between experimental groups. However, the fact that the effect 
of FGF-2 can involve multiple different processes (proliferation, differentiation, 
synergistic effects with other growth factors), using this growth factor may make 
future experiments needlessly complex for little additional insight. 
FGF-2 can be provided in solution or immobilized by various methods such as non-
specific adsorption. 1.5.1.2.2.3. Analysis 
Determining the presence of growth factors in a material or solution can be achieved 
using various methods. Fluorescent or radio-isotope labelling of the protein itself may 
be possible, but may not be suitable for all situations. Quantitative analysis of 
immobilized growth factor may be accomplished by analysing the change in 
concentrations of the growth factor solution during the immobilization process, or by 
adding specific antibodies with fluorescent or catalytic conjugates and measuring 
concentrations indirectly. Chondrogenic differentiation of MSCs can be analysed 
using the expression of Sox9 and cellular markers CD44, CD90, and CD105. During 
chondrogenic differentiation, these markers will undergo a permanent reduction in 
expression levels39. Finally, production of extracellular matrix, including Collagen II 
and Collagen X, provides further insight into the behaviour of affected cells63–66. 
 
1.5.1.3. Hematopoietic stem cells 
Hematopoietic stem cells are precursors for the various blood-related tissues in the 
body, including Megakaryocytes67, Erythroblasts68, Lymphocytes69, and platelets70, 
and can be isolated from bone marrow or primary blood using techniques such as 
magnetic bead isolation to select cells with positive CD34 expression. CD34 positive 
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cells form a heterogeneous population that express a specific expression marker 
rather than a single population, and further isolation of cell types can be 
accomplished by screening for additional cell surface markers71,72. 
1.5.1.3.1. Implementation 
Hematopoietic stem cells are an excellent option for suspension culture. The 
consistent need for appropriate donor blood in medical interventions, such as those 
relating to major trauma or cancer treatment, makes the ex vivo creation of a reliable 
supply of unifversally applicable donor a potentially important medical advancement. 
Likewise, maintaining, replacing or strengthening the populations of a patient’s 
immune system-related blood cells can be relevant in the treatments of afflictions 
such as leukaemia. 
Hematopoietic cells are usually cultured in suspension, making this cell line more 
easily scalable than cell types that require adherent cultures. Hematopoietic stem 
cells or the containing tissue (specifically blood) are commercially available from 
various sources. However, adherent culture-based systems are also shown to be 
viable73,74. The main limitation of culturing hematopoietic stem cells is the cost of the 
culture media, relevant growth factors and other necessary additions to the cellular 
environment. 
Analysis of created hematopoietic cell lines typically involves measurement of 
cellular marker expression, though depending on the desired cell type other analysis 
methods may also be employed (such as enucleation testing for red blood cell 
maturation).  
1.5.1.3.2. Growth factors suitable for use with CD34-positive cells 
Many of the growth factors that are currently under investigation for stimulating 
differentiation of hematopoietic stem cells are frequently used in combinations to 
provide specific effects. Therefore, rather than looking at each of these growth factor 
individually, this section instead focuses on the relevant combinations discussed in 
the literature. 1.5.1.3.2.1. Megakaryocyte differentiation 
Megakaryocyte differentiation is primarily induced by combinations of Interleukin-3 
(IL-3), Stem Cell Factor (SCF, Steel factor) and Thrombopoietin (TPO). 
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TPO directs hematopoietic stem cells to differentiation into Megakaryocytes75, 
especially when supplemented with SCF76. However, some work as also shown that 
TPO in isolation may increase proliferation without inducing differentiation77. The 
addition of IL-3 to TPO-containing cultures further supports Megakaryocyte 
differentiation67,68,78,79, indicating that hematopoietic differentiation may be best 
managed with combinations of growth factors instead of single additions. 
If Low Density Lipoproteins are added to an SCF and IL-3 containing culture, this 
results in greater differentiation towards Mast Cells80. 1.5.1.3.2.2. Erythroid differentiation 
Erythroid differentiation is primarily induced by combinations of Erythropoietin (EPO), 
Interleukin-3 (IL-3) and Stem Cell Factor (SCF, Steel factor). 
EPO both supports progenitor survival and induces erythroid differentiation81, while 
SCP further supports proliferation. EPO combined with IL-3 also supports 
differentiation and proliferation without addition of SCP82. Differentiation with these 
growth factors is shown to also deplete the progenitor population, resulting in limited 
total production83, although further additions to the culture medium can alleviate this 
issue. 1.5.1.3.2.3. Implementation 
Many of the growth factors suggested above can be provided in both soluble and 
immobilized form. However, the need to combine multiple different growth factors for 
use with hematopoietic stem cells substantially increases the complexity and risks 
involved in these processes. Furthermore, the substantial overlap in necessary 
growth factors for different differentiation lineages shows that even minor differences 
can have immediate and far-reaching consequences for cellular behaviour. As this 
project’s main goal is focused on interactions with (modified) surfaces, the use of 
these cell types may provide only limited insight. While initial culture can include 
adherent conditions, the subsequent suspended nature of the cells in question mean 
that any cell-surface interactions will remain extremely limited. Therefore, 
hematopoietic stem cells will not be considered further for this project. 
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1.5.1.4. Embryonic stem cells 
Embryonic stem cells are a cell type that possesses broader differentiation 
characteristics than stem cells harvested from specific adult tissues84,85. These cells 
are usually harvested from embryos that were created for in vitro fertilization but 
were not implanted. Because of their origin, there are considerable moral and ethical 
considerations in their use for medical treatments and research. While they can (in 
theory) be used to form any tissue in the body, it is not possible to acquire embryonic 
stem cells from a patient and the creation of patient-specific tissues is therefore not 
possible. 
Because this project does not require the broad differentiation potential offered by 
these cells, and because of the additional difficulties with using these cells, 
embryonic stem cells are not considered for this project. 
1.5.1.5. Induced pluripotent stem cells 
IPSCs are artificially prepared stem cells created from non-stem cells. This type of 
cell provides a promising new method to create new tissues for therapeutic purposes, 
combining the regenerative potential of embryonic stem cells with the option to 
create these cells using a patient’s own tissues86. However, questions remain 
regarding potential health risks and the best methods to prepare these cells87,88. 
Consequently, the (potential) advantages of this type of stem cell do not outweigh 
the added complexity and risk of complications, and IPSCs are not considered for 
this project. 
1.5.1.6. Summary of cell type options 
Various different cell types are available for research involving cell culture, but not all 
cell types are equally suitable for this project. Because this project focuses primarily 
on the interaction of cultured cells with (modified) surfaces, the optimal choice will be 
a cell type suitable for adherent cell culture. Although both Mesenchymal Stem Cells 
and Hematopoietic Stem Cells can meet this requirement, Mesenchymal Stem Cells 
are the most immediately suitable cell type. Therefore, all future experiments during 
this project will use Mesenchymal Stem Cells as the starting point. Other cell types 
will only be considered if unforeseen problems are encountered that warrant 
changing to a different type. 
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1.5.2. Materials for cell culture environments 
The most common materials used in tissue engineering processes are ceramics and 
polymers, depending on the tissues of interest. Ceramics are typically used to create 
solid or porous substrates, primarily for adherent cell culture involving bone and 
bone-related tissues (such as bone marrow). Studies into ceramic materials primarily 
focus on controlling pore size, crystallinity, degradation and mechanical properties. 
As this project will initially focus on the culture of cells for softer tissues, ceramics are 
not considered as a primary material for use during this project. Hybrid materials that 
include ceramics (such as hydrogels with ceramic particles) will not be investigated 
to avoid impractically high complexity of the final cell culture material89. 
In contrast to ceramics, polymers offer a more varied environment for adherent and 
embedded cell culture. Depending on the polymer type and production method, 
polymers can be created as solid surfaces, hydrogels, and fibrous matrices, making 
this material type suitable for more numerous applications but also requiring care in 
selecting the correct polymer properties for any particular purpose. 
Scientific research on polymers for cell culture primarily focuses on replacing 
extracellular matrix of softer tissues such as cartilage, muscle and spinal cord tissue, 
be it using degradable or (semi-) permanent structures. For this project, polymers 
are the main material of interest, and will be covered in more detail. 
Finally, surfaces constructed of metals, such as titanium, are researched as 
replacements for bone structures, most commonly to counter osteoporosis or 
damage due to trauma90–92. Due to the much greater processing requirements and 
more limited options for modification, metals are not considered during this project. 
1.5.2.1. Polymers 
Polymers form long, interconnected molecular networks with highly variable 
behaviour depending on the chemical structure of the materials, the volume fractions 
of used components, crosslinking density and numerous other details of their 
construction. They are commonly used for tissue engineering and regenerative 
medicine, and a number of necessary properties have been identified over the 
years93,94. First, any polymer used as an environment for cell culture must be non-
toxic both during use and, if applicable, after degradation. Additionally, while long-
term biocompatibility is not always necessary for in vitro experiments, using 
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materials with poor biocompatibility may cause complications when used in vivo due 
to rejection, inflammation, allergic reactions or other biological processes.  
The material properties of the polymers of interest must be matched to the desired 
tissue; many cell and tissue types require elastic moduli, porosity or surface charge 
to remain within specific bounds for optimal cell growth and function. 
For this project, polymers must also degrade slowly or be non-degradable so as to 
maintain their topography, and be suitable for patterning with one or more patterning 
techniques as described below. Finally, the polymer surface must be suitable for the 
immobilization of growth factors, either by direct incorporation of suitable functional 
groups in the polymer chains or by introducing such groups through chemical 
modification after creation of the polymer construct. 
1.5.2.1.1. Synthetic polymers 
Synthetic polymers have the advantage of being chemically defined, with physical 
and chemical properties selected by the user before creation or purchase. Synthetic 
polymers can be made pure or from a mixture of multiple monomer types, allowing 
for the creation of materials with highly customizable behaviours. However, this 
broad selection of possible structures also means the user must select the correct 
properties, more-so than for the use of naturally occurring polymers. 
Unlike natural polymers, synthetic polymers may be created from components with 
substantial toxicity or other health risks, such as irritants or carcinogenic compounds. 
Long-term cell culture on polymers created from toxic components may need 
additional washing and quality control to ensure no unsafe levels of unpolymerized 
components remain. 
Finally, without the need to collect tissue from living individuals or animals, synthetic 
polymers are significantly easier to prepare than natural materials, thus providing an 
additional advantage given the increasingly high demand for cost reductions in 
medical therapies. 1.5.2.1.1.1. Effects of hydrophobicity 
The hydrophobicity of the chosen material has a direct influence on the behaviour of 
both the cells in culture and the scaffold material itself. Materials with a low 
hydrophobicity, such as Poly (Ethylene Glycol), Poly (L-Lactic Acid) or Poly (Lactic-
Co-Glycolic Acid) derived polymers, are frequently used in the form of hydrogels. 
The hydrophilic nature of such polymers causes the material to attract water, thereby 
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causing swelling of the scaffold. In addition, hydrophilic scaffolds typically show low 
protein adsorption and low cellular adhesion due to a lack of available adhesion 
peptides on the scaffold material 95–97.However, some indications show that protein 
adsorption will further increase if hydrophilicity increases too much98. Hydrogels are 
most often used with added cell attachment groups such as RGD or Laminin and/or 
with the cells of interest already embedded within. 
Hydrophobic segments in most proteins allow materials with higher hydrophobicity, 
such as Polystyrene and Polyethylene, to bind more proteins onto their surface. With 
increased adhesion sites available on the scaffold material, cellular adhesion and 
spreading will typically be greater than that for hydrophilic surfaces. However, since 
hydrophobic materials will non-selectively adsorb proteins out of solution, the surface 
of these materials will become both biologically active and poorly defined compared 
to materials that do not bind proteins. Furthermore, strongly hydrophobic materials 
have been shown to interfere with cell attachment and spreading, indicating that 
such surfaces may still need to be modified to ensure optimal culture conditions98,99. 1.5.2.1.1.2. Copolymers 
The use of copolymers can allow development of materials with more varied 
properties. Alternating monomer units within the polymer will influence 
hydrophobicity, cellular adhesion, crystallinity, can introduce additional reactive 
groups to the polymer surface and may alter degradation, thermal and mechanical 
properties and surface tension100. Block-copolymers in particular can also create 
spatially dependent variations in the polymer’s properties, allowing for localized 
addition or modification of functional groups, manipulation of cell phenotype, 
attachment on various material surfaces or directed cell migration101–106, though 
more complex polymer structures are also seeing use107. The vastly increased range 
of possibilities in terms of material properties for copolymers comes at the cost of a 
substantial increase in complexity for the creation of the material. Not only must 
suitable blends of monomers be selected, the choices made for monomer 
concentrations, polymerization processes, and other aspects of the polymer’s 
creation and modification will have far-reaching consequences for the final material. 
Due to the inherent complexity of this type of approach, copolymers will not be 
considered for use during this project. 
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1.5.2.1.1.3. Degradation 
Synthetic polymers can be either degradable or non-degradable, with degradation 
occurring through processes such as hydrolysis, enzyme digestion or photosensitive, 
thermal or chemical reactivity of the polymer chains. Degradable materials are 
typically used in situations where cultured cells (or infiltrating host cells, if used in 
vivo) are expected to produce extracellular matrix (ECM) to replace the lost scaffold, 
including many materials designed for in-vivo therapies. Additionally, the degradation 
properties of the polymer can influence the behavior of cultured cells by enabling a 
time-dependent change in material properties or long-term release of bioactive 
molecules from the polymers108–112. 1.5.2.1.1.4. Identified options for synthetic polymers 
Polystyrene 
Polystyrene is commonly used in cell culture experiments, and is a common ‘default’ 
material for the various well plate designs used in biomedical research. 
Numerous cell types will readily attach and grow on Polystyrene surfaces, including 
hMSCs, reducing the need for modifications to allow for successful cell culture 
experiments. However, the higher hydrophobicity of Polystyrene compared to other 
polymer options means that proteins will readily adsorb out of solution. 
The high chemical stability of Polystyrene means harsher modification treatments 
like metal chlorides113, anhydrides114, plasma115,116 or similarly reactive species117 
are necessary before cell culture surfaces can be further functionalized. 
Poly (Ethylene Glycol) 
PEG is a hydrophilic polymer most commonly employed as a hydrogel, though its 
uses also include crosslinking of proteins and modification of chemicals to reduce 
biological response (known as ‘pegilation’). 
Depending on the volume fraction of PEG used to create a cell culture scaffold, the 
resulting material may be suitable as a semi-solid 2D surface for adherent culture or 
as a porous gel serving as a 3D environment118. 3D Hydrogels can be later seeded 
with cells, though inclusion of cells prior to polymerization of the PEG monomers is 
also a possibility119–123. 
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Using higher volume fractions of PEG, stiffer and more solid gels are created, which 
will retain their topology if patterned using techniques such as photolithography124,125. 
PEG scaffolds are not innately degradable, though the exact method used to 
polymerize the material and/or create crosslinks may introduce chemical groups 
allowing for degradation over time108,109. 
A major advantage of PEG as a material for cell culture is that it is easily modified 
with various bioactive compounds. Inclusion of growth factors, enzymes, and other 
materials of interest can be achieved both using copolymerization using 
functionalized proteins and after completion of the scaffold126. Access to thiolation, 
monoacrylate functionalization and PEGilation processes allows for substantial 
functionalization without the need to introduce major chemical differences in the 
polymer scaffold itself23,24,127,128. 
Because PEG is innately hydrophilic, it shows less protein adsorption than more 
hydrophobic materials. However, the material consequently also provides a less 
favourable surface for cellular attachment, necessitating functionalization with 
compounds such as Laminin118, Fibrin129 and especially RGD 
peptides95,96,130,13197,126,132,133. 
Polycaprolactone 
Polycaprolactone is a hydrophobic polymer suitable for adherent cell culture, in 
particular for osteogenic lineages134,135. Polycaprolactone degrades in physiological 
conditions through hydrolysis of ester groups within the polymer chains. However, 
this process takes a substantial amount of time and partially depends on 
modifications and exposure to stresses and/or more extreme pH levels136–141. 
Consequently, degradation is not expected to be a major issue for the planned 
experimental work.  
In contrast, deliberately inducing hydrolysis in Polycaprolactone allows for an easy 
initial modification with functional groups which can then be used for further 
immobilization of proteins135,142,143. 
Polycaprolactone is most often used for solid materials rather than hydrogels, though 
porous materials can be created using various methods such as electrospinning and 
solvent-based mixtures142,144–146. 
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While cell attachment and culture on Polycaprolactone is possible without 
modification, the material is not ideal for such experiments147. Modification with 
beneficial proteins such as RGD peptides or fibrin, or alteration of surface chemistry 
with plasma treatment may improve culture of different cell types by enhancing 
proliferation, migration, or differentiation134,135,143,148. 
Other materials 
Polyethylene, Poly (lactic acid), Polyacrylamide, and Poly (lactic-co-glycolic-acid) will 
not be considered for this project. While cell culture on these materials has been 
reported in literature, they each presented risks in regards to patterning, degradation, 
chemical modification or material cost that were deemed too great for this 
project19,102,149,150. 
1.5.2.1.2. Natural materials 
Naturally derived scaffolds such as those composed of collagen, fibrin and alginate 
provide a cellular environment that more accurately mimics the extracellular matrix 
found in vivo. Cell adhesion and viability tend to be much less problematic with 
natural materials than with synthetic polymers; however, these materials are also 
less well-defined than synthetic polymers in terms of bio-activity due to bio-active 
components that are present in the material. The mechanical and biological 
properties of such scaffolds depend significantly on the origin (if harvested in vivo) or 
the cells used to create the extracellular matrix (if created in vitro)151,152. 
Natural materials are commonly hydrophilic and degradable nature by either 
hydrolysis or enzymatic digestion153. This makes natural scaffolds well-suited for the 
creation of temporary 3D hydrogels, but limits the usefulness for long-term use 
without replacement of extracellular matrix by cultured (or native) cells. 
Alternatively, naturally derived materials may be added to a synthetic polymer 
support in order to provide greater cell-matrix interaction and improve cell 
survival150,154, and some naturally-derived polymers such as Hyaluronic Acid can be 
synthesized. Due to the need for a precisely controlled environment in planned 
experiments, natural materials will not be used as the (primary) material for creation 
of cell culture environments during this project. 
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1.5.2.1.3. Implementation 
Polymers can be used for cell culture-related techniques in a number of different 
ways. Due to the variety of different options available, possible methods for using 
polymer-based materials are covered in sections 2.3.2 (polymer fabrication 
techniques) and 2.4 (surface modification and protein immobilization) instead of 
summarized here. 
1.5.2.1.4. Summary 
Various different materials are available for use in cell and tissue culture techniques, 
with different properties and associated advantages and disadvantages. 
This project requires material that is well-defined, chemically modifiable, and which 
allows for cell culture without significant degradation during the course of the 
experiments. In addition, non-specific protein adsorption should be minimized where 
possible. Based on these requirements, synthetic polymers are the most immediately 
suitable material type. 
To ensure these requirements are met, the material initially used for creation of cell 
culture surfaces is Poly (Ethylene Glycol), with additional cellular adhesion- and 
cytokine-related surface modifications added to ensure a healthy cell culture 
environment. 
To create these surfaces, Poly (Ethylene Glycol) Diacrylate, or PEGDA, is selected 
as the initial monomer. PEGDA can be polymerized from its liquid state into solid 
PEG using UV-based methods, which will allow for the creation of patterned surfaces 
from a patterned substrate without the need to modify surface topology of solid 
polymer scaffolds. 
1.5.2.2. Polymer fabrication techniques 
At this point, it is not yet clear if the desired cell culture surfaces will be created 
and/or patterned by modification of an existing material or by creating the new 
material in the desired shape. Synthetic polymers may possibly be created in the 
desired patterned topology, though natural polymers will mostly remain limited to (re-
)shaping after acquisition. Therefore, a brief investigation into potential 
polymerization methods for synthetic polymers may shed additional insight into 
possible routes forward. Methods to modify polymer topology after polymerization 
are not covered here and will be found later in this chapter. 
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Synthetic polymers are typically created from a mixture of monomers, either a single 
type or, in the case of copolymers, two or more different types. Monomers are 
polymerized using various different techniques, some of which may be of use during 
this project both for polymerizing the desired cell culture material in the right shape 
and for directly incorporating covalently bound bioactive proteins. 
Techniques using catalysts will have a more reliable crosslinking throughout the 
material but may also require measures to remove waste products once the reaction 
is complete. Techniques relying on heat may cause damage to any proteins included 
in the material prior to polymerization. 
Analysis of the cross-linking of polymers is typically performed using mechanical 
testing (compression or tensile testing) for mechanical properties such as elasticity 
or material stiffness, as well as techniques to analyse chemical bonds present in the 
construct such as spectroscopy (infrared, X-ray) and NMR analysis155–157. 
Directly polymerizing the desired surfaces is potentially suitable for creating or 
strengthening polymer constructs in micro-beads, although there is a risk of forming 
cross-links between polymer segments belonging to different beads. However, good 
results may be found if the chosen process is used on a sufficiently diluted 
suspension or emulsion of particles/droplets, or when the mixture contains additional 
measures to prevent bead-to-bead contact such as surfactants. 
1.5.2.2.1. Addition polymerization 
Addition polymerization directly binds existing monomers without the creation of 
unbound molecules or waste products. Addition polymerization is most often some 
form of free radical polymerization, and typically creates non-degradable polymers 
(unless the monomer components themselves are already degradable). 
Free radical polymerization uses radical-producing end groups or additions to the 
monomer mixture to initiate crosslinking. This technique is typically used with either 
reactive groups on monomers or with initiating compounds, either of which may be 
spontaneously reactive due to chemical instability or which may form radicals when 
subjected to specific wavelengths of light (most commonly ultraviolet radiation) or 
heat. Thermal polymerization reactions are typically controlled through temperature 
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and/or heating time, and some methods can be made reversible by cooling the 
material158. 
Polymers that are suitable for radical polymerization often include carbon-carbon 
double/triple bonds such as those in acrylate groups159 or radical-stabilizing phenyl 
groups along the polymer chain such as those found in styrene/polystyrene49,160. 
If this process is used on an existing polymer such as a hydrogel, this may result in 
(usually isotropic) shrinking of the construct as the additional crosslinking causes the 
polymer network to contract. 
Exposing photo-sensitive polymer constructs to UV light will create cross-links due to 
the emergence of reactive radicals within the polymer chains. Using additional photo-
initiators can improve the process but is not required for all polymer types. Photo-
initiators can be used for polymers that are otherwise not UV-sensitive, as the photo-
initiator is the compound that provides the initial free radicals necessary for the 
cross-linking process. UV polymerization is primarily controlled by the duration and 
intensity of the UV exposure and the concentration of reactive groups in the 
monomer solution. Additionally, adding different polymer components or UV-initiators 
can provide improved process control, for example by adding components that will 
terminate the polymer chain reaction and correspondingly reduce the total amount of 
crosslinking with equivalent exposure161. UV polymerization is very suitable for 
creating or reinforcing 2D surfaces, as the level of control over the UV exposure is 
greatest at the exterior of the construct. It is also suitable for creating or reinforcing 
3D scaffolds, but the depth of penetration of the UV light may be a limiting factor. For 
thick scaffolds, it may be difficult or impossible to get a comparable amount of cross-
linking across the entire construct since the effect will be strongest at the surface. 
Polymerization with spontaneous radical production does not have the geometric 
limitations of photo-initiated reactions but typically requires a high degree or control 
over added initiators or the addition of additional control compounds such as used in 
RAFT polymerization158. 
1.5.2.2.2. Condensation polymerization 
In condensation polymerization, the monomers used to create the polymer chains 
must have reactive end groups capable of polymerizing with the removal of a small 
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molecule (such as water). If a single monomer is used to create the chain it may be 
necessary to include two different reactive end groups. 
Chemical equilibrium ensures that a portion of the monomer chains polymerizes until 
the rates of the polymerization and degradation reactions cancel out. When the 
environment of the mixture is adjusted such that the small molecule created by 
polymerization is continually removed from the environment, such as by evaporation, 
chemical equilibrium drives the reaction towards the fully polymerized state. 
If the material is expected to be used without degradation in an aqueous 
environment, the condensing product must not be water. On the other hand, 
Polymers created using a water-based condensation reaction consequently make for 
excellent candidates for degradable scaffolds as these are guaranteed to be 
degradable in physiological conditions. However, since this project requires long-
term stability of created surface geometries, these types of polymers will not be 
considered. 
Alternatively, more stable water-based polymers can be created using catalysts or 
enzymes to make use of polymerization reactions with otherwise very slow reaction 
rates 162,163. Stable polymers can also be created by condensing small molecules not 
found in the intended cell culture environment, such as volatile liquids/gasses 
105,164,165. 
1.5.2.3. Summary of cell culture material options 
A number of different techniques are available for the creation of new polymer 
materials. Most techniques rely on creating a high-energy environment or adding 
additional chemicals to initiate the polymerization. Techniques that require external 
stimuli (photo-polymerization, thermal polymerization) have more easily controlled 
reactions. This project will use photo-polymerizable PEG-diacrylate based polymers 
for the additional control provided over the crosslinking process. 
1.5.3. Options for surface modification and protein immobilization 
Finally, a method must be selected for the immobilization of growth factors and, 
potentially, other biologically active compounds on the created surfaces. While non-
specific binding can be used to bind proteins, this project’s focus on determining the 
interaction between immobilized growth factors and surface topography means that 
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large amounts of non-specifically bound protein may introduce unwanted effects and, 
consequently, additional noise, bias or measurement errors. 
Furthermore, the desired immobilization method must meet a number of 
requirements. Most importantly, the used techniques must bind growth factors in 
such a way that their functionality remains intact, and the growth factor itself is 
presented to cells on the surface of the construct. Due to a likely need for lengthy 
cell culture experiments to verify effects, the method to link the growth factors may 
not substantially degrade over time or otherwise release growth factors into solution 
(if non-covalent binding is used). 
1.5.3.1. Direct polymer copolymerization 
By conjugating one or more reactive functional groups to the growth factors that 
need to be added to the material, it is possible to directly integrate these growth 
factors when the material is polymerized. 
Photo-polymerization requires additional steps to be performed during the synthesis 
of the construct and growth factor; however these steps are not significantly more 
difficult or equipment-dependent than those required for the photo-polymerization 
process itself. The main challenges are that larger amounts of growth factor that 
need to be used even for 2D surfaces (as the entire 3D structure will contain 
immobilized proteins) and it is necessary to use a polymerization method that does 
not damage the growth factor itself.  
1.5.3.1.1. Implementation 
To link the growth factors to the polymer scaffold during the polymerization process, 
a photo-reactive end group that is compatible with the monomer mix components is 
attached to the growth factor. During the polymerization process, the growth factor 
will be linked to the forming polymer chains much like the chains are linked to each 
other, for example with a thiol-acrylate link23,24. 
Embedding the growth factors into a polymer surface or 3D scaffold requires the 
addition of the growth factor during the polymerization process. The growth factor will 
be present throughout the resulting material, but this consequently also requires that 
the polymerization process doesn’t cause severe degradation of the proteins 
involved. 
Using photo-polymerization to embed growth factors in a polymer structure around 
micro-beads has the same problems as creating a polymer structure around the 
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micro-beads in the first place; only if the polymerization can be limited to within a 
short distance of the micro-beads will this method be useful. 
This method allows very limited control over growth factor embedding and 
presentation; only the concentrations of the different compounds can be controlled. 
Spatial distribution of the growth factors throughout the construct is therefore difficult 
to control, although it may be possible to create a layered structure by exposing a 
small amount of material at a time using a process such as additive manufacturing. 
Analysis of copolymerized growth factors may require advanced measurement 
techniques such as NMR or IR Spectroscopy, or destroying the material itself to 
analyse its components. However, using fluorescence marked growth factors or 
suitable fluorescent antibodies may allow users to evaluate growth factor 
concentrations at the surface of the material (or deeper inside if used in a hydrogel). 
Using photo-polymerization to embed growth factors has the same limits regarding 
scalability as the use of photo-polymerization itself. Large-scale 3D constructs may 
be limited in size due to restrictions of the polymerization process, such as the 
penetration depth of the UV light into the polymer/growth factor solution. 
Unless a highly porous 3D structure is used, many growth factors will be bound 
within the construct instead of being presented at the exterior. Due to the inefficient 
use of growth factors, materials made using this technique will have a higher 
manufacturing cost than those made with more efficient techniques. 
1.5.3.2. Covalent immobilization 
The process to covalently bind proteins is similar to direct copolymerization as 
described above. However, the proteins of interest are not bound directly into the 
material during creation. Instead, for covalent immobilization proteins are added at a 
later stage and chemically reacted with the cell culture surface using methods such 
as thiolation or carbodiimide crosslinkers. Covalent immobilization of proteins onto 
cell culture surfaces consequently relies on the presence (or creation) of reactive 
surface groups, such as esters or primary amines. 
This technique is suitable for numerous types of materials, and has previously been 
used in hydrogels, polymer scaffolds and ceramics23,24,128,166. 
The exact details of the process will depend on the choice of material; however 
proteins are typically bound through the creation of covalent bonds on primary 
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amines or carboxylic acids, or through the introduction of new reactive groups. 
Protein immobilization often includes crosslinkers, and research has shown that 
crosslinker length can have an impact on the structure and effectiveness of bound 
proteins167. 
Rather than describe all the possible methods for covalent immobilization here, 
relevant modification strategies may be found in the sections for specific cell culture 
materials. 
1.5.3.2.1. Chemical surface modification for covalent 
immobilization 
The most common method for covalently binding organic materials such as 
carbohydrates or proteins is the use of carboxylic acid or (primary) amine groups, 
owing to the numerous chemical reactions that can be used with these groups. 
Carbodiimide- and succinimide-based crosslinkers, ester condensations and 
aldehydes can all be used to create covalent bonds without the need for complex 
chemical reactions or mixtures127. Many surface materials can be functionalized with 
such groups through oxidation, with processes ranging from washing in acids or 
bases of varying pH to using catalysts or enzymes such as Ammonium Persulfate, 
Laccase, or Sodium Periodate127,168.  
Another approach for covalent binding of proteins is to focus on using the chemical 
properties of specific amino acids. The addition of thiol-reactive groups to a material 
or crosslinker chain allows for covalent binding of proteins by targeting free cysteine 
residues, typically creating disulphide or sulfone bonds between the protein and the 
reactive group23,24,127. The rarity of cysteine compared to other amino acids in many 
proteins allows for a more controlled linking method and potentially immobilization of 
only specific proteins in solution. Likewise, varying pH levels of a solution allows for 
the selective activation of specific amino acids, further increasing options for targeted 
reactions. 
The greatest advantage of using chemical modification of surfaces to allow for 
covalent immobilization is that most cell culture surfaces can be treated in bulk, 
including the interiors of porous scaffolds, without the need for complex processes or 
equipment. However, chemical modification is substantially less suitable for the 
creation of gradients – adding gradients to such a treatment often requires inclusions 
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of additional effects such as catalyst diffusion, varying electrical charges or modified 
surface submersion times169–171. 
1.5.3.2.2. Plasma-based surface modification 
Surface modification using plasma-based techniques has substantial overlap with 
plasma surface etching described previously in this chapter. The primary difference 
between these two techniques is the level of plasma exposure applied to the surface 
in question. While plasma surface etching directs a stream of plasma with enough 
power to damage and entirely remove existing material, this process uses far lower 
energies and plasma volumes. 
On contact, the highly energetic plasma interacts with the molecular structures in the 
exposed material, disrupting molecular bonds and creating temporary highly reactive 
groups such as radicals. Depending on the choice of plasma, these groups may then 
react with the plasma itself (for example using Oxygen or Carbon Dioxide plasma for 
the creation of Oxygen-containing functional groups), or they may simply decay and 
leave modified surface chemistries based on the original material chemistry (for 
example when using noble gases like Helium or Neon). However, this process can 
also be used for depositing more complex materials, including amino acid groups 
and newly-created polymer chains90,172,173. 1.5.3.2.2.1. Implementation 
A number of considerations must be taken into account for the use of plasma-based 
chemical modifications. Most importantly, the material must not be significantly 
damaged by the plasma jet under the selected exposure. In addition, the material 
must also remain intact in near-vacuum conditions, meaning this process is primarily 
suitable for solid materials while presenting substantial difficulties for use on 
microspheres, hydrogels or 3D scaffolds where the plasma can’t effectively enter the 
material.  
However, with the correct plasma source and material chemistry, this technique 
offers a high degree of control over the type and amount of modification. Variations 
in the energy of the plasma jet, the components of the plasma and the functional 
groups (if any) that are present on the material surface at the start of the procedure 
will all have an impact on the final chemistry presented at the material surface and 
the larger-scale effects on the treated material172,174. 
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Consequently, this method will create different functional groups on the surface of a 
material, allowing for the immobilization of growth factors using different covalent 
binding reactions175,176. 
Plasma surface treatment is relatively scalable and has been previously used for 
samples including fibrous matrices177, cell culture plates178 and feedstock used for 
the creation of surgical implants179; however, the size of the plasma chamber will be 
a limiting factor for the surface area that can be modified at any given time. 
1.5.3.3. Non-covalent immobilization 
In contrast to covalent binding of proteins, non-covalent binding is always of a 
temporary nature. Any bound proteins will be released into the liquid environment 
over time, though depending on the exact method of immobilization this process may 
proceed at various rates; non-specific adsorption will release more quickly than 
specific non-covalent binding methods such as those involving complementary DNA 
or RNA chains or the Biotin-Streptavidin link.  
Non-covalent binding of proteins will occur on every surface regardless of material, 
with the deposition rate, strength of binding and equilibrium surface concentrations 
depending on the chemical properties of the material in question. Surfaces can be 
chemically modified to increase or decrease the adsorption of proteins out of solution. 
In particular, the hydrophobicity of a material is of key importance98. Most proteins 
are amphiphilic, with both hydrophilic and hydrophobic segments, and one of the 
most important processes for protein adsorption is the binding of the hydrophobic 
segments of a protein to hydrophobic surfaces – though this process can also cause 
potential loss of function due to changed protein folding. 
‘Traditional’ non-covalent binding is non-specific: any protein with hydrophobic 
segments can be adsorbed out of solution. This, combined with the temporary nature 
of the immobilization, makes this type of approach unsuitable for the planned work in 
this project. 
However, non-covalent binding can also be used to bind proteins of interest using 
highly specific protein-protein interactions such as those seen in the binding of 
complementary DNA or RNA chains or the binding of Biotin to Avidin or 
Streptavidin180.  
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1.5.3.3.1. Biotin-Streptavidin and Biotin-Avidin immobilization 
The biotin-streptavidin immobilization technique is a particular method that is 
commonly used. As the name implies, it relies on the non-covalent binding between 
the proteins biotin and either Streptavidin or Avidin to attach other bioactive 
compounds to a selected surface or scaffold128,159. Streptavidin tends towards a 
slightly stronger non-covalent binding of biotin. Typically Streptavidin are covalently 
bound to the surface of the material that needs to be enhanced while Biotin is linked 
to proteins as Biotin’s smaller size is less likely to influence protein function. The 
reverse process is also possible, but is typically applied to link smaller materials173. 
The biotin-protein complex can then be placed in contact with the surface to create a 
non-covalent and resilient but reversible bond between the two segments. It is also 
possible to use the Streptavidin complex to create a Biotin-Streptavidin-Biotin 
chain181. 
The Biotin-Streptavidin immobilization is effective for 2D surfaces, and has been 
used by other groups to create functionalized pores in polymer films182. The biotin-
streptavidin immobilization is also suitable for creating functional micro-beads183. 
Finally, the biotin- streptavidin immobilization can also be used to enhance 3D 
scaffolds. However, the permeability of the structure must be considered (non-
porous structures might only bind the growth factors on surface pores). 
The addition of growth factors to a surface using the biotin-streptavidin link is 
primarily controlled by the concentrations of the used solutions. The use of additional 
control mechanisms such as hydrophilic/hydrophobic groups in the polymer is 
possible, but these will need to be included in the process used to create the 
polymer construct. 
The effectiveness of surface immobilization may be analysed using fluorescent 
microscopy, using either fluorescently marked biotin or streptavidin, depending on 
which connection needs to be confirmed. Fluorescent markers for the linked protein 
may also be used, if applicable. 
1.5.3.4. Summary of surface modification options 
A number of different strategies are available for immobilizing proteins onto cell 
culture surfaces, including methods to prepare these surfaces for such efforts 
through chemical modification.  
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As this project requires a high specificity without causing potential damage to the cell 
culture surfaces, the initial choices for immobilizing proteins will be the use of 
carbodiimide crosslinkers, potentially with further protein-protein non-specific binding. 
Other techniques may be considered depending on the choice of materials and 
results of completed experiments. 
1.5.4. Structuring techniques for cell culture surfaces 
Surfaces with highly defined topologies will be evaluated to identify the presence or 
absence of any topology-biochemistry relationships. Surfaces with randomized size 
and shape of features and topology are more easily created, especially in bulk, by 
techniques such as phase separation and additive manufacturing184. Their relatively 
easy production and correspondingly lower cost makes these materials more 
clinically relevant, as such surfaces are used more frequently than more well-defined 
but less affordable options. 
However, the use of surfaces with ordered patterns will provide a more controlled 
experimental environment, providing potential advantages during pre-clinical work. 
The surfaces used during this project will focus on the influence of pore size and 
three-dimensional pore anisotropy on growth factor presentation. Consequently, 
structuring and patterning techniques should ideally be able to provide a defined and 
highly regular topology to the material structure at multiple scales, ideally in the 
range of 0.1-100µm. The applied topology must be similar across the entire 
construct, with a minimum in shape and size deviation between different pores. 
1.5.4.1. Phase Separation 
For phase separation, two liquid components are mixed into a single solution. 
Altering the liquid’s environment, such as by increasing or decreasing temperature or 
allowing elimination of one or more components by evaporation or chemical reaction, 
then causes the two liquids to change phase to a solid material at different times. 
The material that turns solid thus forms a porous scaffold containing the remaining 
liquid. Phase Separation is also called Gas Foaming if one of the materials changes 
to a gas phase to create bubbles rather than liquid pockets. If the mixture instead 
separates into a (semi-) solid and a gaseous phase, the process is also often called 
gas foaming185. 
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1.5.4.1.1. Implementation 
Phase separation relies on adjusting the environmental parameters of a polymer 
mixture in such a way that the mixture spontaneously separates into two immiscible 
components. The most common methods involves the use of a mixture that is 
miscible at high temperatures but separates at low temperatures, but other 
techniques such as pressure differences, freeze drying, and other sources of solvent 
evaporation are also possible133,186–188. Phase separation can be used to create both 
2D surfaces and 3D scaffolds, but is not directly applicable to the creation of 
patterned microparticles within the mixture. However, if the (unseparated) mixture is 
present as a suspension in a second immiscible liquid, it may be possible to apply 
phase separation to these droplets to create patterned particles. 
This process is particularly useful for creating highly porous 3D scaffolds that allow 
cell infiltration of the scaffold, including scaffolds for tissue regeneration of bone or 
cartilage17,185,189. Scaffolds can be created in bulk or formed into smaller, more 
precisely controlled shapes through controlled deposition and polymerization190. 
The phase separation of the mixture can be controlled by modifying the different 
materials and solvents used during this process. Depending on the cells that will be 
seeded onto or within the scaffold, different pore sizes may be required191. While the 
size and porosity of the resulting material can be controlled fairly well, the exact 
topology of the material is not readily controlled and will show significant variation, 
though additional materials such as micro- and nano-particles can be included in the 
mixture(s) for multi-scale properties and altered mechanical properties185,192. 
Because of the higher variation in topology caused by this process, phase separation 
will not be considered for use during this project. 
1.5.4.2. Salt Leaching 
Salt leaching creates porous scaffolds by mixing solid salt crystals into a salt-
saturated mixture of monomers to be polymerized. When the monomer solution is 
polymerized, for example by heating or exposure to UV light, the resulting scaffold 
only fills the spaces not occupied by the salt crystals. Once the polymerization 
process is completed, the salt can be removed, for example by using a suitable 
solvent, leaving only the completed porous polymer scaffold. 
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1.5.4.2.1. Implementation 
Salt leaching functions by polymerizing a salt-saturated monomer or oligomer 
solution containing salt crystals of pre-defined size at a desired volume fraction129,193. 
After polymerization, the salt crystals are dissolved and flushed out of the finished 
construct using a solvent. The resulting polymer structure contains pores with the 
shape, size and position of the removed salt crystals, allowing for the creation of 
pore sizes from 200 µm to as small as <20µm151,193–195. 
Salt leaching is suitable for creating a patterned 2D surfaces and 3D scaffolds, and 
any volume of polymerized material will have a patterned surface at the solution-
atmosphere interface provided the used monomer mixture does not result in full 
submersion of the salt crystals used during the process. Patterned surfaces at the 
solution-container interface may have a patterned surface depending on whether or 
not the salt crystals remain in contact with the container surface prior and during 
polymerization. For 3D scaffolds sufficiently high pore connectivity may be required 
to flush all the salt crystals from the finished product, especially in larger scaffolds. 
However, despite the presence of solid salts within a polymer blend, appropriate 
volume fractions may still allow for the use of techniques relying on the mixture’s 
liquid behaviour, such as electrospinning194,196. 
Salt leaching is otherwise easily scalable; the process is identical for creating small 
or large surface areas and volumes, with the only difference being the resources, 
equipment and time required. The main limit of this process is the possible presence 
of remaining salt particles in the scaffold due to discontinuous pores (only applicable 
to 3D scaffolds, depending on chosen volume fractions). 
The rough pore size and shape can be controlled by filtering the salt crystals prior to 
salt leaching. However, more precise control over the shape distribution of the salt 
crystals will be required for the creation of highly defined patterns such as those 
desired for this project. Depending on the availability of such materials salt leaching 
may be considered or rejected for further work during this project. 
1.5.4.3. Photo-lithography and additive manufacturing 
Additive manufacturing is a process wherein two- or three-dimensional structures are 
created from a feedstock of solid or liquid materials such as metal197, ceramic 
particles198 or (unpolymerized) plastics or hydrogels199–201. Materials are fused 
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together one layer at a time, typically using heat- or UV-induced polymerization, heat 
sintering, or cooling of molten materials. 
The most simplistic method using additive manufacturing is the creation of a single 
layer, possibly on top of an existing structure. The most commonly used technique 
for such structures is photolithograpy, wherein the necessary structures are created 
by polymerizing a photosensitive monomer mixture with spatially-dependent 
exposure to UV light125,186,202. 
1.5.4.3.1. Implementation 
Additive manufacturing techniques are applicable to 2D surfaces, with the primary 
limitation being the resolution limit of the manufacturing equipment. The process for 
creating a 3D scaffold is very similar to that for creating a 2D surface, except it 
requires repeatedly adding additional layers and/or structures over time. Possible 
techniques include laser sintering of powders, ink-jet style chemical printing of 
plastics and hydrogels, and UV-based polymerization of monomer solutions. After a 
layer has been completed, a new layer of the necessary material (either a deposit of 
powder such as metals and ceramics, or a liquid polymer layer) is added on top of 
the existing structure and the process repeats. Variations in the process between 
layers can result in spatially-dependent changes in the properties of the final 
structure199,203. 
Additive manufacturing is not applicable for the creation of micro-bead covers, 
although micro-beads may themselves be incorporated into any created designs204–
206. Depending on the process, growth factors or living cells can be incorporated in 
the created material199,207. In these cases, fabrication parameters must be such that 
manufacturing the product does not damage the growth factors or cells due to, for 
example, excessive heat. 
The amount of control over the process will be highly dependent on the exact 
specifications of the equipment used during this process, as well as the chosen 
material. However, typically a high degree of control over the 3D shape and porosity 
can be attained, with the primary limit being the resolution of the manufacturing 
equipment, the used digital designs and the limits of the source material (such as 
minimum size of sintered particles)197,208,209. Additive manufacturing is typically used 
to create larger scale structures with macro features in the range of µm-mm, and 
pore size is limited by the resolution of the used equipment. Pores of <150 µm have 
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been shown to be possible, though larger pores may be necessary for cell migration 
through a material210. The creation of smaller pores will depend primarily on the used 
material (diameter of the micro/nanoparticles used during the additive manufacturing 
process), though such materials have also been created previously206. 
Analysis and quality control of the manufactured constructs may be performed using 
various microscopy techniques including bright field, fluorescent and polarized light 
microscopy; for small sized patterns methods such as scanning electron microscopy 
or atomic force microscopy may be required to distinguish the smallest details.  
A downside to this process is that additive manufacturing techniques are not readily 
scalable, since the equipment necessary for these processes typically has a number 
of limitations regarding the volume of created constructs. Additionally, producing 
large numbers of constructs may require multiple instances of any piece of 
equipment when time limitations of the manufacturing process restrict higher 
production rates. Additive manufacturing techniques are not typically found in 
clinical/sterile environments; to ensure the product is safe for clinical use additional 
measures may be necessary to prevent contamination by micro-organisms, be it 
during manufacture or by including sterilization steps following surface creation. 
1.5.4.4. Plasma surface etching 
The chosen polymer must not become toxic during etching and must be able to 
remain intact in a near-vacuum. The plasma used to etch the surface of the polymer 
construct either does not alter the surface properties of the polymer, or alters them 
based on desired parameters. Finally, the plasma jet must be sufficiently narrow and 
sufficiently accurate that small-scale topology can be created. 
1.5.4.4.1. Implementation 
With this technique, the surface of a material is etched using a stream of highly 
energetic plasma particles (different plasma compositions are possible, including 
Neon, Argon etc.). The high physical (velocity/temperature) and chemical (radical 
components) energy of the plasma jet causes material on the surface to ablate, 
leaving empty space172,174. Alternatively, a lower energy plasma jet can deposit 
material onto the surface, although the types of materials that can be deposited have 
some strict requirements174. 
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Creation of a 2D surface is the default use of this technique. Plasma surface 
modification is not directly applicable to micro beads or 3D scaffolds, only the 
exposed surface is affected. The unexposed side of any micro-beads and the 
internal parts of a scaffold remains unaffected.  
This technique primarily depends on the type of plasma used, the 
temperature/charge and exposure time, and the properties of the polymer, each of 
which can be strictly controlled. The possible scales of the patterning created using 
this technique will depend on the used equipment and, to a lesser extent, on the 
chosen material. Nonetheless, patterning of >1 µm have been created before on 
Titanium wafers172. 
The analysis of the surface after exposure to the plasma jet will typically involve 
optical, fluorescent, electron or atomic force microscopy, depending on the scale of 
the created patterns and the desired information. 
Plasma surface modification is scalable to a certain limit; this process is dependent 
on the controlled exposure of the construct to the plasma jet(s) and any surfaces to 
be modified will consequently have a maximum size. This technique has already 
been analysed for use in multiple biomedical applications such as surface 
sterilization and biocompatibility enhancement, and proper use should not result in 
any clinical risks90. 
1.5.4.5. Condensation-controlled patterning (Breath Figures) 
Using water condensation to create ordered patterns, also called the ‘breath figures’ 
method, is a promising technique that relies on maintaining a high degree of control 
over the size and shape of liquid droplets at a specific temperature, humidity and 
chemical environment. The breath figures technique has some similarities to the 
phase separation method described above, but alters the final structure of the 
polymer with condensed liquid droplets in a regular pattern. These droplets force the 
solid phase of a polymer/volatile solvent mixture into a specific shape during solvent 
evaporation211, creating more controlled pores than the semi-random effect seen in 
normal phase separation. 
1.5.4.5.1. Application 
A layer made of a blend of one or more polymers and a volatile solvent is used to 
form the scaffold material. An air flow with specified flow and (high) humidity is 
directed onto the surface of the polymer blend at a specific angle, resulting in 
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condensation of the water in the air due to temperature changes as it hits the cooler 
polymers. With the right environmental parameters, condensation setup212 and 
polymer blend properties103,213, droplets formed on the surface will form a 
honeycomb-shaped pattern. During this process, the solvent containing the 
polymer(s) will evaporate, causing phase separation of the polymer blend to occur. 
The solidifying polymer is shaped into the final construct pattern by the water 
droplets. Once the solvent has evaporated completely, the water droplets may be 
removed with various drying methods, and the resulting polymer surface will remain, 
containing the required pore pattern. 
This process is most commonly used to create a 2D patterned surface, although a 
3D scaffold can also be constructed using the breath figures method. Production of a 
3D scaffold requires that water droplets sink into the polymer blend to provide 
additional space for new droplets to form212. Therefore, the environmental 
parameters and the properties of the polymer blend must adhere to more strict 
requirements. The breath figures approach is not applicable to creating patterned 
surfaces of micro-beads, as one of the requirements for this method is the presence 
of a flat polymer solution surface. 
However, despite this process’ limitations, it can provide excellent control over pore 
size (typically creating pores of 0.25-25 µm), shape and pattern, depending on the 
specifics of the technique that is used. It is also possible to add functional groups to 
the surface of the polymer material, both evenly distributed or with local variations 
depending on the polymer blend properties182,212.  
The breath figures approach is also relatively scalable; the process primarily requires 
a well-controlled air flow and solvent evaporation at each point of the polymer 
solution. The creation of large surfaces may yield variations in the surface topology 
from spot to spot if control of the process environment is insufficient. Also, the 
creation of large 3D structures may be difficult since larger polymer layers may 
restrict the evaporation of the solvent. There may therefore be a limit to the number 
of stacked layers that can be created using this method. The breath figures approach 
does not cause any clinical risks not covered by the used materials, provided any 
potentially dangerous solvent is thoroughly removed from the final product. 
The breath figures approach requires does not require a lot of specialized equipment, 
but effectively combining the necessary components (air flow, temperature, etc.) may 
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present some challenges. Likewise, while the principles of the process are quite 
simple, the large number of controllable parameters may require significant testing to 
find the optimal settings for a specific project. 
1.5.4.6. Mould-based patterning 
The last major patterning process is to create patterned surfaces using a previously-
created pattern as a mould. Depending on the method used to create the solid 
material intended for cell culture, as well as said material’s properties, directly 
creating the material in the final, intended shape may be an option. This process is 
the most straight-forward out of all patterning methods, but requires that a suitable 
pattern can be created out of a solid or semi-solid material prior to solidification of 
the final material. 
1.5.4.6.1. Application 
The critical step in using a mould-based patterning process is the creation of a 
suitable pattern prior to deposition of the material to be patterned. Moulds can be 
used to create numerous different patterns, depending on the original mould shape, 
but include convex and concave shapes based on particles, or straight shapes such 
as pillars and grooves based on photolithography214–216. 
However, for this project both a high regularity of the pattern and a low requirement 
for advanced equipment and training is a priority. As such, a promising option is the 
use of particle-based moulds. A regular honeycomb-style pattern will automatically 
form when a supply of spherical particles is allowed to settle under gravity, making 
particle-based moulds a potentially highly reliable and easy to implement process for 
this project. 
Most commonly, these types of pattern are created by the addition of a suitable 
amount of microparticles, such as paraffin154,217, sugar218, silica219 or polymers such 
as polystyrene220, to a liquid solution before solidification. Once the liquid solution is 
solidified using methods such as UV-induced polymerization, cooling, or similar 
processes, the spheres are removed by heating, the use of solvents or other 
techniques. The resulting material then contains pores formed by the space that was 
originally occupied by the beads. 
This process creates a 3D scaffold by default, the number of pore layers is directly 
dependent on the amount of particles used and the volume of the final construct; a 
small volume of beads can theoretically create a patterned 2D surface instead of a 
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3D scaffold. Creating a 3D scaffold requires that the microspheres can be dissolved 
inside the material without damaging the surrounding material, and a minimum 
porosity/microparticle connectivity may be required. If particles embedded within the 
material can’t be removed, the process effectively creates a 2D pattern instead. 
The amount of control that can be applied to mould-based techniques is directly 
dependent on how precise the shape and size of the mould particles can be 
controlled, and therefore depends primarily on the chosen mould material and 
preparation technique. 
Microsphere-based moulds will create pores that are entirely dependent on the size 
of the microspheres, with potential sizes in the order of millimetre to sub-
micrometre154,214,218–220. 
The use of microsphere-based moulds is very scalable; the only requirement is that 
both the beads and polymer solution can completely fill the desired volume. Flaws in 
the volume filling such as air bubbles will result in structural irregularities in the final 
construct. A particular risk is the potential for toxic materials to remain in the final 
product; to ensure safety of the patient it may be necessary to use non-toxic 
materials during one or more steps of the process. 
Using microsphere moulds is a relatively simple technique, but different amounts of 
laboratory or chemistry experience may be required to reliably create patterns or 
microspheres of the correct shape and size. 
1.5.4.7. Summary of structuring technique options 
Various different techniques may be used for patterning materials prior to cell culture, 
from semi-random structures based on spontaneous material changes to directly 
crafted shapes. However, most high-precision patterning methods require substantial 
investments in advanced equipment and appropriate infrastructure, making them 
impractical for use in this project. 
Since this project is meant as a proof-of-concept and more complex surface designs 
are unlikely to add relevant information, this project will only employ simple but 
accurately created patterns. Initially, this project will focus on using microparticle-
based moulds to create suitable patterns, with phase separation and additive 
manufacturing as potential replacements depending on initial results. 
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1.6. Summary of selected options for initial experiments 
A large number of different options exist for the experiments planned during later 
parts of this project. It is not possible to choose all parameters definitively at this 
early stage; only initial selections are made. 
For experimental work, this project will initially focus on the use of Mesenchymal 
Stem Cells, induced into chondrogenesis by exposure to TGF-β1. Cell culture 
environments will consist of Poly (Ethylene Glycol) based materials with covalently 
bound proteins (either directly bound growth factors or Biotin/Streptavidin for non-
covalent binding). Surface patterning will be created using moulds based on dry 
microparticles of uniform size. 
Depending on the results of this project, recommendations for randomized surfaces 
may also be included. This project may also proceed to multiple growth factors for 
immobilization, dependent on the final selections of material type, cell lineage and 
differentiation target, and other relevant considerations such as results of early 
experimental work.  
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          Chapter 2: Creation of micro-scale patterns on cell culture surfaces  
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2.1. Introduction 
This project seeks to investigate the interaction between surface topology and 
growth factor presentation. One requirement of this project is to reliably create well-
defined micro-scale patterning on the cell culture surfaces. 
Due to the numerous possible interaction mechanisms between cells and surfaces 
and the potential for properties to be beneficial or detrimental depending on feature 
size, it is necessary to select the desired feature sizes carefully221. 
In this project, the main focus is on the interplay between surface geometry and the 
effectiveness of biologically active proteins immobilized on these surfaces. Ideally, 
the chosen method will allow for the creation of feature sizes around the size of the 
cells cultured on the surface, as these scales will likely show good variation between 
small and large feature sizes. Scales at cell size or above will primarily influence the 
curvature of the cell membrane and may have effects linked to macro-scale cell 
morphology and the cytoskeletal system. Conversely, scales at or below cell size are 
more likely to show possible effects due to direct distortion of the cell membrane and 
mechanical influences on membrane-bound proteins such as integrins222. 
While nanoscale features have been shown to influence cellular behaviour89,223,224, 
these scales will not be investigated during this project. 
Various different types of patterning are possible, depending on the type of 
technique used to create or modify the desired cell culture surfaces. Most common 
processes, such as electrospinning or phase separation, result in random surface 
topologies with only limited control over the surface features185,191,202,225. Top-down 
techniques such as masked UV polymerization and etching techniques can allow for 
a higher degree of control over the created geometry, but these are typically used to 
create pillars, pits or grooves and provide limited means for curved or 3D features 
172,215,216,224,226. 
Other research focuses on increasing the roughness or porosity of created surfaces 
without creating a specific pattern, either by modifying existing surface roughness or 
by creating a surface out of individual grains of material, most commonly ceramics or 
metals, of the desired size(s) that are then fused together186,188,222,227,228. Combining 
polymers with embedded fragments provides an additional option for creating more 
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complex materials and surfaces188,229. However, while these methods allow for a 
more easy creation of surfaces with varying feature sizes or gradients, the random 
nature of the process means that ordered patterns are typically not possible. The 
choice of method is especially important considering that varying levels of 
randomness in the pattern orientation may themselves have an impact on cellular 
behaviour17,223. 
Because this project focuses primarily on the interaction between surface features 
and immobilized proteins, introducing additional effects due to randomness of the 
pattern is not a priority. All processes are developed with the goal of creating 
patterns with uniformly ordered structures, with no random elements other than 
unavoidable defects. 
In summary, creating highly variable or advanced surfaces is both unnecessary and 
counterproductive; methods that require complex processes or equipment will cost 
additional time to develop and use, but they are unlikely to offer any additional 
insights and may even interfere with the project’s main focus. 
Instead, a simple method that provides the necessary patterning in a reliable way 
would be more suitable, both to avoid extensive troubleshooting and to reduce the 
number of variables that may influence the experimental results. 
A comparatively uncommon method for creating patterned surfaces is to use three 
dimensional moulds to directly shape the surface186,214. 
While this type of process does not allow for easy modifications to change feature 
shapes, using moulds to create the necessary patterns is expected to be the most 
time-efficient way to achieve the necessary progress for the project. 
This part of the project focuses on the creation of these surfaces, based on using 
polystyrene microspheres of varying sizes to create a mould, which is then used to 
mass-produce suitable cell culture surfaces similar to work done by other 
groups154,217–219. Findings of the experiments detailed below will be used to optimize 
the process and the quality of the surface patterns used during the later stages of the 
project. 
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2.2. Aim and goals: 
This part of the project will aim to create mass-producible patterned surfaces in three 
polymer types. To achieve this, the following aspects are focused on: 
- The development of a repeatable method for creating micrometre-scale 
patterning on surfaces made from Poly (Ethylene Glycol), Polystyrene and 
Polycaprolactone 
- The analysis of pattern quality and defects due to the process steps as well as 
environmental factors 
- Modifications to environmental parameters during creation and replication of 
patterned surfaces 
- Mass-production of patterns for use in cell culture experiments in 96- and 24- 
well plates 
2.3. Materials and methods: 
2.3.1. Materials 
Polystyrene microparticles were acquired from 
Phosphorex Inc. USA. Mold Star 15 Slow 
silicone was acquired from Bentley Advanced 
Materials, UK. All other materials are acquired 
from Sigma-Aldrich Company Ltd, UK. 
2.3.2. Creation of initial surface 
patterning 
Based on literature reviewed during chapter 1, 
the method investigated for the creation of micro-
scale patterns is the use of positive and negative 
microparticle-based moulds to imprint the pattern 
into materials suitable for cell culturing. 
The primary pattern is created from plain 
polystyrene microparticles embedded in a 
mixture of a commercially available silicone, and 
 
 
 
 
 
 
   
Figure 3: Schematic representation of 
the pattern creation and copying 
process. The polystyrene 
microparticles (blue) are mixed into 
uncured silicone (green) in a glass petri 
dish. The silicone is then cured and 
used to create a polystyrene negative 
mould (blue) and this mould is used to 
create multiple PEGDA cell culture 
surface material (red). 
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transferred to other materials after creation as shown schematically in Figure 3. The 
initial process development will only be applied to microparticles with a mean 
diameter of 50 µm. 
5 mg of microspheres is mixed with silicone at approximately 3:1 to 4:1 volume ratio 
to ensure packing of the microspheres. While some defects in the pattern are to be 
expected, sufficient microparticles need to be packed together to ensure a cut 
through the material will expose the microparticles along the entire revealed surface 
within the cut, requiring the total amount of silicone in this mixture to be minimized.  
The initial process is tested using solid polystyrene microspheres with a 50 µm 
diameter. 0.5g of the selected microspheres is mixed with silicone at a 4:1 volume. 
The resulting mixture is spread into a glass petri dish with a surface area of approx. 
9cm2, creating a layer with a final thickness of approx. 2.75 mm. Only a limited area 
is used to create the initial patterned surface to ensure homogeneity of the 
microparticle layer, enable the use of different pattern sizes in a single wells plate, 
and reduce the use of high-value resources. 
The silicone mixture is allowed to cure for 2 hours, after which an additional 2 g of 
uncured silicone mix is added to improve structural resilience and ease-of-use of the 
material through the creation of a thicker ‘top’ layer over the microparticles. This 
added volume is not mixed with the existing microparticle-silicone mixture to ensure 
all the microparticles are present at the bottom layer of the material. After addition of 
the extra silicone, the entire mixture is allowed to cure overnight. 
Once the microparticle-silicone composite is finished, the pattern within the material 
must be exposed. Two options are used to access the microparticle volume. The first 
method is by cutting through the mixed volume to expose the microparticles using a 
standard scalpel at room temperature. In the second method, a glass shard 
microtome is used to cut through the material following cooling to sub-zero 
temperatures by pressurized carbon-dioxide. These options are used to determine if 
the elastic nature of the silicone might prevent a good cut through the material, and if 
freezing the mixture can allow for a more precise cut. 
Once the initial cut is created, the surface is washed with Acetone to dissolve any 
remaining polystyrene microparticles and fragments. This will remove the original 
microparticles while retaining the pattern created in the silicone, allowing for 
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evaluation of the surfaces prior to further experiments to transfer the created 
patterns. 
 
Samples processed using the room-temperature scalpel process, are analysed at 
four stages to determine the influence of the Acetone on the silicone matrix. The 
material is imaged before and after exposure to Acetone without first exposing the 
microparticles to determine macro-scale degradation, warping, or other forms of 
damage. The creation of the pattern was investigated by imaging the surface after 
making a cut but before exposure to Acetone (surface including microparticles) and 
after exposure to Acetone (silicone surface only). 
2.3.2.1. Results 
A micro-scale pattern was successfully created using the polystyrene microparticles 
and silicone mixture. The microparticles embedded in the silicone are packed into an 
orderly structure due to gravity, with silicone located throughout the gaps between 
the particles. This creates a functional micrometre-scale pattern at any plane inside 
of the material as seen in Figures 4a, 4b, 5c and 5d. However, some limitations of 
this process were identified. 
First, it is necessary to create a horizontal cut through the created material to expose 
the microparticles. The chosen surface area (approx. 9 cm2) proved too large to 
effectively process in this manner. To create suitable surfaces for analysis, the 
original surface was cut into smaller fragments to ease manual handling and 
processing before the microspheres were exposed. Consequently, all images are 
created from the same initial microparticle-silicone sample. 
Using a carbon-dioxide cooled glass shard microtome, the composite material 
created from the silicone and microparticles showed that while the pattern was 
present, significant defects were present in the material. The most likely explanations 
are that the cooling of the material damages the microparticles or silicone, or that the 
brittleness of the cooled silicone causes the force applied during the cutting process 
to damage the material. 
Microscopy images of the material after the cooled cut can be seen in Figure 4.  
By comparison, creating a cut with a (disposable) scalpel at room temperature on a 
pattern created using identical methods proved more effective. Microscopy images at 
58 
 
each step of the analysis process for the silicone-microparticle material following a 
room temperature cut are shown in Figure 5. 
  
Figure 4: Microscopy images of the mixed silicone + polystyrene microparticle material after cutting with 
a cooled glass microtome blade and soaking the material in Acetone. The original microparticles 
(diameter of the particles is 50 µm) are visible as small white spheres, while defects in the composite 
show as large, white clumps of material such as in the center of image A. Gaps in the micro-scale pattern 
are visible as the larger, dark areas in the center-left area of image A and the lower right area of image B. 
Image A and B represent different locations on a single sample. 
  
  
Figure 5: Microscopy images of the surface of the mixed silicone + polystyrene microparticle material. 
Images show the surface without modifications (A), after treatment with Acetone (B), after creating a cut 
through the material (C) and after creating a cut and treatment with Acetone (D). The scale bar in all 
images is 200 µm; microparticle diameter is 50 µm. Figures A, B, C, and D all represent the same sample 
at different stages of processing, but locations cannot be guaranteed to be the same. 
A        B 
A      B 
C      D 
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2.3.3. Surface area and microparticle volume reduction 
The current method for the creation of microscale patterns in silicone provides 
accurate patterns, as seen in Figures 5C and 5D. However, the total volume of 
microparticles used to create these patterns is comparatively large: only the particles 
located at the plane exposed using the cut actually contribute to the final pattern. 
To improve the process and increase the number of surfaces that can be created 
using each batch of microparticles, a new method was tested. # 
The process for creating patterned surfaces as described previously is repeated, 
with the modification that the microparticles are used without first mixing them with 
silicone. 
Dry 50 µm diameter microparticles are spread over a square 4 mm2 surface in a 
custom-made glass and silicone mould, to a thickness of approx. 2mm. Uncured 
silicone is prepared as before, and is carefully poured onto the microparticles without 
mixing the components together. The silicone is allowed to flow into the microparticle 
layer under the influence of gravity, after which the mixture is allowed to cure 
overnight. 
After curing, the solid silicone material is removed and the created surface is 
analysed using microscopy without creating a cut as was necessary in the previous 
method. 
2.3.3.1. Results 
Using the modified procedure, a patterned silicone surface was successfully created. 
However, inspection using microscopy showed that the created pattern was 
noticeably lower quality than those produced using the previous method. Significant 
defects in both the size and shape of the individual features are present in the newly 
created pattern, as can be seen in Figure 6. 
The most likely cause of these defects is air trapped within the system, which cannot 
escape once the silicone fully covers the surface. At this point the silicone does not 
fully cover the microparticles and as such the features in the created pattern are not 
an exact match to shapes of the original microparticles. Therefore, later experiments 
will continue to mix microparticles into silicone before curing.  
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Figure 6: Microscopy images of the silicone pattern showing overall structure (A) and details at higher 
magnification (B). Both images are the same sample surface, initially created using unmixed 
microparticles covered with silicone. Both scale bars are 200 µm. 
2.3.4. Solvent- and oven-based pattern transfer process development 
The currently developed method allows for the creation of silicone surfaces with 
micrometre-scale patterning. To create more robust, multiple-use patterns, the 
created silicone patterns need to be transferred to a different material to avoid 
degradation and potential release of the polystyrene microparticles embedded within 
the material. 
Therefore, various methods are investigated for transferring the pattern, into solid 
polystyrene (using solvent and oven-based methods), or into silicone. 
For the solvent-based polystyrene method, polystyrene pellets are dissolved in 
acetone at 0.25 g/mL in a ducted fume hood, to a total volume of 10 mL (2.5 g 
polystyrene). The mixture is poured onto the previously created silicone pattern, and 
additional Acetone is manually added to the material every 5 minutes for a total of 1 
hour to keep the polystyrene fully dissolved until any remaining air bubbles are 
eliminated from the acetone-surface interface. Once the mixture is allowed to fully 
cover the pattern without leaving any air bubbles, the acetone present in the solution 
is left to evaporate over 3-7 days. After solidifying, the polystyrene is collected and 
evaluated using optical microscopy. 
For the oven-based polystyrene method, the patterned surface is covered with 
polystyrene pellets and heated to 200 degrees Celsius in an oven. Temperature is 
maintained for 15 minutes, allowing the polystyrene to melt and flow into the features 
of the pattern. 
A        B 
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Once the polystyrene has fully melted and covered the silicone, the material is 
removed from the oven and allowed to cool. The silicone and polystyrene are gently 
separated to avoid damage to the pattern, and the polystyrene is imaged using 
optical microscopy. 
For the silicone-to-silicone method, the piece of silicone containing the original 
pattern is coated in uncured silicone mix which is allowed to cure overnight. After 
curing, a small incision is made at the interface between the two silicone pieces to 
facilitate separation, after which the two silicone segments are gently pulled apart to 
reveal the new pattern. The new pattern is analysed using optical microscopy. 
2.3.4.1. Results 
The solvent-based process for transferring the created patterns to solid polystyrene 
was not successful. While the surface of the polystyrene solidified as expected, a 
significant amount of acetone remained within the deeper parts of the material. As a 
consequence, the evaporation of this Acetone caused a very porous structure in the 
material. Acetone in the deeper layers of the material (approx. 5mm and deeper) did 
not evaporate even after 7 days, preventing the polystyrene from fully solidifying.  
The poor material properties of the created material made analysis highly unreliable, 
but microscopy analysis of the material was performed on a sample that was 
recovered intact from the procedure. This sample indicated a pattern was 
successfully created. See Figure 7 for an example. However, the sample surface 
was significantly deformed from the expected semi-flat surface that was expected. 
Based on the fact that a number of the polystyrene microspheres were still present 
during this process, it is assumed that the pattern found in this sample is a result of 
these particles being preserved when exposed to Acetone rather than the creation of 
a single, solid pattern. 
The deformation and poor properties of the material makes the created patterns 
unsuitable for use in later stages of the project regardless of the quality of the 
patterning that is created. With the additional risk of the pores created by the 
Acetone interfering with the created patterns, this method will not be used for later 
work.  
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Figure 7: examples of patterning created in polystyrene using the Acetone-based method with 50 µm 
diameter microparticles. All images are taken from different locations of a single sample pattern. While 
some patterning is clearly visible, the surface of the material no longer has an even surface with features, 
as indicated by the large areas of the image that are out of focus, especially in images A and B. All scale 
bars are 200 µm. 
The original pattern created using the polystyrene 
microparticles was successfully copied into a polystyrene 
mould using the oven-based method. Some defects in the 
polystyrene pattern are still present. Visual inspection of the 
polystyrene mould indicated a large number of air bubbles 
within the polystyrene. An example of the silicone-polystyrene 
setup, including air bubbles after use of the oven, is shown in 
Figure 8. 
It is thought the presence of air between the silicone pattern 
and the polystyrene pellets causes air bubbles to be trapped 
between the two materials. These bubbles prevent molten 
polystyrene from occupying this space, resulting in flat area 
defects in the copied pattern.  To improve the quality of the 
process, these air bubbles will need to be removed. 
Microscopy images of polystyrene with a copied pattern, 
including defects, are shown in Figure 9. 
    
Figure 9: patterned polystyrene following the oven-based pattern transfer method. Some defects 
are present (including smooth, un-patterned areas and clumps of trapped particles such as on the right 
side of image A and the centre of image B, but at substantially reduced level compared to earlier silicone 
methods. The scale bar is 200 µm, original microparticle diameter is 50 µm. Images A, B and C are 
different locations on a single sample pattern. 
Figure 8: patterned 
silicone (green) with 
polystyrene (transparent) 
before (A) and after (B) the 
oven-based melting 
process. The glass petri 
dish has a diameter of 
3cm. 
A     B      C 
A 
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The original silicone and microparticle pattern was successfully copied into a second 
piece of silicone to form a negative of the original pattern. However, large defects in 
the copied pattern are visible. While the two silicone pieces can be separated 
successfully after curing, the two pieces still stick to each other with sufficient 
strength to cause damage to the pattern. 
The copied pattern is considered too damaged for use in later stages of the project, 
and no direct silicone to silicone pattern transfers will be used. However, alternate 
materials and techniques may still be considered for the transfer of the created 
patterns.  
Microscopy images of the pattern transferred into silicone are shown in Figure 10. 
   
Figure 10: Microscopy images of the patterns copied from silicone to silicone. The copied pattern is 
clearly visible alongside defects. Dark gaps such as those in the lower right corner of image A and the 
centre of image B indicate the presence of holes, likely caused by air bubbles. Smooth areas such as the 
centre right of image C show a lack of patterning where the new silicone was not in contact with the 
existing pattern. All images are taken at different locations of a single sample pattern. The scale bar is 
200 µm; original microparticle diameter is 50 µm. 
2.3.5. Application of vacuum during oven-based pattern transfer 
Further improvements to the patterning and transfer process allow for the creation of 
larger numbers of patterned polystyrene surfaces, however defects due to trapped 
air remain a problem. To prevent formation of air bubbles between the silicone and 
polystyrene, a vacuum oven (Technico TEC-240-010S) is used to remove all air from 
the system before the polystyrene is heated. The microparticles themselves are not 
removed prior to this process, both to prevent any defects due to traces of solvent 
remaining at the pattern interface, and because any particles present at the surface 
will melt and fuse with the added polystyrene. 
 
The oven-based process used to transfer the pattern into polystyrene is repeated, 
with the change that the entire setup is placed under vacuum (<100 mBar remaining 
pressure). The vacuum oven heats the polystyrene to 200 degrees Celsius for 15 
A     B      C  
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minutes (two hours total time including warm-up) to ensure the polystyrene becomes 
sufficiently liquid to flow into the silicone pattern. 
The process is applied to microparticles with a diameter of 50 µm as before, as well 
as microparticles with a diameter of 20 µm to gain further insight into potential risks 
of defects due to smaller feature sizes, such as the polystyrene not properly filling 
the smaller patterns. 
Because the polystyrene flows over the silicone surface, even upwards against 
gravity, the resulting pattern consists of a very thin layer of polystyrene. To create a 
thicker polystyrene construct without introducing defects in the pattern, this method 
is combined with heating in a standard furnace to add additional bulk to the 
polystyrene layer. This way, the pattern retains the intended quality from using the 
vacuum oven, while also having the resilience of the original oven-based method. 
The created pattern is moved from the vacuum oven straight into a furnace 
(Carbolite BWF 1100 Muffle Furnace). Additional polystyrene is added to provide 
sufficient material, and the entire setup is heated to 200 degrees Celsius for 15 
minutes. 
After cooling the material the polystyrene and silicone segments are separated. The 
original silicone piece can be re-used to create additional polystyrene moulds, while 
the new patterned polystyrene is used for the future steps in the process. A 
schematic overview of the process is shown in Figure 11.  
 
Figure 11: Schematic representation of the single oven process with surface defects (A), the vacuum-
based process without surface defects but with possible air bubbles in the bulk of the material (B), and 
an example of the polystyrene pattern prior to the second stage of the process (C). 
2.3.5.1. Results 
The initial microparticle-silicone surface was successfully copied to a solid 
polystyrene material using both 50 and 20 µm patterns. The copied pattern showed 
   A      B        C 
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no indications of damage, defects or air bubbles like the surfaces created without 
applying a vacuum. Microscopy images of the copied 50 µm pattern after the 
vacuum process are shown in Figure 12. The created patterns following polystyrene 
reinforcement in the furnace and removal from the silicone are shown in Figure 13. 
Some fragments of the microparticle-silicone mixture remained on the pattern 
surface, indicating potential degradation of the original pattern and release of the 
embedded microparticles. For future experiments, all surfaces will be washed before 
further use.  
    
Figure 12: Microscopy images of the polystyrene pattern. Note that these images are taken while the 
polystyrene and the silicone materials are still in contact; the polystyrene itself is transparent. Images A, 
B and C are taken from three different samples. The scale bar in all images is 200 µm.  
    
    
Figure 13: microscopy images of patterned polystyrene created from microparticles with a diameter of 20 
µm (A, B, C) and 50 µm (D, E, F) using the vacuum oven. The white fragments are remnants of the 
microparticle-silicone material. Images A, B, C, D, E and F are taken from six different samples. All scale 
bars are 100 µm. 
2.3.6. Creation of Poly (ethylene glycol) diacrylate pattern surfaces 
Patterned polystyrene and silicone surface moulds have been successfully created 
using the vacuum oven-based method. As the planned cell culture experiments will 
take place on Poly (ethylene glycol) for its expected advantages in terms of non-
A     B     C 
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specific adsorption and protein immobilization, the next step is to transfer these 
created patterns from the existing moulds onto new Poly (ethylene glycol) patterns. 
New patterned polystyrene surfaces are created with feature sizes of 1 µm, similar to 
the process described previously. Previously created polystyrene surfaces with 
features of 20 and 50 µm are re-used for this experiment. Surfaces are thoroughly 
cleaned using water and industrial methylated spirit to remove any remaining 
microparticle-silicone fragments that may be present on the surface. 
A 75% w/w Poly Ethylene Glycol (PEGDA) in water mixture is prepared, with 2% w/v 
DMPA as a photo-initiator. The mixture is vortexed for 10 seconds and the DMPA is 
allowed to fully dissolve into the water and PEGDA at room temperature for 30 
minutes while protected from external light. 
The prepared PEGDA mixture is slowly poured onto the created patterned 
polystyrene surfaces. The polystyrene moulds are gently tapped to remove any air 
bubbles that may be trapped at the interface between the polystyrene and PEGDA. 
The PEGDA is only added to a layer of at most 2 mm thick to ensure sufficient UV 
penetration through the material. 
Once the PEGDA is in place, the liquid is polymerized to create the new pattern. A 
portable UV lamp was used to expose the liquid to 254 mm UV light for 60 minutes, 
at an exposure level of approx. 100 µW/cm2. 
Upon polymerization, the material will form a cell culture surface composed primarily 
of crosslinked Poly Ethylene Glycol, with a minor portion of the material composed of 
the crosslinking chains. When the PEGDA is fully polymerized, the new pattern is 
removed from the polystyrene mould and analysed using optical microscopy. 
2.3.6.1. Results 
Patterned surfaces were successfully created using Poly (ethylene glycol) diacrylate. 
50 µm and 20 µm scale patterns were created without major defects in the pattern, 
as shown in Figure 14. However, 20 µm patterns do show an increased chance for 
pattern defects as shown in Figure 15. 
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Figure 14: patterned surfaces created in PEGDA after UV exposure. Original microparticle size is 50 µm. 
The upper left of image A shows how part of the material has broken off, images B and C show the 
created pattern at higher magnification. All images show the same sample pattern. All scale bars are 100 
µm. 
   
Figure 15: patterned surfaces created in PEGDA after UV exposure. Original microparticle size is 20 µm. 
Image A shows a high-quality pattern. Image B shows the same pattern, zoomed in to show a handful of 
defects in more detail. Image C shows a low-quality pattern (too smooth surface without suitable 
patterning). Images A, B and C are taken from three different patterns. All scale bars are 100 µm. 
1 µm scale patterns were created but a significant fraction of the resulting surface 
showed defects in the pattern as see in Figure 16. Furthermore, the size of the 
features in the 1 µm pattern is too small to effectively analyse with the current optical 
microscopy method. The 1 µm patterns will be considered unsuitable until further 
analysis is performed.  
 
   
Figure 16: patterned surfaces created in PEGDA after UV exposure. Original microparticle size is 1 µm. 
Some patterning can be seen such as in the lower centre of image B, but large areas of smooth, un-
patterned material are also present, visible as smooth, white-ish areas such as in the top right of image B. 
Images A, B and C are taken from three different patterns. All scale bars are 100 µm. 
Finally, separating the PEGDA surface from the polystyrene mould proved difficult 
due to the design of the polystyrene mould. At times, the PEGDA would fracture, 
resulting in the loss of part of the pattern as can be seen in Figure 14a. This is 
A     B      C 
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primarily due to the rigid nature of the polystyrene mould used to create the new 
pattern, but improvements to the mould may be possible. 
2.3.7. Contamination risk evaluation in the polymerization process 
The current method for creating patterned PEGDA based surfaces shows good 
results in terms of creating the necessary pattern structure. However, the final goal 
of this process is to create a patterned surface suitable for cell culture. Infections and 
contaminations are a significant risk to cell culture experiments. The UV light used to 
polymerize the PEGDA monomers has a sterilizing effect230, but it is not known if this 
effect sufficiently reduces contamination risk for is sufficient to fully sterilize the used 
materials. 
Therefore, it is necessary to determine if additional sterilization is required before the 
current PEGDA surfaces are suitable for cell culture. A new series of PEGDA based 
surfaces is created using the same materials and process explained previously, with 
some modifications to the process. 
First, a 75% w/w PEGDA in water solution is prepared and left opened. An air flow is 
directed straight onto the solution using the fume hood, such that the solution is 
exposed to significantly more micro-organisms than during normal processing in the 
lab. 
After one hour, 2% w/v DMPA is mixed into the solution, and the unpolymerized 
mixture is added to a number of wells in a 96 well plate. 
The well plate with the unpolymerized mixture is placed in a sterilized air-tight 
container. The container is sealed, and the PEGDA is polymerized by UV exposure 
as described before. 
All further handling of the PEG-based surfaces takes place in Biological Safety 
Cabinets that have been sterilized before use, and the outside of the (sealed) 
container is sterilized when it is placed in the cabinet. 
Nutrient broth is prepared and sterilized by autoclaving. The sterile broth is added to 
the PEG-based surfaces as a culture media, and the 96 well plate is placed in an 
incubator for one week such that any potential infections have the opportunity to 
grow. 
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After one week, the well plate is removed from the incubator and inspected for any 
signs of infection using microscopy. 
2.3.7.1. Results 
No signs of infection were found in the well plates after incubation. Microscopy 
inspection showed no microbial or fungal contaminations. Furthermore, neither the 
culture media nor the PEG-based surfaces themselves showed any sign of 
contamination in the form of colour changes or smell. 
For future experiments, it is assumed that the UV exposure combined with the 
processing methods currently used sufficiently reduces the contamination risks of the 
cell culture environment for further experiments. No modifications to the current 
methods are implemented, but all experiments will be regularly checked to identify 
any contamination. If contamination is found in future experiments, additional steps 
may be taken to further reduce risk of contamination. 
2.3.8. Increased pattern size and reduction of process risks through 
the use of silicone moulds 
During the previous experiments a number of potential problems were identified. It 
was determined that while the patterning created on PEG surfaces can be 
successfully transferred, collecting the rigid patterns from the moulds posed 
significant problems. 
The current shape of the polystyrene mould requires a significant amount of force to 
release the PEG surface. Combined with the lack of easy leverage points, applying 
this force may cause damage to the PEG surface. 
To solve this problem and make the process more suitable for use with other 
material types, a new system of mould designs is implemented to improve the ease 
of access to the patterned materials, be they Polystyrene, PEG, or other materials 
used during later parts of the project. 
As a proof-of-concept, a negative mould of a 96 well late is made by filling the well 
plate with play-dough clay (Hasbro, Inc.), using plastic film to allow for easier 
extraction from the well plate. The clay form is taken out of the well plate, and 
silicone mix (similar to that used for creating the initial micro-scale patterns) is 
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poured onto the material. After curing overnight, the newly created silicone form can 
substitute for the rigid materials used before. An overview of the new design is given 
in Figure 17. 
The vacuum-based process to copy the micro-
scale patterns from silicone into polystyrene is 
performed as described previously, but the 
process is adjusted to include the new ‘plate’. 
The microparticle-silicone patterns are placed 
inside the plate and polystyrene pellets are 
added into the well. The entire setup is placed in 
a vacuum oven and heated to 200 degrees 
Celsius while under a <100 mBar vacuum, for 
two hours total.  
Once the initial vacuum-sealed layer is 
completed, additional polystyrene is added under 
atmospheric conditions to improve the strength 
of the created polystyrene pattern. Additional 
polystyrene pellets are added to the mould, and 
the material is treated at 200 degrees Celsius for 
15 minutes before being allowed to cool to room 
temperature over approximately an hour. 
After cooling, removal of the polystyrene patterns is tested and created patterns are 
analysed with optical microscopy to identify any damage to the material. 
In addition to the above changes, alternate surface sizes are also tested. The initial 
process was developed using 96-well plates in part to reduce to total amount of 
materials needed to create a specific pattern. While this is suitable for testing the 
process and evaluating the created patterns, it does cause problems with later parts 
of the project where cell culture is included. As the total surface area of each 
material is a major limitation for the amount of cells that can be cultured in a single 
sample, the use of larger surface areas for each pattern will allow for larger numbers 
of cells. This in turn will increase the cells in each sample that are available for 
analysis, allowing for more robust measurements. 
 
    
 
Figure 17: schematic representation 
of the use of the new silicone moulds 
compared to previous solid 
polystyrene moulds (A) and example 
of a created silicone mould (B) 
 
A 
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Therefore, the patterning and vacuum-based transfer processes are tested for use 
with 24-well plates in order to identify any new problems related to the larger surface 
area, using the same steps described previously. 
2.3.8.1. Results 
Patterned Polystyrene moulds were successfully created with the new silicone based 
process, with reduced risk of damage due to manual handling. No adverse 
consequences were encountered during any part of the process while creating 15 
new patterns in 96-well plate size, as shown in Figure 18. 
   
Figure 18: Created 96-well plate sized polystyrene patterns prior to separation (A), after separation (B) 
and a created 50 µm pattern under microscope view (C). The scale bar in image C is 100 µm. 
Larger-scale patterns were successfully created in a 24-well 
plate. However, the pattern itself was not created as a flat 
surface. Due to the larger surface area, the additional silicone 
poured into the well caused defects by displacing the already 
present microparticle-silicone mixture as shown in Figure 19. 
To prevent uneven spacing of the microparticles, an excess 
of particles is mixed into the initial amount of silicone, leaving 
a small amount of air trapped both within the mixture and 
between the mixture and the bottom of the well plate. 
Pouring additional silicone into a 96-well plate does not leave 
enough room for major horizontal flow patterns in the silicone, 
but such flow is possible in a 24-well plate. 
Consequently, as shown in Figure 20, a pattern is created on an uneven surface, 
with the final geometry depending on the displacement of the original microparticle-
silicone mixture and the movement of air pockets trapped within the well. Although 
the surface itself does show a high-quality pattern, the larger scale geometry means 
Figure 19: schematic 
representation of 
defects caused by 
displacement of 
particles during the 
addition of uncured 
silicone. 
A     B      C 
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these surfaces are not suitable for the planned work beyond proof of concept 
experiments. 
   
Figure 20: Examples of a larger created silicone pattern with defect caused by an air bubble (A), a larger 
silicone pattern created using microparticle-silicone mix to form the surface (B), and a created (uneven) 
50 µm pattern under microscope view (C), showing a functional but uneven pattern. The scale bar in 
image C is 100 µm. 
Further experiments using this procedure will require modifications to ensure an 
even distribution of the microparticle-silicone mixture. Manually packing the pattern 
before the addition of more silicone, increasing the total volume of the mixture used 
to create each pattern, adding the extra silicone in such a way to minimize disruption 
of the existing layers, applying a vacuum to prevent air bubble formation, and 
allowing the silicone to partially cure before adding more uncured silicone will all be 
considered. 
However, the current (flawed) patterns created during these experiments will still be 
used to further develop later stages in the project, as this geometry may be useful in 
identifying process flaws that might not be readily visible on an evenly distributed 
pattern. 
2.3.9. Adaptation of the patterning process for Polycaprolactone and 
Polystyrene cell culture surfaces 
Based on further experiments with Poly (Ethylene Glycol) based materials (see 
chapter 3 for details), the use of alternative materials for the patterned cell culture 
surfaces was required. 
Reviewing published literature for alternatives, (see chapter 1 for details), 
Polycaprolactone and Polystyrene were selected as additional cell culture materials 
to explore further options suitable for the project. The process used for creating the 
Polystyrene patterns described previously in section 2.3.5 can be used to create the 
required patterned cell culture surfaces without the need for extensive modifications. 
A     B      C 
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However, additional experiments are needed to test the use of Polycaprolactone, 
with the process adapted from that used to treat Polystyrene. 
Polycaprolactone (Mn ≈ 80,000, Sigma Aldrich) pellets are added to a previously 
created 50 µm pattern silicone mould. The material is heated to 150°C under 
vacuum for a total of 1.5 hours, in order to ensure the polymer fully melts into the 
desired pattern. The material is allowed to cool down without removal from the 
silicone mould before further analysis, to prevent warping of the created pattern. 
To maintain sterility of the material for use in cell culture experiments, the created 
patterns are sterilized using an autoclave, and evaluated after sterilization for pattern 
integrity and the presence of defects. 
2.3.9.1. Results 
Polycaprolactone was successfully patterned using the vacuum oven process initially 
developed for use with Polystyrene and silicone. Example patterns are shown in 
Figure 21.  
Some potential problems were identified 
during the process. Unlike Polystyrene, the 
Polycaprolactone used during the process 
remains highly viscous at higher 
temperatures. Consequently, 
Polycaprolactone has a substantially 
greater risk of entrapped air bubbles and 
defects. As such, the main priority during 
the process is to ensure the entire surface 
is covered by Polycaprolactone before the 
atmospheric pressure is restored. This way, 
the air pressure on the material will make it 
deform onto the pattern without air being 
allowed in between the surfaces to cause 
defects. Once there is an air-tight seal 
between the Polycaprolactone and silicone, 
additional Polycaprolactone can be added 
 
 
Figure 21: examples of 50 µm 
Polycaprolactone patterns created under 
vacuum from a patterned silicone mould. 
Image A and B are taken from two different 
samples. 
 
A 
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to the well (optionally by applying additional pressure) without risking the pattern. 
Autoclaving Polycaprolactone proved effective, without damaging the created 
patterns. However, because the autoclave temperature is higher than the melting 
temperature of the material, the surfaces can only be sterilized this way before they 
are removed from the silicone pattern. Furthermore, care must be taken that water 
condensation can’t pool in any of the wells, since this may cause large-scale defects 
in the material. The materials must be covered, possibly with foil, to prevent water 
damage from pooling while still allowing the steam to reach the material. 
For future experiments, the material will be sterilized without the use of an autoclave, 
relying instead on the applied heat and vacuum in the vacuum oven. 
2.4. Discussion 
A method for the creation of Poly (Ethylene Glycol)-based surfaces with micrometre-
scale features from the initial PEGDA monomer solution was developed in this 
chapter. The process proved to be suitably robust, with patterning being created 
successfully even in sub-optimal conditions as seen in 2.3.6 and 2.3.8. The process 
itself is comparatively simple, allowing for straight-forward scale-up or modification to 
expand the process. 
Polystyrene microparticles were chosen for their robust characteristics and 
comparatively straight-forward processing. Using the same material for both the 
microparticles and the first copied pattern reduces the risks of contamination, and 
while Acetone proved unsuitable for use during these experiments, melting the 
Polystyrene allowed for effective pattern transfer without the need to remove 
exposed particles from the pattern surface. The use of other materials without major 
risk of contamination with Polystyrene becomes possible after at least one polymer 
surface has been created. 
The patterning created using the developed method is comparatively simple, a 
uniformly convex shape. While the creation of anisotropic features may be possible 
by applying strain onto the created patterns during transfer to a new material, this 
process is otherwise difficult to modify for different types of features. 
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Other research commonly employs more advanced features such as pillars or 
struts215,216, grooves224, or more angular pockets226. Complex interactions between 
the surface topology and cultured cells, such as combinations of smaller and large 
feature sizes, surface gradients or localized depositions of growth factors on the 
surface are beyond the scope of this project. Instead, the currently developed 
technique is aimed at creating a robust proof-of-concept for enhancing the 
effectiveness of immobilized proteins, focusing on practical implementation over 
investigation of any underlying cellular processes. 
Currently, the largest risk during the patterning process is the creation of the initial 
pattern by embedding microparticles in silicone. All other surfaces can be mass-
produced by repeatedly copying the pattern, but the first pattern can only be created 
once.  
As a consequence, the steps in the process that rely on copying the existing patterns 
into solid silicone still have a small risk of introducing defects from an imperfect 
surface interface, trapped air bubbles, etc. This does not appear to be a major 
problem at this point in the project, but it may result in difficulties when smaller 
feature sizes are being created. For further experiments, adding the uncured silicone 
mixture in a vacuum may be considered. 
Finally, one of the main limitations of the developed process is the reliance on 
adherent cell culture. Current research increasingly focuses on 3D cell culture to 
create functionalized hydrogels and injectable scaffolds for therapies231,232, limiting 
the usefulness of this method for developing improvements to clinically relevant 
methods. However, there is also an increasing amount of research focusing on the 
use of suspended micro-carriers to combine the benefits of both adherent and 
suspension-based cell culture233. Any insights into surface topology gained from this 
work would be highly relevant to these types of processes, although some work may 
be necessary to translate the advantages (if any) of the experiments during this 
project to work with micro-carriers rather than surfaces. 
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         Chapter 3: Creation of microparticles for protein immobilization analysis 
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3.1. Introduction 
This project focuses on the interaction between patterned cell culture surfaces and 
immobilized growth factors on these surfaces in the context of cell culture. 
Consequently, quantifying the amount of growth factors available to the cells in 
culture would improve the understanding of the cellular environment and enable a 
more precise evaluation of protein influence. To this end, it is necessary to determine 
how much growth factor is present at the surface and how much is immobilized at 
inaccessible sites deeper in the material. In this chapter a method for quantifying 
protein immobilization onto Poly (Ethylene Glycol) microparticles using Flow 
Cytometry was tested. 
Analysing solid surfaces with immobilized proteins presents a number of unique 
challenges; depending on surface characteristics conventional cell culture 
techniques and analysis methods may not be suitable. Many analysis techniques 
used in biomedical research rely on measuring protein solutions (such as infrared or 
UV spectroscopy, NMR or mass spectrometry) or liquid suspensions (such as flow 
cytometry or bead-based ELISA assays), none of which can be used on solid 
surfaces. Certain optical techniques can be modified to operate on surface-bound 
proteins instead of solutions, though such methods do require precise controls to 
allow for qualitative instead of quantitative measurements234. The quality of 
references and controls has a profound impact on such methods235, and more 
accurate methods may require equipment or chemicals which were deemed too 
difficult to acquire for this project. For example, proteins labelled with radioactive 
isotopes could be used for direct quantitative measurement while avoiding 
measurement errors due to covalently bound fluorescent markers, but would also 
require a substantial investment in training and use of equipment not currently 
available to Loughborough University’s Center For Biological Engineering, as well as 
the purchase of these radiological compounds. 
A further issue is that published research into immobilized proteins frequently only 
describes the total concentration of protein in the material20,95,97,133,236–238. While such 
descriptions can be useful for cell culture experiments where the cells are dispersed 
throughout the material (such as in cell-seeded hydrogels), without looking at the 
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actual proteins that are made available on the surface of the material this information 
is difficult to use for comparisons to surface-bound proteins. 
Rather than focusing on these methods and attempt to measure protein absorption 
on the surfaces directly, a different approach was chosen.  
This chapter focuses on the creation and analysis of microparticles meant as an 
alternative for the cell culture surfaces to be used during later parts of the project.  
These particles can be analysed with Flow Cytometry such that, when combined with 
the particles’ size and chemical properties, they should give a quantifiable measure 
of proteins per surface area on the created surface. A particle-based approach is 
expected to be more robust than surface-based measurements such as ELISA due 
to eliminating biases caused by complex surface topology; surfaces with complex 
topology and/or unknown roughness will require an estimation of total surface area 
compared to sample surface area that is not currently available for this project’s 
samples. 
Various methods for the creation of polymer microparticles are available, with the 
most common methods using microfluidics- or emulsion-based processes123,239–243. 
Membrane emulsification was chosen as the process for this project, due to the 
greater ease at setting up the necessary equipment compared to microfluidics. In 
addition, membrane emulsification is already under investigation at Loughborough 
University, allowing for easier access to instruction and experimental support. 
Most literature focusing on functionalized particles aims at creating such particles as 
temporary carriers, meant to release bound proteins through diffusion or degradation 
of the polymer111,244–247. Other work focuses on creating porous microparticles for 
various purposes including internalized and surface cell culture239,248–251. 
Consequently, little data is available on using microparticles for permanent protein 
immobilization. While this lack of comparisons may make interpretation more difficult, 
this is not considered sufficiently problematic to require a different method and may 
indeed be a net positive due to the novelty value. 
In this chapter, the initial process for creating microparticles in the 5-20 µm range is 
developed and adjusted for use with UV-based polymerization. Following the 
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successful creation of microparticles, particles that include covalently bound 
Streptavidin are created. 
Following the creation of the Streptavidin-functionalized particles, biotinylated 
markers are used to enable the analysis of these particles using Flow Cytometry, 
and the process is evaluated and adjusted to deal with possible measurement errors 
including non-specific binding and temperature dependence. 
3.2. Aim and goals 
The aim of this part of the project is to measure the amount of protein that can be 
(specifically) bound onto a cell culture surface of a defined total area. In order to 
acquire this information through the analysis of functionalized microparticles, the 
following goals need to be reached: 
- Create Poly (Ethylene Glycol)-based microparticles of approximately 5-10 µm 
diameter 
- Functionalize these particles with Streptavidin to ensure these particles have 
similar potential for immobilizing relevant proteins as the planned cell culture 
surfaces 
- Determine specific (Biotin-Streptavidin) binding and non-specific (adsorption 
onto the particle’s polymer surface) binding of biotinylated proteins 
- Determine the ratio of accessible Streptavidin at the surface of the created 
particles compared to the total Streptavidin content 
3.3. Materials and methods 
3.3.1. Materials 
Poly (ethylene glycol) diacrylate, 2,2-Dimethoxy-2-phenylacetophenone and Acrylate 
Poly(Ethylene Glycol)-N-hydroxysuccinimide were purchased from JenKem 
Technologies Co. Ltd. 
Biocytin-Alexa Fluor 488 and biotin-R-Phycoerythrin) were purchased from Thermo 
Fischer Scientific, Inc. 
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Quantum Alexa Fluor 488 MESF and Quantum R-Phycoerythrin MESF were 
purchased from Stratetch Scientific, Ltd. 
Water-soluble blue food dye was purchased from TESCO Stores, Ltd. 
Unless otherwise specified, all other chemicals were purchased from Sigma Aldrich, 
Inc. 
The membrane emulsification setup used is a Micropore Technologies Ltd (Derbys, 
UK) Dispersion Cell, equipped with a hydrophobic steel disk membrane with 
uniformly placed 10 µm diameter pores. Exact shear stress and rpm values were not 
calculated for these experiments, but are estimated at 200-600 rpm252,253. 
The UV lamp used is a 3UV (8W) handheld lamp from UPV, LLC. The lamp is set to 
the 254nm wavelength for all experiments. 
3.3.2. Preparation of membrane emulsification materials 
To create the necessary micrometre-scale particles, a membrane emulsification 
system is used, wherein a dispersed phase is added dropwise into a continuous 
phase while stirred to ensure a uniform size distribution of droplets. Before 
experimental work with membrane emulsification begins, the necessary components 
of the mixture must be prepared.  
The continuous phase is kerosene with 2% v/v Span80 as a surfactant. The 
continuous phase is created prior to experiments by adding the Span80 into 
kerosene and stirring the mixture overnight to ensure the two components are fully 
mixed prior to the start of the membrane emulsification process. 
For the initial emulsion tests, the dispersed phase is a solution of 75% w/w PEGDA 
in water. The dispersed phase is created prior to experiments by adding 25% w/w 
water to PEGDA, vortexing the mixture for 1 minute and leaving the mixture for at 
least one hour before the start of the membrane emulsification process to eliminate 
any air bubbles. 
For membrane emulsification experiments with the purpose of creating solid 
microparticles, 2% w/w DMPA is added to the mixture described for the emulsion 
tests while keeping all other parameters equal. 
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For membrane emulsification experiments with the purpose of creating dyed 
microparticles, an additional 10% v/v food dye is added to the mixture described 
above for the solid microparticles while keeping all other parameters equal. 
The membrane emulsification setup used is a Micropore Technologies Ltd (Derbys, 
UK) Dispersion Cell, equipped with a hydrophobic steel disk membrane with 
uniformly placed 10 µm diameter pores. Exact shear stress and rpm values were not 
calculated for these experiments. 
3.3.3. Initial membrane emulsification testing 
For the planned flow cytometry measurements, the size of the created particles will 
have a direct impact on the total amount of fluorophores each particle can bind. 
Consequently, while the exact diameter of the particles does not have a specific 
requirement, a narrow size distribution will allow for substantially easier analysis than 
a broad distribution.  
Before creating actual microparticles, the process is performed with varying flow 
rates and stirring speeds to test the reliability of the 
process for creating emulsions with sufficiently 
narrow size distributions. Unlike later steps in the 
process, the emulsions are not yet polymerized 
using UV. 
Emulsions and microparticles are created using a 
membrane emulsification setup. Briefly, membrane 
emulsification works by mixing two immiscible liquids 
together as one of the liquids is pumped through a 
porous membrane. The shear from mixing that is 
applied to the liquid as it flows through the 
membrane causes the liquid stream to disperse into 
an emulsion with a homogeneous size distribution. 
Initial parameters for the membrane emulsification 
are a flow rate of 0.5, and 1 ml/min for the dispersed 
phase, and a stirring voltage of 12 and 16 Volt. Tests 
with 5 and 15 mL/min flow rate were also attempted, 
 
Figure 22: Schematic representation 
of a membrane emulsification 
system. The continuous phase 
(kerosine and Span80) is in blue, the 
dispersed phase (water, PEGDA and 
optionally DMPA and coloring) is in 
red. 
 ↑ ↑ 
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but these rates resulted in emulsions with droplet size and density that were judged 
to be too large to be suitable for further work, and these test runs were therefore not 
analysed in more detail. 
The created emulsions are analysed with a top-down microscope immediately after 
the end of the emulsification process (< 30s) to provide additional information on the 
size distribution of the droplets. Exact values for stirring rate, shear stress on 
droplets or fluid transfer per membrane pore are not calculated as these details are 
not considered necessary for the project. 
Finally, an emulsion created with 16V stirring and 1 ml/min flow rate was analysed at 
multiple time points to determine the change in droplet size over time. A top-down 
microscope is used to image the created emulsion immediately after the end of the 
membrane emulsification process (< 30s), as well as at 2 and 5 minutes afterwards, 
to compare droplet size, distribution, and coalescence. 
A schematic representation of the membrane emulsification process is shown in 
Figure 22. The membrane emulsification cell and processing equipment are shown 
in Figure 23.  
 
Figure 23: The experimental setup used during the membrane emulsification experiments. Parts are as 
follows: 1) Power source for the stirrer 2) Pump for the dispersed phase 3) syringe and tubing containing 
the dispersed phase prior to the experiment 4) stirrer part of the membrane emulsification cell 5) 
container and membrane of the membrane emulsification cell 6) stir plate used to stir emulsions during 
UV exposure 7) UV lamp used to polymerize created emulsions 
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3.3.3.1. Results 
The initial membrane emulsification process successfully created an emulsion of 
PEGDA and water in kerosene. Varying the flow rate with a constant stirring speed 
resulted in significantly differing emulsions with droplet sizes of approx. 10-200 µm 
were created, as can be seen in Figure 24.  
  
  
Figure 24: PEGDA+water emulsions in kerosene, created with settings: 12V stirring voltage and 0.5 
ml/min flow speed (A), 12V stirring voltage and 1 ml/min flow speed (B), 16V stirring voltage and 0.5 
ml/min flow speed (C) and 16V stirring voltage and 1 ml/min flow speed (D). 
The emulsion that is measured at multiple time points indicates that coalescence 
occurs over several minutes once the emulsion is allowed to settle. Coalescence 
does occur during the membrane emulsification process itself, but only in limited 
amounts as a large number of small droplets were still present in the emulsion right 
after the process is completed. The coalescence of the emulsion droplets can be 
seen in Figure 25. Settling time was minimized for all later experiments to reduce the 
effects of coalescence. 
A         B  
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Based on these measurements, it is determined that the membrane emulsification 
setup can be used to create an emulsion with a sufficiently reliable size distribution 
for use in later experiments. 
3.3.4. Microparticle fabrication with UV polymerization 
Initial tests of the membrane 
emulsification method allowed for the 
creation of a water-in-oil emulsion. 
However, to create usable 
microparticles, the created droplets 
must be polymerized while in the 
emulsion to create solid particles. 
For this experiment, the droplet 
emulsion is created using the same 
methods described above. In addition 
to the membrane emulsification setup, 
a UV lamp is used to expose the 
created emulsions and polymerize the 
dispersed phase.  
Initial membrane emulsification 
settings are a flow rate of 0.5 ml/min 
and a stirring voltage of 16V. After 
emulsification, the emulsion is 
transferred to a 250 mL beaker and 
exposed to UV light (254nm 
wavelength at approx. 100-500 
uW/cm2, depending on depth) for 15 
minutes to polymerize the resulting 
particles.  
Initial analysis of the created 
microparticles is performed by 
imaging the particles under an optical 
 Figure 25: Change of PEGDA+water emulsions in 
kerosene over time, created with 16V stirring speed 
and 1ml/min flow rate. All images are the same 
sample, taken at 0 minutes (A), 2 minutes (B) and 5 
minutes after stirring ends (C). 
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microscope. 
3.3.4.1. Results 
The initial process for creating microparticles proved to be unreliable. While some 
particles were created, coalescence still occurred in the final suspension. As can be 
seen in Figure 26, the size distribution of the droplets in the processed emulsion 
quickly shifts to fewer, larger droplets. This indicates a portion of the dispersed 
phase has not fully polymerized and is still present as a liquid. Furthermore, during 
the experimental analysis it was observed that the suspension of water/PEGDA in 
kerosene will eventually settle into a two-phase system, with the kerosene on top 
and an unpolymerised mixture of water and PEGDA underneath. Polymerized 
microparticles are present in both the kerosene and the unpolymerized mixture, but 
the majority of the particles are found in the heavier PEGDA/water mixture as can be 
seen in Figure 27.  
All created microparticles are diluted in water for storage, to ensure no further 
crosslinking of the particles and suspension liquid will occur. 
   
Figure 26: Microscopy images of a single created microparticle suspension immediately after UV 
exposure (A) and five minutes after the UV exposure (B). 
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Figure 27: Microscopy images of the kerosene part of a settled emulsion (A) and PEGDA+water part of a 
settled emulsion (B). Microparticles are present in both liquids, visible as small dots, though the majority 
is found in the un-polymerized PEGDA+water solution. Both images are collected from the same initial 
sample suspension. 
3.3.5. Prevention of coalescence prior to particle polymerization 
In the previously developed method, microparticles were successfully created but the 
total yield of the process was still lower than anticipated due to unpolymerized 
PEGDA remaining after UV exposure. 
To counter the very limited polymerization of the particles, the process is modified to 
increase the total UV exposure of the emulsion before coalescence occurs.  
The UV exposure time is increased to 45 minutes. To prevent coalescence from 
occurring during the UV exposure of the emulsion, the liquid is slowly stirred using a 
magnetic stirring rod and plate (approx. 3Hz stirring speed) to prevent settling and 
phase separation of the two emulsion mixtures.  
Furthermore, to improve the UV exposure of the particles without increasing the 
necessary time of exposure, the total surface area of the emulsions exposed to UV 
light was increased. Rather than using the previous method, the emulsion created 
with membrane emulsification is transferred into three beakers (approx. 5cm 
diameter each), or into a larger dish (approx. 20 cm diameter) prior to UV exposure 
to provide a larger total surface area. 
All other aspects of the membrane emulsification process were kept identical to 
those of the previous experiment. 
Finally, to determine the stability of the created particles, a small amount of Acetone 
is added to the suspension to briefly disrupt the surface tensions of any droplets or 
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semi-liquid particles. During this process, the suspensions are visualized under a 
microscope to spot any coalescence or disruption of the particles or droplets. 
3.3.5.1. Results 
Using the two different setups for increased surface area resulted in few differences 
between the two situations as can be seen in Figures 28 and 29. Both situations 
show a majority of small, non-coalesced particles with a smaller number of larger 
coalesced droplets. 
  
Figure 28: Microscopy images of emulsions created using multiple smaller beakers and stirring during 45 
minutes of UV exposure, before (A) and after adding Acetone (B). Both images are the same sample. 
  
Figure 29: Microscopy images of emulsions created using the larger dish and stirring during 45 minutes 
of UV exposure, before (A) and after adding Acetone (B) to disrupt droplet formation. Both images are the 
same sample. 
Stability of the particles in both situations was analysed by addition of Acetone to the 
particle suspension. The addition of Acetone caused significant disruption of the 
particles depending on the used method of UV exposure. Particles created by using 
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the smaller beakers showed some coalescence but mostly remained stable during 
the Acetone exposure. 
Particles created using the larger dish instead showed significant coalescence with a 
large portion of the particles merging into larger droplets. Therefore, particles created 
using this method were not fully solidified despite the larger surface area that was 
exposed to UV at any given time. 
Due to the poor polymerization of the particles using the larger dish approach, it is 
assumed that only part of the larger dish was sufficiently exposed to UV light to 
cause polymerization of the droplets. This, combined with less effective stirring, then 
leads to only part of the emulsion being polymerized and other parts remaining liquid. 
In later experiments, only the smaller beakers are used during UV exposure to 
ensure stirring allows even exposure and polymerization of droplets. 
The increased UV exposure did not result in complete polymerization of all PEGDA 
in the dispersed phase. Like in the previous method, the suspension or emulsion will 
separate out into a two-phase system with both microparticles and unpolymerized 
PEGDA in the heavier second phase. However, particle production was improved 
and during the process, sufficient droplets are polymerized and turned into 
microparticles for future use. 
While the presence of unpolymerized PEGDA is not considered a major problem, 
further improvements to the process may be investigated to increase particle yield. 
3.3.6. Size analysis of created microparticles 
With the newly developed process, microparticles can be reliably produced with a 
narrow size distribution as determined by optical microscopy. The next step is 
analysis of the created particle suspensions for a quantified size distribution, using a 
Coulter LS130 particle sizer. 
The created microparticle suspensions are added dropwise to the measurement 
chamber with the dilution liquid, until the Coulter registers an obscuration value of 7-
13%. Once the obscuration has an acceptable value, the measurements are started. 
Each measurement lasts 60 seconds, with a wait time of 30 seconds between 
measurements. All measurements are performed in triplicate to reduce the influence 
of measurement errors and noise. 
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To prevent possible measurement errors caused by differing refraction index of the 
dilution liquid, the initial measurements use a 75% PEGDA in water mixture similar to 
the unpolymerized emulsion for the dilution liquid during the measurement. The 
refractive index of this mixture is determined to be 1.4452 using a Leica Abbe Mark II 
refractometer. 
Measurement data is graphed for further analysis using Matlab (The Mathworks, 
Inc.). 
3.3.6.1. Results 
The size distribution measurements showed a very large amount of noise. The 
obscuration values measured by the Coulter fluctuated wildly, and many 
measurements could not be completed due to extremely low obscuration values (1-
5%). 
It is now thought that the low contrast between the particles and the suspension 
liquid caused by the very similar materials (polymerized vs. unpolymerized PEGDA) 
prevents the Coulter from gaining correct data. As can be seen in Figure 30, there 
were little to no overlapping features between the measurements. 
Based on these results, it is assumed that any particle sizes measured in these 
experiments are noise from air bubbles.  
 
Figure 30: Measured size distributions of multiple samples (each sample measured in triplicate) using the 
first experimental procedure. The X-axis indicates the size of the particles (the axis is exponential from 0 
to 900 µm). The Y-axis shows the relative volume fraction of the particles at the indicated size range. 
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3.3.7. Contrast improvement for microparticle size analysis 
Due to the high similarity in contrast between the solid microparticles and the 
unpolymerized dilution liquid, additional contrast needs to be introduced to the 
suspension before accurate measurements of the size distribution can be taken. 
New particles are created using the previously described methods, but using a 
dispersed phase that contains an additional 10% blue food dye. 
The dilution liquid is the same as used previously; a 75% w/w PEGDA in water 
solution with no added dye. 
When the particle suspension is diluted during the preparation for the analysis, the 
liquid will become more transparent due to the dilution while the particles are less 
severely altered and will therefore contain a higher proportion of dye. 
All size measurements are performed using the following settings: 120 seconds for 
each measurement with all measurements performed in triplicate (tree different 
samples taken from each emulsion to be tested), with a target sample obscuration of 
7-13%. 
3.3.7.1. Results 
Using dyed microparticles, more accurate measurements of the particle size 
distribution were acquired. Size distributions for three separate samples are shown 
in Figures 31-33. Results are an excellent match, showing good consistency in the 
size distribution between samples. While some differences between these 
measurements are visible, in particular the more skewed size distribution in sample 1 
as compared to samples 2 and 3, this is not considered a major problem. 
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Figure 31: Size distribution of sample 1, using repeat measurements of a single sample volume. The X-
axis indicates the size of the particles (the axis is exponential from 0 to 900 µm) The Y-axis shows the 
relative volume fraction of the particles at the indicated size range. Some measurement errors from air 
bubbles are visible as extra peaks to the right of the main peak. 
 
Figure 32: Size distribution of sample 2, using repeat measurements of a single sample volume (different 
sample than shown in Figure 31). The X-axis indicates the size of the particles (the axis is exponential 
from 0 to 900 µm) The Y-axis shows the relative volume fraction of the particles at the indicated size 
range. 
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Figure 33: Size distribution of sample 3, using repeat measurements of a single sample volume (different 
sample than shown in Figures 31 and 32). The X-axis indicates the size of the particles (the axis is 
exponential from 0 to 900 µm) The Y-axis shows the relative volume fraction of the particles at the 
indicated size range. Some measurement noise is visible at very small sizes. 
3.3.8. Modified suspension liquid for microparticle size analysis 
Accurate size measurements for the created microparticles have been acquired. 
However, since the created microparticles are eventually expected to include 
immobilized proteins, including the food dye to improve contrast between the 
particles and the surrounding liquid is not a suitable modification to the process for 
later stages of the project. 
Instead, as a final modification to the process, the analysis of the particles is 
performed while using water instead of the un-polymerised 75% w/w PEGDA 
solution as a dilution liquid. 
For the analysis the refractive index is set to 1.3330, but some minor errors may be 
introduced by this change as the refractive index will no longer be exactly correct 
due to the small volume of unpolymerized PEGDA still present in the particle 
suspension. The measurements with the modified dilution liquid are compared to 
earlier measurements to determine if the dilution liquid causes unacceptable 
deviations in the particle size measurements. 
A new series of microparticles is created using the method described for the 
previous experiment, except no dye is added to the dispersed phase. 
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All size measurements are performed using the following settings: 180 seconds for 
each measurement with all measurements performed in triplicate, target sample 
obscuration of 7-13%. 
3.3.8.1. Results 
Diluting the particle suspensions in water did not introduce major errors in the 
measurements of the size distributions. As can be seen in Figures 34-36, each 
measurement has peaks at the same approximate location as were found in the 
previous experiments, though some additional peaks are also present due to air 
bubbles. 
One result visible in these experiments is that unlike the measurements using 75% 
PEGDA for dilution, these measurements indicate a second peak just to the right of 
the main peak, distorting the size distribution slightly (especially visible in Figures 35 
and 36). The location of this distortion at approx. twice the particle diameter of that of 
the main peak indicates the most likely cause is aggregation of two particles which 
are then measured as a single event. It is not known if this occurs only using the 
water-based dilution or if this also occurs in the 75% PEGDA-based dilution and this 
has not been found due to random chance. 
The particle size is not distributed in a Normal Distribution, as determined by the use 
of one-sample Kolmogorov-Smirnov tests on the acquired data. 
Based on both these results and the results of the previous experiments, the process 
is considered ready to create microparticles with an approximate diameter of 4-5 µm 
for the purpose of functionalization and protein immobilization analysis. 
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Figure 34: Size distribution of sample 1, using measurements of a multiple sample volumes. The X-axis 
indicates the size of the particles (the axis is exponential from 0 to 900 µm). The Y-axis shows the relative 
volume fraction of the particles at the indicated size range. In this sample, large measurement errors due 
to air bubbles can be seen in the peaks on the right. 
 
Figure 35: Size distribution of sample 2, using measurements of multiple sample volumes. The X-axis 
indicates the size of the particles (the axis is exponential from 0 to 900 µm). The Y-axis shows the relative 
volume fraction of the particles at the indicated size range. Measurement errors due to particle 
aggregation can be seen as a distortion on the right side of the left peaks, and errors due to air bubbles 
can be seen in the peaks on the right. 
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Figure 36: Size distribution of sample 3, using measurements of multiple sample volumes. The X-axis 
indicates the size of the particles (the axis is exponential from 0 to 900 µm). The Y-axis shows the relative 
volume fraction of the particles at the indicated size range. Like in sample 2, measurement errors due to 
particle aggregation can be seen as a distortion on the right side of the left peaks, and errors due to air 
bubbles can be seen in the peaks on the right. 
3.3.9. Component preparation and processing for functionalized 
particles 
Now that the process to create suitable microparticles is complete, the next step is to 
immobilize suitable proteins onto these particles for further analysis. In this section, 
particles are functionalized with Streptavidin so that biotinylated proteins can be 
immobilized onto the particle surfaces. 
Streptavidin is linked to Acrylate Poly(Ethylene Glycol)-N-Hydroxysuccinimide by 
mixing the components at a ratio of 1:35 (1 mg Streptavidin = 16.66 nmol, 3 mg 
Acrylate-PEG-NHS = 600 nmol), based on work by Hempel254 to ensure crosslinking 
of every Streptavidin molecule. The mixture is stirred overnight at 4-7°C.  
The continuous phase consists of kerosene with 2% Span80 as a surfactant. 
To create the dispersed phase, 75% w/w PEGDA in water with 2% w/w DMPA is 
used as the primary mixture. Depending on the required concentrations of proteins in 
the microparticles, varying amounts of the previously created Acrylate-PEG-
Streptavidin solution are added. The total water content is adjusted to compensate, 
ensuring that the final PEGDA concentration is maintained at 75% w/w. 
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Figure 37: Newly created 
microparticle suspension, 
with a visible separation 
into two phases. 
The highest Streptavidin concentrations used in the creation of the particles is 0.5 
mg/mL (8.33 nmol/ml), making the concentration in the actual particles an 
approximate 2.08 nmol/ml. Additional functionalized particles are created from a 
dilution series of the Streptavidin solution, to a concentration 2, 4, 8, 16, 32, 64, 128, 
256 or 512 times lower (down to ≈0.004 nmol/ml). Particles are labelled based on the 
concentration of Streptavidin, from ‘Type 1’ at the highest concentration to ‘Type 10’ 
with a 512 time dilution. ‘Type N’ particles are particles created without Streptavidin. 
Combined with the size measurements described earlier (approximate diameter of 
4µm, volume of 33.5 µm3), this means that theoretically the mean number of 
Streptavidin molecules per microparticle is 42,000 for the highest concentration. 
Only one concentration of particles is created at a time, varying concentrations are 
not mixed. 
Once the polymerization mixture is completed, the microparticle suspension is 
created the previously described process. The microparticle suspension is exposed 
to UV light (254 nm wavelength) at approx. 500-1000 uW/cm2 for 45 minutes to 
polymerize the resulting particles. The microparticle suspension is continually stirred 
at low intensity to ensure even exposure of the particles. 
After completion of the process, the particle suspensions are stored at 4-7°C until 
further processing and analysis.  
3.3.9.1. Results 
Particle suspensions were successfully created for particles of 
Type 1-3, Type 5-10 and Type N, with estimated Streptavidin 
content ranging from ≈0.004 nmol/ml to ≈ 2.08 nmol/ml. No 
particles were created of Type 4 (≈ 0.26 nmol/ml Streptavidin), 
as the Streptavidin solution for this sample was lost during 
processing due to accidental spilling. Recreating the 
necessary starting solution of Streptavidin was not feasible in a 
practical timeframe, and further experiments were performed 
without this sample type. 
One notable difference between the newly created 
suspensions and those seen in previous experiments was that 
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the newly created microparticles will separate into two different phases after removal 
of the remaining kerosene. The majority of the suspension remains the mostly-clear 
liquid seen in previous experiments, but a noticeable portion forms into an opaque, 
foam-like phase that floats on top of the remaining liquid. See Figure 37 for an 
example. 
Both liquid phases are analysed using microscopy to verify the presence of 
microparticles. As shown in Figure 38, the created microparticles are predominantly 
found in the clear phase similar to previous experiments. Because the opaque phase 
still contains substantial amounts of kerosene and surfactant (seen in the form of 
larger bubbles) in addition to the microparticle suspension, all samples are taken 
exclusively from the clear phases in all following experiments. 
  
Figure 38: microscopy images of the opaque (A) and clear (B) phase of a single suspension. 
Microparticles are present in both liquids, seen as the small spheres (<10µm). 
All samples created this two-phase system, though the exact cause remains 
unknown. One possible cause for the formation of the opaque foam is that the 
Streptavidin in the solution is adsorbed on the water/oil interface. This behaviour is a 
known risk especially for amphiphilic proteins, though information for Streptavidin 
specifically could not be found. Because of the complexity of the adsorption process, 
which may depend on the liquids used, the surfactant, protein rigidity and folding 
mechanisms255–259, it is unlikely the problem can be solved in a sufficiently timely 
manner. Furthermore, the differences between Streptavidin-containing and 
Streptavidin-free particles in later measurements indicate that at least a portion of 
the Streptaivin does remain in the created particles. While foam presents a potential 
problem with loss of protein during the emulsification step and further improvements 
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would be necessary for a more efficient process, the created particles are expected 
to be sufficient for the current proof-of-concept plans. Therefore, the foam and 
possible methods of preventing its formation were not analysed further. 
3.3.10. Common aspects of flow cytometry measurements 
Following the creation of particles with varying concentrations of Streptavidin, these 
particles need to be analysed. Although various details of the following experiments 
vary from experiment to experiment, in particular sample preparation, most of the 
flow cytometry measurements itself were performed using the same standard 
methodology. This process is described here, with any further deviations from this 
method noted in the sections for each individual experiment as appropriate. 
Prepared samples are stored protected from direct light by covering the samples with 
foil. All samples are analysed using a FACSCanto II Flow Cytometer (BD 
Biosciences). Prior to loading in the flow cytometer, each sample is briefly vortexed 
to ensure an even suspension of particles and to prevent clumping and subsequent 
measurement of doublets. Each sample is measured at the slowest acquisition 
speed to preserve sample volumes in case repeat measurements are necessary, 
and event limits are set at 100,000 events total. A 200V forward scatter (FSC-A) 
threshold is implemented to exclude debris. 
Once measurements are complete, measurement data is exported and further 
analysed using FlowJo (FlowJo LLC, USA). 
In FlowJo, particle populations are selected based on the forward and side scatter 
values for events (FSC-A and SSC-A) so that deformed particles can be excluded. 
All measurements showed a clear particle population with a tight distribution of 
forward and side scatter values, with a lengthy trail of poorer quality particles with 
high side scatter values (indicating non-spherical shape). Typical scatter data for the 
total measurement and the selected particle population are shown Figure 39.  
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Figure 39: examples of forward scatter (FSC-A, horizontal axis) and side scatter (SSC-A, vertical axis) 
plots of the all measured events (A) and the selected particle population (B) of a typical flow cytometry 
measurement using created PEG microparticles. 
New population selections are defined for each experiment to account for modified 
measurement parameters and potential day-to-day differences, but within 
experiments identical population criteria are used for all measured samples. 
Following population selection, additional thresholds are applied to the fluorescence 
intensity (FITC-H and/or PE-H) to exclude non-fluorescent events caused by air 
bubbles as a consequence of the 
vortexing prior to the measurement, as 
shown in Figure 40. 
Once the particles are selected, the 
geometric mean of the fluorescence 
intensities of interest (FITC-H, PE-H or 
both) is calculated for the remaining 
population. 
The measured fluorescence values are 
then converted into estimates of the 
total number of fluorophores on each 
particle using the QuickCal calculation 
process provided by Bangs Laboratories, 
Figure 40: example of a typical 
fluorescence histogram after selection of 
the particle population. Note the peak at 
zero fluorescence caused by small 
numbers of bubbles remaining in the 
suspension following vortexing. 
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Inc. The QuickCal excel files are configured using measured fluorescence intensities 
of Quantum MESF particles analysed prior to the particle measurements (using 
identical flow cytometer settings). 
The calculated fluorescence or MESF values of the particles are then used for 
analysis as described in further detail for each experiment. 
3.3.11. Initial flow cytometry method testing 
The first flow cytometry experiment is intended to determine if the functionalized 
particles created with the membrane emulsification process can be analysed using 
the selected method. While samples are incubated with biotinylated fluorophores to 
create a fluorescent signal, the actual fluorescence results acquired from this 
experiment are of secondary concern. Instead, the main focus is detecting any major 
problems that need to be solved before the particles can be analysed during later 
experiments. In particular, particle counts, preparation requirements and 
measurement settings are investigated. 
Ten samples are created by incubating Type 1 particles (estimated 2.08 nmol/ml 
Streptavidin) in various concentrations of biocytin-Alexa Fluor 488 for two hours and 
fifteen minutes. Concentrations are based on the expected Streptavidin content of 
particles, calculated by assuming equally distributed Streptavidin throughout the 
entire PEG solution (during membrane emulsification) and solidified particles (during 
flow cytometry). 
Fluorophore is added to the particle suspension at a 32:1 molar concentration for the 
brightest staining, with particles using lower concentrations receiving 16:1, 8:1, 4:1, 
2:1, 1:1, 1:2, 1:4, 1:8 or 1:16 ratios of fluorophore to estimated Streptavidin content. 
As a control group, particles that have not been incubated with fluorophore are also 
analysed using the same measurement settings. 
Because the density of the microparticles is nearly equal to that of the suspension 
liquid, collection or concentration of the microparticles by centrifugation is not 
possible. No washing step is included in order to minimize the irreversible dilution of 
the particles prior to measurements. 
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The particles are analysed using a FacsCANTO II Flow Cytometer (BD Biosciences). 
Particles are diluted 1:40 in Phosphate Buffered Saline before the measurements. 
Signal thresholds for forward scatter, side scatter and FITC fluorescence are set at 
200V to eliminate signal noise caused by possible bubbles, (fluorescent) debris and 
other small-scale artefacts in the particle suspension. 
Fluorescence signals are quantified using Quantum Alexa Fluor 488 MESF 
reference particles using the QuickCal system provided by Bangs Laboratories, Inc. 
After measurements are completed, data is collected and analysed using FlowJo 
(Flowjo LLC) and Microsoft Excel. Unless specified otherwise, all shown 
fluorescence values are the calculated geometric mean of each measurement. 
First, sample measurements are gated to select only the desired (spherical) particles 
by eliminating particles with higher side scatter values, manually selected from the 
forward scatter-side scatter plot in FlowJo. All samples use identical population 
selections. 
The selected population is then analysed by comparing the fluorescence intensity, 
calculated as the geometric mean of the FITC signal in each sample population. 
Finally, measured fluorescence values are converted to absolute MESF values to 
estimate total fluorophores per particle, using the fluorescence values of the MESF 
reference particles in the QuickCal conversion method offered by Bangs 
Laboratories, Inc. 
3.3.11.1. Results 
Created particles were successfully analysed with the flow cytometry method 
described above.  
Measured data show a clear connection between the initial fluorophore concentration 
and the calculated fluorescence of the particles. A linear fit of: 𝐹𝐹𝑠𝑠 = 27.99𝑅𝑅𝑠𝑠 +104.4 with Fs the fluorescence of the given sample and Rs the ratio of Fluorophore to 
Streptavidin of each sample, provides a fit of the results with an R-squared of 0.9022, 
with both measurements and model fit shown in Figure 41. 
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Figure 41: Fluorescence (MESF) values for the 
created dilution series and model fit Fs. Note the 
non-linearity of the X-axis. 
While this model provides a good fit, the 
found value of only 104.4 as the 
fluorescence due to specific binding 
indicates that a large portion of the 
Streptavidin did not bind fluorophores. 
Furthermore, no plateau was observed at 
higher ratios, indicating that even with a 32-
fold excess of fluorophore no saturation of 
the particles occurred and non-specific 
binding and adsorption can still increase. 
Comparison to the non-fluorescent 
control indicates that the particles do 
bind more fluorophores with Streptavidin present; however the comparatively similar 
levels of fluorescence mean that an accurate quantification of the total fluorescence 
per Streptavidin molecule is not possible without further investigation of the binding 
process. 
A potential explanation for this result is that the biocytin-Alexa Fluor 488 used during 
this experiment was not fully bound to the available Streptavidin. Streptavidin 
molecules on the surface will bind fluorophores first, and it is possible that the 
concentration gradient between the inside of the particles and the suspension liquid 
is insufficient to cause enough diffusion of the fluorophore into the particles. This 
effect will be especially pronounced for the lower concentrations due to the 
comparatively larger influence of non-specific binding. As such, determining the 
amount of non-specific binding is a priority for further experiments. 
3.3.12. Analysis of binding saturation during flow cytometry 
Initial testing of the flow cytometry method was promising, but results remained 
highly dependent on the concentration of fluorophores used during incubation. It is 
unclear if the used microparticles were fully functionalized during the previous 
experiment or if free Streptavidin remains, and how much non-specific binding takes 
place on the particles. To this end, additional experiments are run with increased 
ratios of biotinylated fluorophores to Streptavidin in order to determine non-specific 
binding and saturation. 
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Figure 42: Fluorescence values for the different 
particle types after incubation with the same 
fluorophore concentration. 
For this experiment, the fluorescent marking process described above is repeated 
with a biotinylated fluorophore concentration of 32:1 excess compared to the total 
Streptavidin content of Type 1 particles (estimated 2.08 nmol/ml Streptavidin). Only 
one type of fluorophore is used for any sample, fluorophores are not mixed. All other 
particle types are incubated using an identical fluorophore concentration, to eliminate 
differences due to varying non-specific binding. Samples are created for all particle 
types after incubating with the same concentration (64:1 excess for Type 2, 128:1 
excess for Type 3, etc.). All measurements are performed in triplicate. 
Further processing and analysis are otherwise identical to the previous experiment. 
Fluorescence signals are quantified using Quantum Alexa Fluor 488 MESF 
reference particles as described before. 
3.3.12.1. Results 
Particles of each type except Type 4 
were incubated with the same 
concentration of fluorophore to 
determine potential saturation of 
Streptavidin on particles. The 
resulting measurements indicate a 
nearly constant fluorescence between 
particles, as shown in Figure 42. 
Consequently, the fluorophore binding 
of each particle appears to be 
independent of the Streptavidin content on each particle type. Non-specific binding 
occurs at a sufficient level to eclipse the signal from any biotin-Streptavidin binding 
that occurs in the samples. For further experiments, work will focus on not just 
adding varying amounts of fluorophore to the particles of interest but also on 
removing non-specifically bound fluorophores after incubation. 
3.3.13. Analysis of non-specific binding during flow cytometry 
Previous experiments showed sufficiently great non-specific binding that estimation 
of the specific binding through the Biotin-Streptavidin link was impossible. Therefore, 
a different approach is tested for determining the non-specific binding onto the 
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microparticles. While the Streptavidin-biotin bond is difficult to break, non-specific 
binding is easily disrupted and will vary depending on the fluorophore concentration 
in the surrounding medium. By measuring a single sample of functionalized particles 
over an extended period of time after sudden dilution, additional insight may be 
gained into how the fluorophore binding changes for that sample. 
Biotinylated R-Phycoerythrin is used as an additional fluorophore and possible 
alternative for Alexa Fluor 488. The higher molecular weight of the chosen R-
Phycoerythrin fluorophore (≈240 kDa compared to the previously used Alexa Fluor’s 
≈1 kDa) may provide additional clues to potential binding issues involving steric 
hindrance of the Streptavidin in the particles. 
Type 1 particles (estimated 2.08 nmol/ml Streptavidin) and non-Streptavidin 
functionalized particles are incubated at room temperature with a 40:1 excess of 
either biotinylated Alexa Fluor 488 or biotinylated R-Phycoerythrin for one week prior 
to measurements. 
For the flow cytometry measurement, the final samples are created by diluting the 
existing microparticle suspension in Phosphate Buffered Saline at a ratio of 1:10, 
1:20, 1:40 and 1:80. Sample measurement takes place immediately after dilution 
(start within 1 minute). All samples are stored protected from light at 4-7°C, and 
measured again at 1, 2 and 3 hours after dilution. Final measurements are 
performed after 20 days to determine the equilibrium for the particle fluorescence.  
Thresholds for the Flow Cytometry are 200V for the forward scatter, side scatter, 
FITC and PE signals. Fluorescence signals are quantified using Quantum Alexa 
Fluor 488 MESF reference particles or Quantum R-Phycoerythrin MESF reference 
particles, as appropriate. 
3.3.13.1. Results 
The fluorescence of the measured particles shows a strong dependence on both the 
presence of Streptavidin on the particles and the dilution of the particles prior to 
measurements, as seen in Figure 43. For particles stained with biocytin-Alexa Fluor 
488, fluorescence intensity shows the expected progression with the Streptavidin 
containing particles having the highest fluorescence at the lowest dilution and signal 
strength dropping as dilutions are increased or Streptavidin is absent. 
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Particles stained with biotinylated R-Phycoerythrin show a different result however, 
with samples showing wildly varying fluorescence both between concentrations and 
over time. In particular, several of the samples show fluorescence intensities 
increasing over time, a change that should not occur as a consequence of the 
sample dilution prior to the first measurement. 
Consequently, the R-Phycoerythrin measurements indicate the presence of an 
unknown effect on the fluorescence that may depend on the molecular weight 
difference between Alexa Fluor 488 and R-Phycoerythrin.  
  
Figure 43: Fluorescence intensities 0, 1, 2, and 3 hours after 10-80x dilution for Alexa Fluor 488 (A), and 
R-Phycoerythrin samples (B). Streptavidin-containing particles are AF and RPE respectively; 
Streptavidin-free particles are AFN and RPN respectively. All measurements are performed as N=1. 
  
Figure 44: difference in fluorescence values between Streptavidin containing particles and Streptavidin-
free particles at 0, 1, 2 and 3 hours after 10-80x dilution for Alexa Fluor 488 (A) and R-Phycoerythrin (B).  
Streptavidin-containing particles are AF and RPE respectively; Streptavidin-free particles are AFN and 
RPN respectively. All measurements are performed as N=1. 
Differences between Streptavidin and non-Streptavidin particles approach 
equilibrium for Alexa Fluor F488, indicating a possible value for the specific binding 
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as seen in Figure 44. Assuming a 10 nm thick layer accessible to solution95, the 
expected volume of available binding sites on particles with a diameter of 4 µm is ≈ 
0.5 µm3. With a 2.08 nmol/mL Streptavidin concentration, this would result in 
approximately ≈ 626.5 total molecules available on the surface. 
In comparison, fluorescence values for Alexa Fluor 488 approach an average of 
approx. 1500 units of fluorophore per particle. Consequently, with these assumptions 
even a best-case scenario would indicate that more than half of the current signal is 
caused by non-specific binding. 
In published literature, Hern et al also noted that for their choice of peptide and 
spacer, only 10% of the available sites might be available to cells due to steric 
hindrance95. This provides further support for the difference seen between Alexa 
Fluor binding and R-Phycoerythrin binding, and suggests that the binding dynamics 
are sufficiently unfavourable that the fluorophores undergo only limited binding to the 
presented Streptavidin. Therefore, adjustments may be necessary to ensure 
sufficient binding of fluorophores. 
3.3.14. Analysis of time and temperature dependence of 
fluorophore binding 
The differences between the binding of Alexa Fluor 488 and R-Phycoerythrin found 
in the previous experiment suggest an effect due to differing molecular weights and 
steric hindrance. The most likely parameter to be influenced due to this difference is 
the binding speed and affinity of the two fluorophores. Based on this, it is thought the 
storage conditions for the fluorophore and particles may negatively impact the 
binding dynamics. If the fluorophore only partially binds to the particles, this will 
cause a reduction in the signal strength. 
A new experiment is run to compare how much influence storage conditions during 
incubation affect the fluorescence of the particles. Furthermore, additional time will 
be allowed for binding to occur, in order to acquire a stronger signal. 
Type 1 particles (0.433 nmol/ml Streptavidin following dilution) are compared with 
non-functionalized particles using two different storage temperatures. Biocytin-Alexa 
Fluor 488 or biotin-R-Phycoerythrin is added to the particles, with the total amount in 
both situations equal to that needed for a ratio of 10:1 fluorophore to Streptavidin for 
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the functionalized particles (4.33 nmol/ml). After addition of the relevant fluorophore, 
the mixtures are stored at different temperatures. One mixture of each type of 
fluorophore is stored at room temperature (20° C) and one mixture of each type of 
fluorophore is stored in the fridge (4-7° C) similar to previous experiments. 
Flow cytometry measurements are performed to determine the fluorescence of the 
particles after 1, 2, 3 or 4 days in storage. 
Before the first measurements on any specific day, samples are prepared for 
analysis as quickly as possible to minimize potential changes over time between 
sample preparation and measurement. All measurements begin within 1 minute after 
the initial sample preparation and removal from their storage temperature (for 
samples stored at low temperature). 
Samples are diluted in PBS immediately prior to the first measurement 
(measurement starts within one minute from mixing) at two concentrations: one set 
of samples is diluted 1:10, one set of samples is diluted 1:100. Each prepared 
sample is measured at 0, 1, 2 and 3 hours after initial preparation. Samples are 
stored at room temperature between measurements. 
Thresholds are used to prevent measuring possible bubbles, (fluorescent) debris and 
other small-scale artefacts in the particle suspension. Thresholds used are 200V for 
forward scatter and 200V side scatter minima. No thresholds are used for 
fluorescence. 
Voltages used are 10V for forward scatter, 250V for side scatter, 500V for FITC and 
500V for PE. Fluorescence signals are quantified using Quantum Alexa Fluor 488 
MESF reference particles and Quantum R-Phycoerythrin MESF reference particles. 
3.3.14.1. Results 
Particles were measured and analysed on four separate days, with four time points 
on each day and different storage conditions depending on the sample. 
Streptavidin-free particles that were stained with Alexa Fluor 488 and stored in the 
fridge could not be measured for day 4, and the sample for Streptavidin-free particles 
that were stained with Alexa Fluor 488 and stored at room temperature was lost 
during the measurement. These samples are not included in the analysis. 
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Alexa Fluor 488 did not show major differences between room temperature and 
fridge storage for any of the sample parameters. However, numerous samples show 
a drop in fluorescence over time after dilution. This may indicate that a significant 
portion of the measured fluorescence is caused by reversible (i.e. non-specific) 
binding of fluorophores. This is further supported by the higher fluorescence of the 
1:10 dilution samples compared to the 1:100 dilution samples. This difference, seen 
even on the earliest time points immediately after dilution, further indicates there are 
two different types of loosely-bound fluorophore: one that rapidly disperses into the 
surrounding liquid (causing the difference between 1:10 dilution and 1:100 dilution at 
time=0), and a further amount of fluorophores that slowly disperses into the liquid 
(causing the gradual drop of fluorescence over time seen in the measurements). See 
Figure 45 for examples. 
Possible explanations include varying binding mechanics for the fluorophores 
depending on presentation and steric hindrance, as well as fluorophores that may be 
bound deeper within the particles. However, the underlying mechanics are not 
investigated further. 
  
Figure 45: Fluorescence intensities 0, 1, 2, and 3 hours after 10-100x dilution for Alexa Fluor 488 stained 
particles stored cold (A), and at room temperature (B) on day 3. Streptavidin-containing particles are AF, 
Streptavidin-free particles are AFN. All measurements are performed as N=1. 
R-Phycoerythrin stained particles showed similar behaviour for most sample types, 
but with a smaller difference between Streptavidin-containing and Streptavidin-free 
particles, as shown in Figure 46. R-Phycoerythrin stained particles, measured after 
1:100 dilution in PBS, showed much higher fluorescence values than expected, but 
this is thought to be an outlier. Possible causes are accidental incubation with a 
higher-than-intended concentration of R-Phycoerythrin prior to incubation and 
storage, though this was not confirmed. The samples are otherwise comparable to 
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those incubated with Alexa Fluor 488, indicating that the molecular weight of the 
fluorophore is not a problem for binding onto the surface of the particles.  
 
Figure 46: Fluorescence intensities 0, 1, 2, and 3 hours after 10-100x dilution for R-Phycoerythrin stained 
particles stored cold (A), and at room temperature (B) on day 3. Streptavidin-containing particles are RPE, 
Streptavidin-free particles are RPN. All measurements are performed as N=1. 
Minor differences were seen between different days, but overall the behaviour was 
very similar. Particles stained with fluorophores all showed a near constant 
fluorescence levels, with only minor reductions in fluorescence on days 2, 3 and 4, 
as shown in Figure 47. Dilution of the particles appears to have only limited effect on 
most samples, with fluorescence remaining largely constant in most samples. The 
main exceptions are the samples of Streptavidin-containing particles that were 
stained with R-Phycoerythrin and diluted 1:100 prior to measurements, which 
showed a reduction in fluorescence of as much as 50%. However, the 1:10 dilution 
samples showed very little change in comparison. This may indicate that R-
Phycoerythrin in particular may have a high non-specific binding to available 
Streptavidin and not to the remainder of the PEGDA material, but more robust 
measurements would be needed to determine this with any confidence. 
  
Figure 47: Fluorescence over time for Streptavidin-containing particles stained with R-Phycoerythrin, 
after 1:100 dilution following cold storage (A) and room temperature storage (B). All measurements are 
performed as N=1. 
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However, a major problem with these results is that while the samples do provide 
some useful information, the results are unsuitable for determining the actual non-
specific binding of the measured particles. While each sample could potentially be 
used to calculate how much non-specific binding occurs, variation between the 
samples is too great to acquire a single, dependable value. There are not enough 
measurements to determine an accurate level of noise between measurements, but 
there is a high level of variation seen in samples such as the fridge-stored Alexa 
Fluor 488 particles on day 1 or the room temperature R-Phycoerythrin particles on 
day 4, as seen in Figure 48. This indicates that errors due to noise or undocumented 
variations in the process are likely severe enough to prevent these measurements 
from providing sufficiently high quality data for accurately measuring the binding of 
proteins to Streptavidin on the particles. 
 
Figure 48: Fluorescence over time for particles stained with Alexa Fluor 488, after 1:10 or 1:100 dilution 
following cold storage on day 1 (left), and particles stained with R-Phycoerythrin, after 1:10 or 1:100 
dilution following room temperature storage on day 4 (right). Note the fluorescence intensity increasing 
from hour 0 to hour 1, despite the recent dilution, for AF 10, RPE 10 and RPN 10. All measurements are 
performed as N=1. 
3.4. Discussion 
A membrane emulsification process was used to create solid Poly (Ethylene Glycol) 
Diacrylate microparticles. 
Using the modified UV exposure methods, the microparticles created with the 
membrane emulsification setup are suitable for further analysis. A portion of the 
PEGDA/water mixture is not polymerized, but the particles are solid and can be 
safely stored for longer periods of time if the suspension liquid is diluted with water 
right after the particles are created. 
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The Flow Cytometry measurements encountered a substantial number of problems, 
especially variations between measurements from particular samples and difficulties 
in determining the non-specific binding of proteins. While the experiments do 
suggest that specific binding occurs, variation was severe enough that no accurate 
levels of this binding could be determined. 
The most likely cause of the problems identified during these experiments is that the 
UV exposure necessary to polymerize the PEGDA into solid particles is much higher 
than that used for creating hydrogels particles in literature120,243,245,248,260,261, though 
times of up to an hour have been reported for non-functionalized particles262. The 
currently used UV exposure may be high enough to cause Streptavidin degradation; 
consequently the Streptavidin may no longer be able to properly bind biotinylated 
proteins such as the used fluorophores. Because the Flow Cytometry method used 
to determine the amount of available Streptavidin is directly reliant on the 
functionality of the immobilized Streptavidin, it is not possible to identify differences 
between particles with damaged or missing Streptavidin. 
Additional problems may arise from the use of the membrane emulsification process 
itself; the interaction between Streptavidin and the continuous phase (both kerosene 
and Span80) is not known in detail. It is therefore possible that the surfactant or the 
interface between the continuous and dispersed phases may disrupt Streptavidin 
folding or leech Streptavidin-containing polymer chains out of the solution that forms 
the eventual solidified microparticles. The appearance of a two-phase separation in 
Streptavidin-containing solutions that did not occur in Streptavidin-free particles 
further supports the idea that there may be deeper problems with the membrane 
emulsification process. While a reduction in (functional) Streptavidin content is not a 
critical failure on its own, it does compound further problems encountered during the 
flow cytometry measurements. 
In retrospect, the use of microfluidics instead of membrane emulsification for the 
creation of the PEGDA particles may have been a better choice. While microfluidics 
would have required a larger amount of time and effort to establish a suitable 
process, it would also have been easier to ensure an even exposure of the created 
droplets to the UV used to polymerize the material or modifications to exposure 
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times243,261. Diameter variation might likewise be reduced242, though varying 
dimensions do not necessarily hinder further analysis. 
Different choices for the continuous phase, surfactant and other parameters of the 
process may have provided better results. However, the time restraints imposed by 
this project mean that more extensive optimization simply wasn’t feasible. 
For future work, the use of alternative polymerization methods may prove more 
successful, and other analysis methods such as NMR or directly labelling 
Streptavidin with fluorescent or radioactive markers might be useful to determine the 
presence of Streptavidin in the created particles. These alternatives are not further 
investigated during this project due to time constraints. 
While the concept of a microparticle-based analysis method as a surrogate for 
surface measurements remains sound, the challenges encountered during this 
chapter suggest the experiments performed during this chapter may have been 
chosen in the wrong order. An initial verification of protein immobilization, even if 
merely qualitative, may have been a faster and easier route to identifying the 
problems encountered here than immediately moving to quantitative measurements 
using flow cytometry. Because of time constrains and the continuing difficulties 
encountered during these experiments, the decision was made to cease further work 
on quantifying the available Streptavidin in the created material and move to 
qualitative analyses and cell culture work instead. 
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         Chapter 4: Chemical modification of cell culture surfaces  
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4.1. Introduction 
While the functionalization and patterning of the materials for cell culture are a major 
part of this project, it is still necessary to confirm if the designed materials are 
suitable for cell culture, and whether the desired proteins can be effectively 
immobilized prior to cell culture. 
Numerous different materials are used for cell culture, depending on the 
requirements of the cells in question, the chosen process, and other limitations or 
demands of the culture system. Initially, a Poly (Ethylene Glycol) based material was 
selected for further experiments as shown in chapter 1. However, the results and 
problems from subsequent experimental work with PEG-based microparticles (see 
chapter 3) indicated that there may be insurmountable difficulties with the current 
process for using PEG-based surface chemistry for the immobilization of growth 
factors. Therefore, a review of alternatives materials may be necessary. 
Specifically, while the particles themselves worked fairly well for the flow cytometry 
measurements, difficulties with specific and non-specific binding on the created 
particles suggest that the underlying problems are caused by the choice of material 
and chemical modification strategy. Because the immobilization of proteins onto the 
selected surfaces is critical for further cell work, the choice was made to focus on 
quantitative surface modification and cell culture tests rather than continue work on 
quantifying immobilization prior to cell culture experiments. 
The main requirements for the material are that it is possible to mould it into specific 
shapes, ideally through melting or in-situ polymerization, that it is possible to 
covalently bind proteins onto the material surface using one or more crosslinking 
processes, and that the material itself should have a low non-specific adsorption of 
proteins. However, it may not be possible to create a ‘perfect’ surface material; 
improvements for cell culture or attachment may come at the cost of reduced protein 
immobilization or an increase in non-specific binding and subsequently increased 
noise in any measured effects on cell culture. Currently, non-specific adsorption is 
considered a lower priority: the main goal at this time is to create a material suitable 
for cell culture that can be modified with covalently bound proteins. 
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PEG-based materials have relatively low hydrophobicity, and will adsorb fewer 
proteins out of solution than more hydrophobic alternatives234 when used for cell 
culture experiments. This was deemed a sufficiently advantageous property to 
warrant further use despite the expected need for further modification of surfaces to 
allow for cell attachment. However, although PEG-based surfaces are expected to 
provide advantages in terms of non-specific binding of proteins, sufficiently extensive 
modification with cell attachment proteins may lead to a needlessly complex process 
that eliminates the main advantage of using PEG over other, less hydrophilic 
proteins.  
Further work with PEG diacrylate showed substantial difficulties in immobilizing the 
necessary proteins onto the surface, as seen in chapter 3. As such, rather than 
attempting to gain an exact value of immobilized protein concentrations, the choice is 
now made to test for cell culture suitability of PEG and other materials before further 
quantifying protein immobilization. 
Poly (Ethylene Glycol) is still the most advantageous candidate in terms of controlled 
surface presentation, due to a reduced non-specific protein adsorption. However, 
PEG is less suitable without further modification, and the necessary processes for 
functionalizing the surface are more complex than those for Polystyrene or 
Polycaprolactone. The need to combine radical-based chemical cross-linkers, UV 
exposure and, ideally, a two-stage process to use the Streptavidin-Biotin non-
covalent link means that this process has an increased number of potential failure 
points. 
In contrast, Polystyrene has the advantage of being substantially more beneficial in 
terms of cellular attachment; treated Polystyrene is a common material for 
commercially available well plates. However, protein adsorption is high due to the 
material’s hydrophobic nature, and the chemical stability of the material prevents 
easy covalent binding of proteins, as required for this project, without harsh or 
dangerous processes. While methods such as plasma treatment115,263,264, exposure 
to energetic radiation such as UV or Microwaves117,265, or harsh pH are possible, 
more direct chemical modification will require highly reactive species such as radical 
oxygen or anhydrides113,114,116. 
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Polycaprolactone is another polymer that may be a suitable candidate. Active groups 
suitable for immobilization of proteins can be introduced by hydrolysis in Sodium 
Hydroxide solutions135,143, and cell attachment occurs on Polycaprolactone even with 
the introduction of additional hydrophilic groups135,147. MSCs can be cultured on this 
material both with and without further surface modification134,142. Polycaprolactone is 
also more advantageous compared to Polystyrene due to its lower hydrophobicity, 
which results in a slower adsorption of proteins out of solution. 
Polyacrylamide, Polyethylene, Polyurethanes, Poly (lactic-co-glycolic-acid) and 
Hyaluronic Acid were all considered as alternative materials, but were discarded due 
to expected difficulties with surface creation and patterning, material degradation, 
chemical modification or overall suitability for cell culture. 
Based on the material requirements, PEG remains the primary candidate for further 
work. Polycaprolactone and Polystyrene will be included as secondary choices, 
should the need for higher hydrophobicity and higher adsorption of proteins be 
considered an acceptable trade-off for improved cell attachment and proliferation. 
Briefly, the following types of immobilization processes are considered suitable for 
use during this project.  
Non-covalent adsorption is the most straightforward process, wherein materials 
adsorb proteins out of solution without the need for chemical immobilization. 
Hydrophobic materials adsorb more proteins due to the stronger binding with 
hydrophobic segments found in most biologically active proteins234. While this 
process requires no prior treatments, it is considered unsuitable due to the length of 
planned cell culture experiments and the need for a strong, specific binding of 
selected proteins. 
Covalent binding of proteins is performed using various different chemical reactions, 
such as using amine- or carboxylic acid-reactive crosslinkers to create stable amide 
bonds, or using photo-reactive crosslinkers127,128,266. Covalent binding can include 
crosslinkers with longer chains to prevent protein denaturation, but this process still 
retains higher risks due to the need for direct attachment to the proteins of interest, 
especially if additional reactive groups need to be introduced (such as with thiolation 
for disulphide linking)23,24.  
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Non-covalent, specific protein immobilization can be achieved with a two-stage 
process, first binding protein combinations with a high specific binding such as 
complementary DNA or RNA sequences (most commonly for biosensors or 
assays)267–269 or Biotin combined with Avidin or Streptavidin165,173,181,270. This 
requires covalent binding of sequences or binding proteins, but afterwards allows for 
easy binding of multiple different proteins (such as proteins with covalently bound 
biotin or DNA/RNA sequences) using a single process. This approach maintains a 
high degree of specificity, but allows proteins to be conjugated with smaller and safer 
binding chains, reducing the risk of denaturation and loss of function. A process 
based on the Biotin-Streptavidin binding process was used during chapter 3, and is 
included in the evaluations during this chapter. 
In this chapter, the use of PEG, Polycaprolactone, Polystyrene and a number of 
material modification strategies including the original PEG-based method, are 
evaluated for cell culture suitability and effectiveness of protein immobilization. This 
information will be used to define the final treatment process applied for the 
combined patterning/protein immobilization experiments. 
Methods and results are described throughout this chapter due to the iterative nature 
of the experimental work. 
4.2. Aim and goals 
This part of the project aims to verify the suitability of specific material surfaces for 
long-term culture following functionalization. To do so, this chapter will focus on the 
following goals: 
- Determining the suitability of modified Poly (Ethylene Glycol), 
Polycaprolactone and Polystyrene surfaces for cell culture by verifying cell 
attachment and proliferation on selected surfaces 
- Verify if the selected covalent or non-covalent protein immobilization 
techniques can be used to create surfaces with controllable concentrations of 
immobilized growth factors 
- Selecting the most suitable cell culture material and modification method for 
later cell culture experiments by comparing growth factor immobilization and 
cell attachment 
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4.3. Materials and methods 
4.3.1. Materials 
Acrylate-PEG-NHS and Biotin-PEG-NHS were acquired from Jenkem Technology, 
USA. 
RoosterBio hMSC high performance media kit was acquired from RoosterBio, USA. 
TrypLE, Trypsin, Sodium Hydroxide, Hydrochloric Acid, Fibronectin, StemPro culture 
media, Glutamax, MES buffered saline, 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were acquired 
from Fisher Scientific Ltd, UK. 
Polycaprolactone, Polystyrene, Poly (ethylene glycol) diacrylate, 2,2-dimethoxy-2-
phenylacetophenone, Streptavidin, RGD and TGF-β1 were acquired from Sigma 
Aldrich Company Ltd, UK. 
Fluorescent antibodies and isotypes were acquired from BD Biosciences, UK. 
4.3.2. Initial creation of PEG-based surfaces 
Before analysis can begin, the PEG-based surfaces of interest must first be created, 
using a process similar to that described in chapters 2 and 3. A schematic overview 
of the process outlined in this section is shown in Figure 49.  
 
Figure 49: Schematic overview of the cytokine immobilization process, starting from individual 
components (dimensions not to scale). 
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Similar to previous methods (see chapters 2 and 3), PEG solutions were created 
from a mixture of 75% w/w PEG-diacrylate (PEGDA, Mn ≈ 575) with 1 mM Acryl-
PEG-N-hydroxysuccinimide (Acryl-PEG-NHS, Mn ≈ 2000) and 1 v/v% 2,2-
dimethoxy-2-phenylacetophenone (DMPA) as photo-initiator95,119,124,236,271. Cell 
culture surfaces are initially created in 96-well plates. 
After mixing, the material is polymerized by UV-exposure (312 nm wavelength at 10 
mW/cm2 for 45 minutes24,95,272) and washed with sterile PBS to remove any unbound 
components that remain in the material. 
4.3.3. Cell attachment and culture on modified PEG-based surfaces 
Since Poly (Ethylene Glycol) Diacrylate (PEG)-based surfaces are not suitable for 
cell culture without modification95,119,237,273,274, it is necessary to evaluate the 
effectiveness of including additional cell attachment proteins on the material surface. 
Therefore, the created surfaces are tested in a cell culture experiment to determine 
attachment and viability of cultured cells. 
Human mesenchymal stem cells (Rooster Bio Inc.) are cultured from passage P+2 in 
serum-free media to determine the effectiveness of the selected materials. While 
MSC culture commonly includes the use of fetal bovine serum, serum-free culture 
environments have been shown to provide increased performance in MSCs275–279. 
The medium used for this experiment consists of StemPro MSC serum free media 
with added Glutamax as per manufacturer’s instructions (2 mM concentration). 
Initially, four experimental groups are compared: 
- PEG-based surfaces with no treatment after UV-induced polymerization 
- PEG-based surfaces with added Streptavidin  
- PEG-based surfaces with added Streptavidin and Biotin-PEG-RGD 
- Untreated tissue culture plastic (control group) 
The PEG-based surfaces are otherwise identical prior to treatment and culture, and 
are created as flat surfaces without any added patterning or surface features. 
4.3.3.1. Creation and modification of experimental surfaces 
Streptavidin was prepared for immobilization by mixing the Acrylate-PEG-N-NHS 
linker with Streptavidin at a 4:1 molar ratio, to a total concentration of 3 mg/mL 
Streptavidin. The protein and linker are allowed to bind overnight under gentle 
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agitation at 4-7°C. Any remaining NHS groups are assumed to have hydrolysed at 
the conclusion of the process. 
For Streptavidin-containing experimental groups, Acrylate-PEG-Streptavidin was 
added to the unpolymerized PEG-Diacrylate solution prior to polymerization 
described in 4.3.2., to a total concentration 60µg/mL Streptavidin. 
RGD was prepared for immobilization by mixing the Biotin-PEG-NHS linker with 
RGD at a 2:1 molar ratio, to a total concentration of 2mg/mL RGD and allowing the 
protein and linker to bind overnight at 4-7°C. Any remaining NHS groups are 
assumed to have hydrolysed at the conclusion of the process. 
Biotin-PEG-RGD was diluted 1:15 and added to the appropriate created and 
functionalized cell culture surfaces at a total volume of 32 µL per well, then allowed 
to incubate overnight. After incubation, surfaces are washed with sterile PBS. 
Four 24-well well plates are created, with total numbers of 9 wells each of PEG, PEG 
+ Streptavidin and PEG + Streptavidin + RGD.  
4.3.3.2. Cell culture and analysis 
Human Mesenchymal Stem Cells are seeded from P+2 at a density of 5000 
cells/cm2, and cultured in StemPro culture medium (84 mL StemPro media + 15 mL 
StemPro supplement + 1 mL Glutamax for 2mM concentration). Following cell 
culture, cells are analysed on day 1 using a Nucleocounter NC-250 (Chemometec, 
Denmark), and days 3, 6 and 8 using optical microscopy. 
For Nucleocounter analysis, cells were detached by incubating with TrypLE (32 µL 
per well, 10 minutes at 37°C), and cells were counted after pooling collected cells 
from three wells. 
For microscopy analysis, wells are imaged directly without staining or further 
treatment of cells. All wells are kept for further analysis on later days, and no 
measurements are sacrificial. 
4.3.3.3. Results 
NucleoCounter analysis of the collected samples on day 1 showed very low cell 
counts (<1*104 cells total), including measurements on the control group. This 
indicates a failure to collect sufficient (viable) cells from the cell culture surfaces. 
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Microscopy analysis on days 3, 6 and 8 showed that while cells seeded on the 
control surface could attach and proliferate normally, those seeded on the PEG-
based surfaces did not. Cells seeded on PEG surfaces, whether functionalized or not, 
showed severely reduced attachment and a rounded phenotype. This result was 
expected for untreated PEG surfaces, however a greater amount of cell attachment 
was expected for the Streptavidin-functionalized and especially the Streptavidin + 
RGD-functionalized surfaces. This indicates a possible failure in the immobilization 
of Streptavidin, Biotin-PEG-RGD, or both. Results for day 8 are shown in Figure 50.  
  
  
Figure 50: Representative microscopy images for the untreated PEG surfaces (A), Streptavidin-
functionalized PEG surfaces (B), Streptavidin+RGD functionalized PEG surfaces (C) and control group (D) 
at day 8. Note the low seeding density, particularly notable in the contrast between the large, empty 
spaces in images A, B and C and the small amount of cells (seen as small, round dots). 
4.3.4. Expanded cell attachment analysis 
The lack of cell attachment during the first experiment casts doubts on the suitability 
of the Streptavidin-based immobilization of RGD. To determine if cell attachment 
during the first experiment failed as a consequence of using RGD as the cell 
attachment protein, or because the proteins themselves were not properly 
immobilized, the experiment is repeated with the addition of Fibronectin as a 
comparison. 
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While Fibronectin was initially not used due to the increased risk of undesired 
interactions with the cells (including allowing increased adsorption of proteins out of 
solution), the increased molecular size and availability of cell attachment regions on 
Fibronectin ensures this material serves as a more powerful cell attachment protein 
than RGD. As such, Fibronectin will be used as a substitute for RGD, to both serve 
as a control group and to determine if the previous failure is more likely to be caused 
by the Streptavidin binding process or the RGD binding process. 
Five experimental groups are included in this experiment: 
- Untreated PEG 
- PEG with added Streptavidin  
- PEG with added Streptavidin and Biotin-PEG-RGD 
- PEG with added Streptavidin and Biotin-PEG-Fibronectin 
- Untreated tissue culture plastic (control group) 
4.3.4.1. Creation and modification of experimental surfaces 
New polymer surfaces are created for the coming experiments. The processes for 
creating the 24-well sized untreated PEG surfaces, as well as the addition of 
Streptavidin and Biotin-PEG-RGD were identical to the methods previously 
described in this chapter. Biotin-PEG-Fibronectin was created by mixing 0.5 mg 
Fibronectin with 0.11 mg Biotin-PEG-NHS, for a 1:100 molar ratio and a 0.5 mg/ml 
concentration of Fibronectin. The solution is allowed to react for 45 minutes at 4-7°C, 
and is used immediately afterwards for surface functionalization. 
Once the Biotin-PEG-Fibronectin is prepared, 50 µL of the solution is added to the 
appropriate Streptavidin-functionalized PEG surfaces. Surfaces in the other four 
experimental groups receive 50 µL of PBS to prevent any additional differences due 
to this step in the process. The well plates are incubated at 37°C for six hours. 
4.3.4.2. Cell culture and analysis 
In addition to the surface modification, three different media types are investigated 
due to potential relevance of adsorption of proteins out of solution in the Fibronectin-
containing wells. 
- RoosterBio medium: RoosterBio serum-free hMSC culture medium prepared 
as per manufacturer instructions (Roosterbio, Inc.) 
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- Serum-free medium: 84% v/v Gibco StemPro serum free hMSC culture 
medium +15% v/v Supplement + 1% v/v Glutamax (ThermoFisher Scientific) 
- Serum medium: 75.6% v/v Gibco StemPro serum free hMSC culture medium 
+13.5% v/v Supplement + 0.9% v/v Glutamax + 10% v/v Fetal Bovine Serum 
(ThermoFisher Scientific) 
Cells are seeded onto surfaces as 
described before, and each surface + 
medium combination is cultured in five 
96-well plate wells at 37°C and 5% 
CO2. Cell cultures are analysed with 
optical microscopy at days 2, 4 and 6. 
Culture media is fully replaced every 
three days. 
4.3.4.3. Results 
A number of important differences 
were seen in the attachment tests 
performed during this experiment. 
Cells showed proper attachment and 
proliferation on tissue culture plastic as 
expected. However, no attachment 
occurred on untreated PEG, 
functionalized PEG surfaces with 
Streptavidin, or surfaces further 
improved with RGD or Fibronectin. 
The culture medium used had no 
detectable effect on cell attachment. 
Representative cell culture results for 
day 2 are shown in Figure 51. 
Long-term analysis of the cell cultures 
was not possible due to bacterial 
contamination of the samples. 
 Figure 51: Microscopy imaging of cell attachment 
on day 2 for culture in serum-free medium, on 
surfaces with Fibronectin (A), RGD (B) and tissue 
culture plastic (C). Note the rounded shape of cells 
in image A and B, indicating poor attachment and 
cell viability. 
 
A 
 
 
 
B 
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However, the total lack of attachment on PEG-based surfaces, even with Fibronectin, 
indicates that the functionalization process was not sufficient to enable cell culture on 
PEG. 
The most likely cause for the failure of the surface treatment process is the 
comparatively high UV exposure time needed to fully polymerize the PEG (up to 45 
minutes, compared to <5 minutes in literature95,97,126,133,237. This is not a major 
problem for purely PEG-based surfaces; however, inclusion of Acrylate-PEG-
Streptavidin during this process exposes the Streptavidin itself to the UV as well. It is 
unclear how much Streptavidin degradation occurs due to UV exposure, but 
sufficient degradation of the Streptavidin would prevent immobilization of biotinylated 
proteins, including the RGD and Fibronectin used during this experiment. 
4.3.5. Cell attachment on modified Polystyrene and Polycaprolactone 
Previous experiments showed a persistent lack of success in the creation of modified 
PEG-based cell culture surfaces. Further analysis of the developed process is 
possible, for example by measuring the exact concentrations of immobilized proteins 
on the surface. However, the choice was made to reduce the risk of further failures 
by using Polycaprolactone and Polystyrene instead of PEG for future experiments. 
New modification techniques are investigated to acquire a suitable cell culture 
material. 
Based on further review of relevant literature, the first surface modification process 
chosen is the treatment of Polycaprolactone with a Sodium Hydroxide solution, 
based on published work by Drevelle, Sun and Yeo135,143,280. Short-term exposure to 
the Sodium Hydroxide solution results in degradation of the ester groups in 
Polycaprolactone, creating new oxygen-rich functional groups at the surface of the 
polymer, which can be used for further immobilization processes. Long-term 
exposure will not be tested as this can result in not only surface chemistry alterations, 
but also significant degradation of the material at macro-scale levels148. 
The second process chosen for this experiment is the treatment of Polycaprolactone 
and Polystyrene with a solution of Laccase C. The Laccase acts as a catalyst for the 
creation of reactive oxygen species from molecular oxygen, which in turn react with 
the polymers for the creation of new functional groups. The greater reactivity of the 
created oxygen species is expected to cause more rapid modification of surface 
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chemistry, as well as more rapid degradation of the polymer. However, the higher 
health and processing risks that must be considered for the use of Laccase solutions 
means that Sodium Hydroxide treatment remains the preferred method. 
Regardless of the method, the created functional groups (carboxylic acids, alcohols, 
aldehydes) on the Polycaprolactone and Polystyrene surfaces may then be used for 
immobilization of various proteins, but this step is not performed during this 
experiment and all surfaces are only chemically treated with no additional proteins. 
This experiment focuses on the suitability of treated and untreated Polycaprolactone 
and Polystyrene for adherent cell culture of human Mesenchymal Stem Cells. 
4.3.5.1. Cell attachment on modified Polystyrene and 
Polycaprolactone 
The following experimental groups are included in the experiment: 
- Untreated Polycaprolactone as a control group 
- Untreated Polystyrene as a control group 
- Polycaprolactone surfaces treated with 0.5M NaOH, for a duration of 1, 2 or 4 
hours of exposure. 
- Polycaprolactone surfaces treated with 0.25 u/mL Laccase C, for a duration of 
2 hours of exposure. 
- Polystyrene surfaces treated with 0.25 u/mL Laccase C, for a duration of 2 
hours of exposure. 
Note: Laccase concentrations are provided as ‘unit per mL’ and not the molar 
concentration, to account for potential differences in enzymatic activity between 
different batches and suppliers. 
Initial surfaces are created using the vacuum oven-based process described in 
chapter 2. Surfaces are kept sterile and, where appropriate, treated with Sodium 
Hydroxide or Laccase C in a biological safety cabinet to prevent contamination. 
After treatment, MSCs are seeded onto the surfaces at a density of 20,000 cells/cm2 
in RoosterBio media as described before, and cultured at 37°C and 5% CO2 for 24 
hours to allow for attachment. 
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Following attachment, cells are stained with a 1%w/v Toluidine Blue solution for 10 
minutes. Cell attachment and morphology on the different surface types is evaluated 
using optical microscopy. Cell attachment and health will primarily be evaluated 
based on morphology, spread, and cell density per surface area. No additional cell 
culture is performed past the initial 24 hours. 
4.3.5.2. Results 
After 24 hours of incubation time, most of the selected surface materials showed cell 
attachment. The main differences between materials are found in the ratio between 
fully attached and spread out cells, and the amount of cells that remain in a rounded 
morphology, indicating limited attachment and health. 
  
  
Figure 52: hMSC attachment on surfaces made of untreated Polystyrene (A, B) and Laccase-treated 
Polystyrene (C, D). Note: due to light reflections from the material interfering with analysis, image 
brightness was modified for clearer visualization. No other alterations to the images are made. 
Both untreated and Laccase-treated Polystyrene showed excellent attachment, as 
was expected due to the higher hydrophobicity of the starting material. Almost all 
cells are fully attached and showing the desired, spread out morphology. This shows 
the Polystyrene-based surfaces allow for good cell culture environments, though 
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increased influence of protein adsorption still makes these surfaces a secondary 
choice. Representative surfaces for both Polystyrene types are shown in Figure 52. 
Untreated Polycaprolactone and Laccase-treated Polycaprolactone show attachment 
from the seeded cells, but also show a number of cells with a rounded morphology. 
These surfaces therefore allow for cell attachment, but may be reconsidered for 
further use due to potential difficulties with long-term cell viability and expected non-
specific binding of proteins and other components out of the culture medium. 
Representative surfaces for untreated and Laccase-treated Polycaprolactone are 
shown in Figure 53. 
  
  
Figure 53: hMSC attachment on surfaces made of untreated Polycaprolactone (A, B) and Laccase-treated 
Polycaprolactone (C, D). Note: due to light reflections from the material interfering with analysis, image 
brightness was modified for clearer visualization. No other alterations to the images are made. 
Polycaprolactone surfaces that were treated with Sodium Hydroxide showed 
different levels of cell attachment depending on the total treatment time. Treating the 
surface for one or two hours resulted in good cell attachment comparable to 
untreated Polycaprolactone. The surfaces treated for four hours showed fewer cells 
with the desired attachment and morphology, with the majority of cells having either 
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failed to attach or showing a rounded morphology. Treatments of four hours or 
longer are therefore not considered suitable and will not be used for any further work. 
One- and two-hour treatments do allow for suitable cell attachment, providing results 
comparable to the two-hour Laccase treatment. Representative surfaces for all three 
Sodium Hydroxide-treated Polycaprolactone materials are shown in Figure 54. 
  
  
  
Figure 54: hMSC attachment on surfaces made of Polycaprolactone treated with Sodium Hydroxide for 1 
hour (A, B), 2 hours (C, D), and 4 hours (E, F). Note: due to light reflections from the material interfering 
with analysis, image brightness was modified for clearer visualization. No other alterations to the images 
are made. 
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While it was not possible to acquire quantitative measurements for cell attachment 
for this experiment, it does provide sufficient information to continue with further cell 
culture experiments. Both Polystyrene and Polycaprolactone can be modified without 
eliminating the capacity for cell attachment on the surface. 
Based on these results, both the 2-hour Laccase treatment and the 1-hour or 2-hour 
Sodium Hydroxide treatments on Polycaprolactone are considered suitable for 
surface modifications. For later experiments, Polycaprolactone incorporating a 2-
hour treatment with Sodium Hydroxide will be used to ensure sufficient functional 
groups. 1-hour Sodium Hydroxide treatment may be considered if further problems 
are encountered in later experiments; Laccase treatment will not be included due to 
the higher costs and risks involved in the use of the required Laccase solutions. 
4.3.6. TGF-β1 immobilization on functionalized Polycaprolactone 
It is now possible to create cell culture surfaces with the necessary groups for 
(covalent) binding of proteins. Before cell culture experiments using these surfaces 
can begin, it is necessary to verify both the immobilization of such proteins and 
whether it is possible to create varying surface concentrations through alterations of 
the treatment process. 
Based on literature, soluble TGF-β1 concentration ranging from approximately 0.01 
nM to 1 nM during cell culture 20,24,47,281 can induce both differentiation and 
upregulated production of extracellular matrix in hMSCs. To ensure a similar 
concentration of total growth factors per well using immobilized TGF-β1, the peak 
surface concentration should be 0.5 pmol TGF-β1 per square cm, or 25 ng/cm2 (total 
surface area is 2 cm2 per well). 
The following experimental groups are included in the experiment: 
- Untreated Polycaprolactone as a control group 
- Untreated Polystyrene as a control group 
- Polycaprolactone surfaces treated with 0.5M NaOH, for a duration of 1, 2 or 4 
hours of exposure. 
- Polycaprolactone surfaces treated with 0.25 u/mL Laccase C, for a duration of 
2 hours of exposure. 
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- Polystyrene surfaces treated with 0.25 u/mL Laccase C, for a duration of 2 
hours of exposure. 
 
Sterile flat Polycaprolactone and Polystyrene surfaces were created in a vacuum 
oven, using the process described in chapter 2. Briefly, polymer pellets were placed 
in a silicone mould based on the shape of a 24-well plate and melted at a 
temperature of 175°C for 30 minutes. Samples were then placed in a sterile, sealed 
autoclave bag and kept at 175°C for a further 60 minutes to ensure sterility. 
After samples have cooled down, they are transferred to sterile storage for later use. 
Created samples are functionalized as described before. All surfaces are washed 
with PBS between steps of the functionalization process. 
Polycaprolactone samples are treated with 0.25 u/mL Laccase for 2 hours, or with 
0.5M Sodium Hydroxide solution for 1, 2 or 4 hours. Polystyrene surfaces are treated 
only with 0.25 u/mL Laccase for 2 hours. Functionalized surfaces are then treated 
with a solution of 0.380 mg/mL EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride) and 0.575 mg/mL NHS (N-Hydroxysuccinimide) in MES buffered 
saline (0.1M, 0.9% sodium chloride, pH 4.7) for 15 minutes. 
Finally, all surfaces are washed and treated for two hours with TGF-β1 solutions in 
PBS of 0.4 µg/mL, 0.2 µg/mL, or TGF-β1-free PBS as a control group. 
After treatment, non-specific binding is blocked by addition of 1.5 mg/mL Bovine 
Serum Albumin for 15 minutes, followed by washing in sterile PBS. 
TGF-β1 immobilization is verified by incubating all samples with fluorescent 
antibodies (Alexa Fluor 488-conjugated anti-TGF-β1) at manufacturer’s 
recommended concentration for 30 minutes. Samples are washed with PBS, and 
fluorescence intensity is measured using a FLUOStar Omega plate reader. 
Fluorescence is compared to a dilution series of Alexa Fluor (0.165 nMol – 1.29 pMol 
per well) to calculate the total amount of immobilized TGF-β1 antibody in each well. 
All individual measurements are performed as N=1, with no replicates. 
 
131 
 
4.3.6.1. Results 
Calculation of the amount of immobilized 
TGF-β1 antibody showed a number of 
important differences between the 
materials used in this experiment. The 
calculated antibody values for the different 
materials are shown in Table 1. 
Polystyrene showed higher fluorescence 
than Polycaprolactone, but this was largely independent of the concentration of TGF-
β1 used to treat the surfaces. This result, especially the high value for the TGF-β1-
free surface, indicates that most of the signal is caused by nonspecific binding of the 
fluorescent antibody, though differing optical properties of the material compared to 
Polycaprolactone may also play a part in the comparatively higher values. 
Laccase treatment of Polystyrene substantially reduced antibody binding, further 
supporting this interpretation as the reduced hydrophobicity of the Polystyrene would 
reduce nonspecific binding. This also indicates that any added capacity for specific 
binding through the EDC + NHS crosslinking process is responsible for a smaller 
portion of the signal than nonspecific binding. More long-term treatment of the 
surface could further clarify this effect, but such measurements were not performed. 
Untreated Polycaprolactone showed a substantially higher fluorescence than treated 
Polycaprolactone, which is again in line with the expectations regarding a higher 
hydrophobicity resulting in increased specific and non-specific binding. The 
fluorescence of Sodium Hydroxide-treated and Laccase-treated Polycaprolactone 
surfaces exposed to 0.4 µg/mL TGF-β1 are consistently higher than surfaces treated 
with 0.2 µg/mL TGF-β1, which in turn show a higher signal than TGF- β1-free 
surfaces. This indicates that despite measurement issues a repeatable difference in 
the amount of immobilized protein could be established. Resulting immobilizations 
are similar enough that each method is likely equally suitable, offering little 
advantage or disadvantage of selecting one over the other. However, Laccase- and 
4-hour Sodium Hydroxide-treated surfaces show a reduced fluorescence without 
TGF-β1, suggesting a further reduced non-specific binding and a higher level of 
hydrolysis on the treated surfaces. The consistent differences in the measured 
 0.4 µg/mL 
TGF-β1 
0.2 µg/mL 
TGF-β1 
No added 
TGF-β1 
PS Untreated 3.65 4.01 4.43 
PCL Untreated 4.18 2.94 3.69 
PS + Laccase 2.21 0.80 1.47 
PCL + Laccase 2.10 1.52 1.15 
PCL + 1h NaOH 2.41 1.28 1.68 
PCL + 2h NaOH 2.26 1.90 1.65 
PCL + 4h NaOH 2.15 1.92 1.05 
Table 1: calculated TGF-β1 antibody 
immobilization onto surfaces, in pMol per 
well. 
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immobilization based on used TGF-β1 concentrations suggest both the Sodium 
Hydroxide-based treatment and the Laccase C-based treatment would provide good 
control over surface properties for future experiments. 
However, the measurements do show substantial variation in fluorescence that can’t 
be attributed to the surface chemistry and proteins. In particular, several of the 0.2 
µg/mL TGF-β1 samples show a lower fluorescence than samples without TGF-β1, 
especially in the untreated and Laccase-treated experimental groups. Consequently, 
the exact values of measurements may be unreliable and only larger trends should 
be used to inform decisions regarding future experiments. It is unclear what caused 
these effects, though a potential explanation may be that small differences in the 
geometry of the samples resulted in differing reflection or refraction, which may have 
an impact on the measured fluorescence intensity. 
4.4. Discussion 
The work performed in this chapter showed substantial difficulties in creating 
functional cell culture surfaces as originally designed in chapter 2. The 
immobilization of proteins for mediation of cell attachment on the surface failed to 
support cell attachment and further culture both for the inclusion of RGD sequences 
and Fibronectin. 
Although the exact cause of the failed immobilization is not known, the fact that 
neither modification was successful suggests that the problem lies in the original 
immobilization process, failing to bind functioning Streptavidin. The failure to bind 
this protein despite successes reported in literature may be due to the need for a 
more rigid structure and, consequently, a higher PEG-to-water ratio in the created 
material compared to the hydrogels created by Zhu, Hern and Nuttelman that were 
used as the initial starting point for the experiment designs95,133,282. Additionally, the 
longer UV exposure necessary for full polymerization compared to that for such gels 
may likewise have caused a negative impact on protein immobilization through a 
more substantial degradation of Streptavidin. 
After modifying the experimental design to include different materials, a method for 
immobilizing bioactive proteins onto the cell culture surfaces was successfully 
developed. Modified Polycaprolactone surfaces were shown to provide variable 
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protein immobilization under controlled conditions, suitable for the remainder of the 
experiments planned for this project. The calculated amounts of immobilized protein, 
while only approximations, will allow for the creation of multiple different 
concentrations of immobilized protein during later experiments. 
The use of Polycaprolactone also provides a minor benefit in that patterns may be 
created without the need for on-site polymerization. 
In retrospect, determining a rough estimate of immobilization effectiveness would 
have been more effective than immediately attempting to quantify the proteins in 
terms of surface area. This perhaps illustrates the importance of not staying overly 
reliant on results in literature, and to perform smaller scale verification of a process 
before proceeding to full-scale experiments and improvements. 
Despite these setbacks, a suitable cell culture surface was developed. Based on the 
experimental results shown in this chapter, Polycaprolactone surfaces provide a 
good balance of desired properties. Polycaprolactone allows for cell attachment and 
proliferation both with and without functionalization, while at the same time enabling 
a controlled level of immobilization of relevant growth factors following induced 
hydrolysis and Carbodiimide crosslinking. Furthermore, while treated surfaces do 
show some non-specific binding, they result in lower such binding than seen with 
Polystyrene-based materials. These results, when compared to the use of Poly 
(Ethylene Glycol) or Polystyrene, show a clear advantage for the use of 
Polycaprolactone. 
Therefore, Polycaprolactone-based surfaces will be used for the remainder of the 
experimental work in this project. As longer treatment with Sodium Hydroxide shows 
little improvement past 2 hours, future cell culture experiments will initially use 
Polycaprolactone surfaces treated with 2h of Sodium Hydroxide exposure similar to 
the process described by Drevelle and Yeo135,280.  
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          Chapter 5: combined patterning and immobilization for cell culture  
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5.1. Introduction 
With the completion of the experiments described in the previous chapter, it is now 
possible to perform a cell culture experiment incorporating both patterned cell culture 
surfaces and immobilized growth factors. 
In this chapter, the patterning process developed and described in chapter 2 is 
combined with the material modification and protein immobilization developed in 
chapters 3 and 4.  
Due to the complexity of the cellular environment and the numerous methods of 
manipulation and analysis possible for cell culture of human Mesenchymal Stem 
Cells, it is necessary to decide which aspects to cover and which to ignore. Given 
that the goal of this project is not aimed at solving a specific medical challenge but 
has focused primarily on chondrogenesis as its proof of concept, the final 
experiments must be placed in this context. 
As such, the experimental work described in this chapter will focus primarily on 
inducing differentiation and matrix production in human Mesenchymal Stem Cells 
using the different patterning sizes and protein immobilization concentrations 
analysed during previous chapters. As before, culture surface patterning will include 
feature sizes around the approximate cell size as this range is thought to be the most 
promising for creating synergistic effects and identifying further underlying 
mechanisms after the experiments have concluded. 
Analysing the rate and growth factor requirements of cellular differentiation will show 
whether patterning and/or immobilization of growth factors can be used during early 
stages of cell culture, while total matrix production can provide insight into potential 
long-term advantages or disadvantages. In particular, the need for cultured 
chondrocytes to not only show the correct phenotype but also produce suitable 
extracellular matrix for viable tissue engineering procedures (such as the creation of 
artificial cartilage) means that overall Collagen production should provide critical 
insight into whether cultured cells mature into a fully functional chondrocyte 
phenotype. 
Both surface topology and cytoskeletal alterations have already been implicated in 
altered behaviour of focal adhesion sites in adherent culture of mesenchymal stem 
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cells18,222, as well as having a direct impact on cell differentiation283,284. Together, 
these findings strongly suggest that alterations of cell morphology and adhesion 
characteristics may have further effects not only on the sensitivity of cultured cells to 
exposed growth factors, but specifically to growth factors at the contact between 
cells and the underlying substrate. 
Feature sizes are selected primarily to provide a wide range of potential effects. 
While most published work focuses on either regular patterning of sub-cellular 
feature sizes (<1µm)215,224, larger-scale features have also shown substantial 
influence216. As such, the selected feature sizes are chosen to allow analysis of both 
these approaches, with the range of used feature sizes centred on (approximate) 
cellular size and extending towards both sub-cellular scale and scales substantially 
larger than the cultured cells. Sub-micron feature sizes and features larger than 
100µm will not be considered during this project due to practical limitations. 
Likewise, the selected TGF-β1 concentrations used during these experiments are 
chosen to provide a sufficiently wide range of concentrations to identify potential 
saturation effects, based primarily on previous work by Fisher, Hume, McCall and 
Mann20,23,24,281. TGF-β1 concentration ranges outside of the 0.02 - 0.2 pmol/cm2 or 
equivalent soluble concentrations may be considered depending time constraints. 
Beyond the process developed in previous chapters, the introduction of new 
techniques is minimized to avoid adding additional complexity to the planned 
experiments. The main exception to this is the analysis of the cultured cells, which is 
more thorough than that used during previous experiments. Cultured cells will be 
analysed using Flow Cytometry to determine early marker expression, fluorescent 
staining of deposited Collagen II to evaluate extracellular matrix production, and 
metabolic activity during cell culture is quantified. 
5.2. Aim and goals 
This part of the project will attempt to test the hypothesis suggested in chapter 1 of 
this thesis: 
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- Topological features of cell culture surfaces will influence the effective 
concentration of immobilized growth factors, with smaller feature sizes 
resulting in a higher effective concentration 
In order to test this hypothesis, the following goals are set for this part of the project: 
- Determine the influence of pattern size (topology) on the differentiation of 
hMSCs and the extracellular matrix production of differentiated cells 
- Determine the effectiveness of immobilized growth factor TGF-β1 compared 
to providing this growth factor in solution 
- Identify, where applicable, synergistic or antagonistic effects of combining 
patterned cell culture surfaces and the use of immobilized or soluble growth 
factors 
5.3. Materials and methods 
5.3.1. Materials 
The experimental work described in this chapter used microparticles acquired from 
Polysciences Europe GmbH, Germany, rather than Phosphorex Inc. USA (the 
previous supplier). 
Mold Star 15 Slow silicone was acquired from Bentley Advanced Materials, UK. 
RoosterBio hMSC high performance media kit was acquired from RoosterBio, USA. 
Polycaprolactone, NHS, TGF-β1, Anti- Collagen II conjugated Rabbit IgG and FITC-
conjugated anti-Rabbit IgG were acquired from Sigma-Aldrich Company Ltd, UK. 
EDC, MES buffered saline and Rabbit IgG were acquired from Fisher Scientific Ltd, 
UK. 
FITC-conjugated anti-CD90, PE-conjugated anti-CD105 and their isotype controls 
were acquired from BD Biosciences, UK. 
5.3.2. Design of combined patterning-immobilization experiments 
The final experiment of this project was developed as a paired two-level factorial 
design with center-point, one for the cultures on surfaces created with immobilized 
TGF-β1 and one for cultures with TGF-β1 in solution. 
Although additional options were initially considered for both pattern scales and 
concentrations of TGF-β1, only three options are included during these experiments: 
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two corner points each for pattern feature size and concentration, respectively. 
Expanding the number of different environments used during the coming experiment 
could provide additional information, but would also result in greatly increased 
workload to create and modify the necessary surfaces prior to cell culture and 
analysis.  
The two-level factorial design will only provide a preliminary description of any 
relationships between patterning, growth factor concentrations and cell behaviour, 
but it can still be used to estimate a linear model between these parameters as well 
as identify potential non-linear effects such as exponential or logarithmic 
relationships even if such relationships cannot be precisely parameterized using the 
current experimental design. This approach is the most efficient for addressing the 
original hypothesis as stated in chapter 1, while providing further support for 
additional experiments that may be considered in the future. 
Both corner points and centre points in this experiment are initially planned to be 
performed with two replicates for metabolic analysis, marker expression analysis, 
and Collagen production analysis. Each replicate consists of a single well. However, 
do note that this planned design was not kept for the marker expression and 
Collagen production aspects during the experimental run due to adverse results (see 
section 5.4.2 and 5.4.3 for more details). 
As before, surface feature sizes were selected to provide features ranging from 
smaller than cell size (of Mesenchymal Stem Cells) to larger than cell size. The 
surface topologies used during cell culture are pattern sizes of 49.1 µm diameter for 
larger-than-cell-size features, 1.93 µm diameter for sub-cellular sized features, or 
18.8 µm diameter for center-points of approximately equal size to cultured cells. 
Used TGF-β1 concentrations for the experiments with immobilized TGF-β1 are 0.2 
pmol/cm2, 0.02 pmol/cm2, or 0.1 pmol/cm2 for center-points, while used TGF-β1 
concentrations for the experiments with soluble TGF-β1 are 0.4 pmol/mL, 0.04 
pmol/mL, or 0.2 pmol/mL for center-points. Flat surface materials and TGF-β1-free 
culture conditions are included as controls but are not part of the main experimental 
analysis. 
To distribute labour more evenly, half the selected samples are seeded, cultured and 
analysed at a one day offset compared to the other half. All center-point samples are 
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cultured in duplicate, one each starting during initial culture and one starting at the 
offset. This will enable detection of potential bias due to the later cultures having 
received one additional day of preparatory culture prior to seeding at T=0. 
Combined, the following sample types are included in the experiment: 
Immobilized TGF-β1 samples: 
- 0.2 pmol/cm2 + 49.1µm pattern 
- 0.2 pmol/cm2 + 1.93 µm pattern 
- 0.02 pmol/cm2 + 49.1 µm pattern  
- 0.02 pmol/cm2 + 1.93 µm pattern  
- 0.1 pmol/cm2 + 18.8 µm pattern (centerpoint, standard culture time) 
- 0.1 pmol/cm2 + 18.8 µm pattern (centerpoint, offset culture time) 
 
Soluble TGF-β1 samples: 
- 0.4 pmol/mL + 49.1µm pattern 
- 0.4 pmol/mL + 1.93 µm pattern 
- 0.04 pmol/mL + 49.1 µm pattern 
- 0.04 pmol/mL + 1.93 µm pattern 
- 0.2 pmol/mL + 18.8 µm pattern (centerpoint, standard culture time) 
- 0.2 pmol/mL + 18.8 µm pattern (centerpoint, offset culture time)  
 
Control samples: 
- TGF-β1-free + 18.8 µm pattern 
- TGF-β1-free + flat surface 
- 0.1 pmol/cm2 + flat surface 
- 0.2 pmol/mL + flat surface 
5.3.3. Creation of patterned surfaces for cell culture 
Patterned cell culture surfaces were created using the process developed and 
described in chapter 2. 
Silicone micrometre-scale patterns were created from commercially available 
microparticles with diameters of 49.1±1.34 µm, 18.8±1.20 µm or 1.93±0.05 µm. 
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Microparticle solutions were placed in 24 well plate wells and dried at 90°C for up to 
three days to create a dry powder composed of regularly stacked microparticles. The 
dry particles were then carefully covered with uncured silicone mix, created per 
manufacturer’s instructions, while ensuring the particle layer receives only the 
minimum amount of disruption by adding only small volumes of silicone at a time. A 
vacuum is applied to degas the silicone mixture and to remove any air bubbles that 
might remain, after which the silicone mix was allowed to cure overnight. Once cured, 
the created silicone surfaces have a topology of regular patterns with feature sizes 
equal to the dimensions of the used microparticles. 
The silicone patterns were then copied into solid Polystyrene. The silicone surfaces 
were removed from the well plates, and Polystyrene pellets were added and heated 
to 175°C for 1 hour under vacuum. After fully melting, the Polystyrene is allowed to 
cool, and the Polystyrene and silicone are carefully separated. 
The process for creating silicone patterns was then repeated using the polystyrene 
patterns, rather than the original microparticles, as the base mould to create a total 
of ten silicone patterns of each pattern size. 
Finally, these silicone patterns were used to create Polycaprolactone patterns by 
adding Polycaprolactone pellets and heating to 175°C for 30 minutes under vacuum. 
The created surfaces were placed in a sealed, paper autoclave sterilization bag and 
kept at 175°C and atmospheric pressure for an additional 60 minutes to ensure 
sterility. A total of 40 Polycaprolactone surfaces were created for each pattern size, 
as well as an additional 40 ‘flat’ surfaces without any microparticle-based pattern that 
are intended for use as control groups. 
Created Polycaprolactone surfaces were allowed to cool and were stored sterile at 4-
7°C until further processing. Examples of created surfaces are shown in Figure 55. 
5.3.4. Immobilization of TGF-β1 onto prepared surfaces 
With the creation of the patterned surfaces for cell culture, the next step is to add the 
desired immobilized growth factors. TGF-β1 immobilization is based on the 
hydrolysis and crosslinking process developed and described in chapter 4.  
All previously created Polycaprolactone surfaces are treated by submersion in filter-
sterilized 0.5M Sodium Hydroxide solution for 2 hours. This process is used to add  
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Figure 55: examples of three created patterns used during the experiment with feature sizes of 49.1µm 
(A), 18.8µm (B) and 1.93µm (C). Scale bars are 100µm in the left and middle image, and 20µm in the right 
image. 
functional oxygen groups to the surface by hydrolysis of the ester groups in the 
Polycaprolactone polymer chains. 
Treated samples are then washed with sterile PBS, and placed in 24-well plate wells. 
Each sample is treated with 1.5 mL per well of a solution of a 0.380 mg/mL EDC (1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) and 0.575 mg/mL NHS 
(N-Hydroxysuccinimide) in MES buffered saline (0.1M, 0.9% sodium chloride, pH 4.7) 
for 15 minutes. 
Immediately after, all surfaces assigned to groups with immobilized TGF-β1 are 
washed in sterile PBS and treated for 2 hours with the appropriate sterile solutions of 
TGF-β1 in PBS. TGF-β1 solutions used are 1.5 mL per well at 26 ng/mL, 13 ng/mL 
and 2.6 ng/mL, which based on the results of the work from chapter 4 will create 
surface concentrations of approximately 0.2 pMol/cm2, 0.1 pMol/cm2 and 0.02 
pMol/cm2 respectively. Surfaces assigned to groups with soluble TGF-β1 are 
washed and kept in sterile PBS for 2 hours.  
After immobilization of TGF-β1, samples are washed in sterile PBS and stored at 4-
7°C until the start of the cell culture. 
Samples without immobilized TGF-β1 receive the same treatments using sterile PBS 
without any added EDC, NHS or TGF-β1. 
5.3.5. Cell culture on created surfaces 
Following the creation and functionalization of the polymer surfaces, the next 
experimental step is the addition of cells for long-term cell culture on these materials. 
A    B     C 
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 All media used for cell culture (TGF-β1 free, low, medium and high concentration 
media) is prepared before cell culture begins, with unused media stored in the fridge 
at 4-7°C until use. 
Prior to experiments, hMSCs were taken out of nitrogen storage, thawed, and 
cultured for one week at an initial density of 5000 cells/cm2 to ensure cells no longer 
suffer any potential lingering negative effects of cryopreservation. At the time of 
seeding, cells were at passage P+3. Two separate flasks are used for initial culture 
to account for the staggered experimental work, as described in the section on 
experimental design. 
Cells are seeded onto the prepared surfaces at an initial concentration of 20,000 
cells per well (10,000 cells/cm2). Cells are added to the surface in a single drop (30 
µL at 6.6*105 cells per mL, calculated using a Nucleocounter cell counter) in order to 
prevent cells from spilling over the side of the treated samples and attaching on the 
bottom of the well plate well.  
Cells are allowed to attach for 3 hours at 37°C based on Mobasseri and Rana285,286 
after which an additional 1.5 mL of cell culture medium is carefully added to each 
well. 
Cell culture takes place at 37°C, 5% CO2 and 90% humidity, and the culture medium 
is changed every 3 days. Because the size and shape of the samples prevents 
implementation of a complete medium change, a partial medium change of 500 µL 
per well is used instead. 
All spent media collected during the media change is stored frozen at -20°C for later 
analysis of metabolic activity. 
Cells are cultured in separate well plates for each intended measurement time point. 
With the exception of media collection, all measurements are sacrificial and remove 
the entire well plate from culture. Wells are sacrificed for analysis at day 2, day 4, 
day 14 and day 21. 
5.3.6. Analysis of metabolic activity 
Media collected every three days during the cell culture is analysed for metabolic 
activity using a Cedex Bio HT Analyzer (Roche Diagnostics GmbH). Previously 
143 
 
frozen samples are thawed, vortexed and centrifuged at 1000g for 5 minutes prior to 
analysis. Tests are performed in a randomized order to prevent time-based 
measurement biases. Samples are tested for Glucose and Lactate concentrations 
with two replicates based on the original experimental design (i.e. one measurement 
per well). 
5.3.7. Analysis of early culture marker expression 
At day 2 and 4, cells are analysed for surface markers indicative of cellular 
differentiation. As cellular expression markers CD90 and CD105 are downregulated 
during differentiation into chondrocyte lineage39, the presence of these markers is 
tested using flow cytometry.  
First, all relevant surfaces are transferred to new wells. The used wells are checked 
with microscopy to identify potential populations of cells that have grown on the 
bottom of the plate instead of the treated surfaces, for example due to spilling of cells 
during the initial seeding process. 
The transferred surfaces are placed into a 0.25% Trypsin-EDTA solution and are 
incubated at 37°C for 10 minutes. Trypsin was used as a more powerful alternative 
to TrypLE to reduce risk of cells being left on the surface. Although Trypsin has been 
shown to degrade expressed surface markers287, short incubation times will cause 
only minor reductions in signal and this degradation was not considered a problem. 
To reduce the risk of insufficient data points during each measurement, all original 
replicates are pooled, reducing the number of replicates to one but reducing the risk 
of the remaining measurement. The pooled volume is used for both standard and 
isotype measurements. Samples are centrifuged and washed in PBS, then split into 
two groups. 
Samples were incubated in 1 mL of fluorescent antibody solution or equivalent 
Isotypes for 30 minutes, all at a concentration of 1 test per mL or equivalent Isotype 
concentration. PE-conjugated anti-CD105 and FITC-conjugated anti-CD90 were 
incubated simultaneously for stained groups. PE-conjugated Rabbit IgG Isotype and 
FITC-conjugated Rabbit IgG Isotype were incubated simultaneously for Isotype 
controls. 
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Following incubation, cells were analysed using a BD FACSCanto II Flow Cytometer, 
using the following measurement parameters: FSC=150V, SSC=150V, FITC=450V, 
and PE=450V. An FSC threshold of 2500 was applied to filter out debris from the 
measurements. Compensation for spectral overlap was calculated and used at 0.75% 
for PE to FITC and 23.5% for FITC to PE. All collected material was used for 
experiments to ensure maximum recovery of cells and event count for each sample. 
All cells were kept at 4-7°C and protected from all light between incubation with 
fluorescent markers and each sample’s measurements. 
Measured data was collected and prepared for analysis using FlowJo (FlowJo, LLC). 
Measured events were gated for cells using forward scatter and side scatter plots, 
using the same selection for all measurements. Insufficient events were acquired to 
further differentiate cells based on marker expression, and analysis was applied to 
the entirety of the selected cell populations. After cell populations were selected, 
further gating was used to remove any debris or air bubbles on a case-by-case basis 
by applying a gate on FITC fluorescence for the included events. Example plots of 
the implemented gating strategy may be found in Figure 60 in section 5.4.2. 
For each selected sample population, geometric means are calculated for the 
fluorescence levels of FITC (CD90) and PE (CD105). Measured fluorescence values 
will be converted to MESF to estimate total fluorophores per cell using the 
fluorescence values of the MESF reference particles in the QuickCal conversion 
method offered by Bangs Laboratories, Inc. Event counts, as well as standard 
deviations of all measured values, are calculated but are not included in the initial 
analysis. 
5.3.8. Analysis of late culture Collagen-II production 
Production of Collagen-II was determined by measuring total fluorescence of 
samples after staining with primary and secondary antibodies on day 14 and day 21 
of cell culture. Because of very low expected ECM deposition, the choice was made 
to expand analysis with additional isotype measurements. Planned replicates from 
the original experimental design are split into a marker group and an isotype group. 
Consequently, all measurements are performed as N=1 with no replicates. 
Prior to measurements, the relevant surfaces are transferred to new 24-well plate 
wells and incubated for 30 minutes at 37°C with anti-Collagen-II Rabbit IgG or Rabbit 
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IgG isotype, both at 5 µg/mL and 1 mL per sample. The wells from the initial well 
plate are checked with optical microscopy to identify cells that have grown on the 
bottom of the plate, similar to the process used at 2 and 4 days. 
After incubation, samples are washed in PBS, transferred to new wells and 
incubated for 30 minutes at 37°C with FITC-conjugated anti-rabbit IgG at 10 µg/mL 
and 1 mL per sample. Samples are washed with PBS, and fluorescence is measured 
with a FLUOStar Omega plate reader. Sample fluorescence is measured with both a 
gain of 1000V and 1500V. 
5.3.9. Statistical analysis of measurement data 
Collected data was analysed using Minitab 18 (Minitab Inc. USA). The data from the 
completed measurements is analysed as a two-level factorial model design with one 
center-point. Analysis will initially focus on the main and interaction effects of the 
patterning, growth factor concentration, and potential interaction. Further analysis 
includes Pareto analysis for the relative impact of various parameters, as well as the 
influence of immobilizing growth factors compared to using soluble growth factors. 
Statistical significance for all statistical analyses is set at 5%, while stepwise 
modelling used α=0.15 for both adding and removing terms. Stepwise modelling 
keeps a hierarchical model at all steps. 
5.4. Results 
In this chapter the methods developed through chapters 2, 3 and 4 were combined 
to investigate the interaction of patterning and immobilization of TGF-β1 on the 
differentiation and ECM production of mesenchymal stem cells. Cell culture using the 
developed methods was performed and analysed, the results of which are presented 
below. 
Five experimental groups could not be measured at day 21 as these became 
contaminated during cell culture. Discarded samples are: one well from 49.1µm 
pattern + 0.2 pMol/cm2 TGF-β1, both wells from 49.1µm pattern + 0.02 pMol/cm2 
TGF-β1, and both wells from 1.93µm pattern + 0.2 pMol/cm2 TGF-β1. 
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5.4.1. Metabolic activity during cell culture 
Analysis of the data acquired using the Cedex showed a substantial loss of 
metabolic activity.  
Glucose concentration at the time of measurement consistently increased as culture 
progressed, as shown in Figure 56. This indicates that consumption of glucose by 
cells in culture did not exceed the addition of Glucose through media changes or the 
increasing concentrations due to media evaporation. Glucose concentration 
increases to above 4500 mg/L (the starting media concentration) at later time points, 
indicating that media evaporation takes place over the time of culture. 
 
  
Figure 56: measured concentrations of Glucose (A) and Lactate (B) during culture, determined from 
spent media collected during media changes. Samples with immobilized TGF-β1 are shown in blue; 
samples with soluble TGF-β1 are shown in red. Results are shown as mean ± standard deviation for all 
samples regardless of surface type or TGF-β1 concentration. 
Likewise, Lactate concentration sees a decline across all samples after the initial 
peak at day 3 and 6. As a portion of the produced Lactate is removed with each 
media change, this indicates that metabolic activity is maintained at most several 
days into culture with longer-term culture seeing no major metabolic activity or 
further proliferation of cells. 
Three control samples, all flat surfaces with no added TGF-β1, showed noticeably 
higher metabolic activity across all time points with higher Glucose consumption 
(concentrations down to 4200-3500 mg/L) and Lactate production (concentrations up 
to 250-1000 mg/mL). However, this behaviour was not seen in any of the other 
samples cultured under these conditions, indicating that these differences may be 
caused by the initial seeding situation, such as an erroneously high seeding density 
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caused by insufficiently stirred cell suspension prior to seeding. These results are 
treated as outliers, and are not included during further data analysis. 
Barring new production or consumption, both Glucose and Lactate will regress to the 
values of unused culture medium due to the partial media change. Total Glucose 
and Lactate changes over time can be calculated from the measured values, with the 
current activity calculated as  ΔCurrent(𝑇𝑇) = ΔTotal(𝑇𝑇) − ΔTotal(𝑇𝑇 − 3) ∗ 23 and total 
activity over cell culture calculated as Δ𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 = ∑ Δ𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑇𝑇)𝑇𝑇=18𝑇𝑇=3 . However, as 
Glucose concentration was already seen to increase due to (presumed) media 
evaporation over the culture period, Lactate will be used as the main indicator of 
metabolic activity, since changes over time will be proportionally larger to base value 
and total Lactate content does not change due to media changes as Glucose content 
does due to media changes. 
As shown in Figure 57, cumulative Lactate production over time are largely 
determined by the first week of cell culture, with days 9 and later having an 
effectively negligible effect on the cumulative metabolic activity during culture. 
  
Figure 57: Calculated day-to-day (A) and cumulative Lactate production (B) during cell culture, 
determined from spent media collected during media changes. Samples with immobilized TGF-β1 are 
shown in blue; samples with soluble TGF-β1 are shown in red. Results are shown as mean ± standard 
deviation. 
Together, these results indicate either a substantial loss of cells during culture, or a 
near-total cessation of metabolism in cultured cells. While a small drop in metabolic 
activity is expected due to cells differentiating from the initial hMSC phenotype to a 
chondrocyte phenotype, the reduction seen in these measurements is too great to be 
fully explained by this process. Proliferation will continue even in chondrocytes, and 
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any reduction in metabolic activity solely due to reduced proliferation would be 
expected to be accompanied by an increase in metabolic activity due to upregulated 
ECM production288. Consequently, the most likely explanation for the measured 
activity is a large-scale loss of cultured cells. It is not known if cells die during culture, 
be it through apoptosis or environmental factors, or if cells are lost due to other 
factors such as detachment from the surface. 
Statistical analysis of the measured metabolic activity shows a number of important 
effects. The center-point samples used during the experiments showed substantially 
lower metabolic activity than all other samples in the immobilized TGF- β1 variants, 
and a substantially higher metabolic activity when used with soluble TGF- β1 as 
seen in Figure 58. As such, these points are considered outliers and will not be 
included for further analysis and interpretation of the measurement data. 
Furthermore, samples using immobilized TGF- β1 on 49.1 µm diameter patterns 
showed a consistently higher metabolic activity than most other samples, and low 
concentrations of immobilized TGF- β1 showed increased metabolic activity 
compared to higher concentrations. 
  
Figure 58: Main effects (A) and interaction plots (B) for measured Lactate levels at day 3 of cell culture 
using immobilized TGF-β1. Note the measured centre-point values at the bottom of the graphs. 
However, the experiments with soluble TGF- β1 instead showed a negligible effect of 
pattern size and an advantage at high concentrations of TGF- β1 in solution, as seen 
in Figure 59. 
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Figure 59: Main effects (A) and interaction plots (B) for measured Lactate levels at day 3 of cell culture 
using soluble TGF-β1. Note the measured centre-point values at the top of the graphs. 
These stark contrasts, combined with the rapid loss of metabolic activity as cell 
culture progresses, suggest that the size and health of the initial cell population are 
the driving factor behind most of the changes seen in these measurements. That 
said, samples using immobilized TGF-β1 showed a higher metabolic activity than 
samples with soluble TGF-β1 (average Lactate concentrations of 130mg/L compared 
to 100mg/L, respectively), which may indicate a potential effect of immobilized 
proteins on initial cell attachment and survival. This interpretation is supported by 
results found in literature, though the complexity of the protein environment in cell 
culture makes direct comparison difficult289–291. 
Statistical analysis of the measurement data did not show statistically significant 
(σ<0.05) links between the patterning, TGF-β1 concentration, or combined effects for 
most time points. The only statistically significant effects were Patterning at day 6 
and 12 on Glucose concentration for samples with immobilized TGF-β1, pattern + 
concentration combined (second-order effect) for Glucose concentration on day 12 
for samples with soluble TGF-β1, and Pattern for Lactate concentration on day 12 for 
samples with immobilized TGF-β1. None of these effects were significant for these 
samples on different time points, nor for other experimental groups. 
However, one notable difference between the experimental groups was found in the 
relative effects of the various environmental parameters. Although most time points 
did not show statistically significant effects, both immobilized and soluble TGF-β1-
based samples showed clear trends. Samples with soluble TGF-β1 consistently 
showed a higher effect from TGF-β1 concentration on both measured Glucose and 
Lactate than patterning, shown in Figure 60. By contrast, the samples using 
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immobilized TGF-β1 consistently showed a greater effect from the patterning instead 
of the TGF-β1 concentration, as seen in Figure 61. 
 
  
Figure 60: Pareto Charts of the contribution of pattern and growth factor concentration on metabolic 
activity (Lactate production) on days 3 (A), 6 (B), 9 (C) and 12 (D) for samples with immobilized TGF-β1. 
This suggests that although none of these effects were statistically significant at 
each individual time point, there may nonetheless be a relevant effect. While 
influence from the second-order effects of patterning and immobilized concentration 
were not significant and in most case substantially smaller than first-order effects, 
the fact that immobilizing TGF-β1 appears to make patterning much more influential 
suggests an interaction between the surface pattern, the immobilized proteins and 
the cells in culture. This is further supported by Regression Modelling of the relation 
between Glucose or Lactate concentration and pattern size and soluble or 
immobilized concentrations of TGF-β1. Although R2 values were low, Regression 
Modelling of a linear relationship as: CFactor = 𝐴𝐴 + 𝐵𝐵 ∗ 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑃𝑃𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 + 𝐶𝐶 ∗ 𝐶𝐶𝑇𝑇𝑇𝑇𝑇𝑇−𝛽𝛽1 gave 
substantially higher values for B in samples with immobilized TGF-β1 (-0.3 to -14 for 
Glucose, +0.4 to +1.1 for Lactate) than for samples with soluble TGF-β1 (-0.6 to +0.5 
for Glucose, -0.1 to +0.1 for E) from day 3 to day 12, as shown in Table 2. Insight 
into non-linear behaviour was impractical due to the unusual response seen in center 
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points, as shown in Figures 58 and 59, and is therefore not included. Samples from 
day 15 and 18 were not included so loss of samples would not skew results for later 
time points.  
 ALactate BLactate CLactate AGlucose BGlucose CGlucose 
T=3, Soluble 96.2 - 0.135  94.3 4513.0 - 0.551 - 124 
T=6, Soluble 93.7 - 0.137 117 4585.1 0.27 - 161 
T=9, Soluble 69.4 0.024 76.1 4627.2 0.502 5 
T=12, Soluble 48.0 0.113 46.0 4736.6 - 0.122 -87 
T=3, Immobilized 119.9 0.423 -103 4510.3 -0.333 -231 
T=6, Immobilized 120.8 1.114 -269 4513 -4.28 976 
T=9, Immobilized 85.7 0.814 -178 4465 -13.61 3222 
T=12, Immobilized 61.8 0.762 -165.1 4757.2 -0.826 76 
Table 2: Regression Model fits for relationships between measured Lactate and Glucose concentrations 
and the patterning and TGF-β1 concentrations used. 
5.4.2. Early expression of cellular markers CD90 and CD105 
Analysis of the Flow Cytometry measurements into the expression of CD90 and 
CD105 provided limited information. Event counts for all measurements were 
substantially lower than intended due to (suspected) cell loss during culture, 
supported by the findings of metabolic activity shown above. While surfaces were 
initially seeded with ≈ 20,000 cells, most measurements included only 600-800 
events in total. Examples of the measured events and population gating used are 
shown in Figure 62. 
To compensate for the low event counts seen during this analysis, all samples 
belonging to each corner point or center point are pooled prior to analysis so that 
individual measurements gain access to larger numbers of cells for analysis. While 
this ensures no replicates are available for these measurements, this change to the 
experimental design was considered a better option than risking further loss of data 
due to insufficient flow cytometry event counts. 
Consequently, these results should not be extrapolated to predict behaviours of 
hMSCs in culture for more successful culture conditions. In addition to potential 
signalling effects of cell death during culture or continuing adverse influences from 
the environment, the remaining cells may represent only a sub-population of the 
initially seeded cells. 
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Figure 61: Pareto Charts of the contribution of pattern and growth factor concentration on metabolic 
activity (Lactate production) on days 3 (A), 6 (B), 9 (C) and 12 (D) for samples with soluble TGF-β1. 
    
Figure 62: Example of measured events in the forward scatter – side scatter plots. The majority of 
measurements showed a large amount of debris, visible as extensive spread out events with low values 
of forward scatter on the total population (A). The gated cell population has very limited event counts (B). 
Although the metabolic activity of the center points for immobilized TGF-β1 culture 
were unusually high, no major differences for CD90 or CD105 staining for these 
samples were found at Flow Cytometry analysis on day 4 as shown in Table 3. 
Likewise, the unusually low metabolic activity of the center points during soluble  
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Sample T=2, CD90 T=2, CD90 
Isotype 
T=2, CD105 T=2, CD105 
Isotype 
T=4, CD90 T=4, CD90 
Isotype 
T=4, CD105 T=4, CD105 
Isotype 
49.1 µm,  
0.2 
pMol/cm2 
22084±25764 1497±904 3922±2540 4961±3616 27090±18934 1232±818 3866±2459 3804±2265 
49.1 µm, 
0.02 
pMol/cm2 
45185±31759 1767±1281 4807±3671 5517±4241 22403±21076 448±1705 5720±4739 916±5448 
1.93 µm, 
0.2 
pMol/cm2 
47580±36850 1915±1462 5825±4298 6186±4560 16317±25159 2766±2076 5154±4274 8110±6268 
1.93 µm, 
0.02 
pMol/cm2 
33319±29385 1534±809 4817±3617 4268±3030 29016±25059 335±1322 6007±3792 397±4864 
18.8 µm, 
0.1 
pMol/cm2 
T=+0 
24683±20309 1305±862 2003±2732 3324±3089 20986±51144 3149±1468 5499±2674 7530±3697 
18.8 µm, 
0.1 
pMol/cm2 
T=+1 
24683±20798 1228±1054 2721±2540 3431±3846 23820±31403 2482±2137 4619±4199 5833±4674 
49.1, µm, 
0.4 
pmol/mL 
36924±30876 1857±1076 5121±3344 6005±3820 23933±23319 1598±1587 3927±3394 4669±4201 
49.1 µm, 
0.04 
pmol/mL 
35048±33192 1376±811 4454±4187 4272±3057 25138±29533 1585±1348 3519±2175 4481±2613 
1.93 µm, 
0.4 
pmol/mL 
31706±20534 1710±954 4543±3020 5367±3487 13715±14716 271±1063 3803±2977 424±4935 
1.93 µm, 
0.04 
pmol/mL 
25862±14923 1343±753 3516±2661 4171±3065 13429±13004 1637±856 3439±1945 4825±2252 
18.8 µm, 
0.2 
pmol/mL 
T=+0 
19086±23727 1263±924 2633±2966 3738±2796 21001±14813 1334±916 3404±1818 3651±2715 
18.8 µm, 
0.2 
pmol/mL 
T=+1 
13465±33116 1658±880 4392±3500 5868±3592 19594±13121 1605±965 4043±2757 4749±3107 
18.8 µm, 
TGF-β-free 
22084±16869 1003±949 3071±2379 2285±3384 16892±12200 1504±924 3445±1883 4339±2921 
Flat, TGF-
β-free 
45185±34831 1530±792 5940±3078 5308±2876 435±38810 2013±4035 234±4937 5279±3445 
Flat, 0.1 
pMol/cm2 
47580±36090 1451±1194 5470±4123 4437±3471 23996±26207 203±159 4890±3863 1500±7935 
Flat, 0.2 
pmol/mL 
33319±46469 1747±821 4552±2884 6300±2955 19671±18905 1531±999 4360±2369 4229±3057 
Table 3: Flow Cytometry measurements of cultured cells at T=2 days and T=4 days. A number of 
unusually low values, such as CD90 Isotype fluorescence for 49.1 µm, 0.02 pMol/cm2 were caused by 
very low numbers of cells and correspondingly higher influence of measurement artefacts. 
TGF-β1 culture was not accompanied by similarly large differences in expression, 
although expression of CD105 was slightly elevated compared to standard 
154 
 
experimental groups. The observed higher metabolic activity seen in cell cultures on 
larger-scale patterning with immobilized TGF-β1 was not accompanied by higher 
expression of CD90 or CD105. 
Together, these results suggest that metabolic activity and phenotype are not 
strongly linked in these experimental conditions. 
Further differences between samples with soluble TGF-β1 and samples with 
immobilized TGF-β1 can be found in the measured expression of CD90 and CD105. 
While cells cultured with soluble TGF-β1 showed a consistently higher expression of 
both of these markers on large patterns, cells cultured on samples with immobilized 
TGF-β1 showed a lower expression on large patterns, especially on day 2, as shown 
in Figure 63. Unlike earlier results seen with regards to metabolic activity, neither 
pattern type nor concentration showed significant effects on measured marker 
expression or a clear hierarchy in terms of relative contributions. 
Together, this further supports a potential interaction of immobilized proteins with the 
underlying pattern as suggested by the metabolic interaction, as further differences 
are found between these two groups despite the fact that factors within these groups 
do not themselves add any substantial effects. 
  
Figure 63: Main Effects Plots for CD90 expression after 2 days, for samples cultured with soluble TGF-β1 
(A) or immobilized TGF-β1 (B). Note the shift from higher expression at large patterns with soluble TGF-
β1 to lower expression when using large patterns with immobilized TGF-β1. Center-points were 
considered outliers as explained before. 
5.4.3. Cumulative production and deposition of Collagen-II 
Measured fluorescence intensities of the various samples showed a number of 
important things. Most importantly, numerous sample measurements showed a very 
high fluorescence when stained with Isotypes, as shown in Table 4. This includes 
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several samples that showed a higher fluorescence than the corresponding 
antibody-stained samples. It is unclear what caused this effect, and results should 
therefore be considered questionable unless consistent patterns are found across 
multiple samples.  
Sample type Antibody, T=14 Isotype, T=14 Antibody, T=21 Isotype, T=21 
49.1 µm, 0.2 pmol/cm2 184290 244687 174230 Sample lost 
49.1 µm, 0.02 pmol/cm2 175624 154960 Sample lost Sample lost 
1.93 µm, 0.2 pmol/cm2 154279 124795 Sample lost Sample lost 
1.93 µm, 0.02 pmol/cm2 106457 154525 99044 128534 
18.8 µm, 0.1 pmol/cm2 
(standard) 120222 143519 140595 120928 
18.8 µm, 0.1 pmol/cm2 
(offset) 109901 175600 179534 179168 
49.1 µm, 0.4 pmol/mL 155486 212648 183133 156180 
49.1 µm, 0.04 pmol/mL 255222 108872 170862 135290 
1.93 µm, 0.4 pmol/mL 83472 185629 167388 146195 
1.93 µm, 0.04 pmol/mL 140078 129944 120055 118281 
18.8 µm, 0.2 pmol/mL 
(standard) 136132 114112 205386 177502 
18.8 µm, 0.2 pmol/mL 
(offset) 185208 151676 241550 168162 
18.8 µm, TGF-β1-free 133642 145082 144892 170256 
Flat surface, TGF-β1-free 119621 128178 111498 101910 
Flat surface, 0.1 pmol/cm2 171258 140614 108931 116850 
Flat surface, 0.2 pmol/mL 120377 122951 112116 94491 
Table 4: measured fluorescence values of each sample type at day 14 and day 21. Five samples were lost 
due to contamination prior to measurements on day 21. 
Though all samples showed fluorescence values around 150,000 units, results 
showed the highest values in samples with large-scale patterning (49.1 µm). These 
samples did not show substantially higher metabolic activity during culture, 
suggesting that the fluorescence intensity after staining for Collagen II is at least 
partially independent of overall cell activity in these samples. This indicates that 
extracellular matrix deposition occurred despite the low rates of proliferation and 
attachment seen during the experiment, and that higher matrix deposition was due to 
altered cell behaviour rather than an increased number of ECM-producing cells. 
Regression Modelling of the gathered data indicated that a potential link exists 
between early metabolic activity (production of Lactate) and the measured 
fluorescence at day 14, with an R2 of 21.82% and p-value of 0.007 for a linear 
correlation. However, the same correlation was not statistically significant at day 21, 
with an R2 value of 9.69% and a p-value of 0.114. It is possible that the statistically 
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significant effect found for day 14 was due to chance, and that there is no true 
relation between these properties. Alternatively, while Collagen can dissolve into 
solution only under the correct circumstances (commonly requiring acidic pH), cell-
produced Collagen monomers are water-soluble prior to crosslinking and forming the 
extracellular matrix network292. It is possible that without further cellular activity or 
ECM deposition, the created Collagen does not reach sufficient density and 
crosslinking to be fully bound to the surface. This would result in loss of ECM over 
time and weakening any statistical link between metabolism and measured 
fluorescence. However, as the measured fluorescences for the surfaces are of 
comparable values this was not considered a likely cause for this result. 
After 14 days of cell culture, analysis of collagen deposition shows a continuation of 
the trends observed during the earlier analysis of metabolic activity and marker 
expression. Samples appear to provide the highest collagen deposition on large-
scale patterns with both soluble and immobilized TGF-β1. Samples with soluble 
TGF-β1 appear to have the highest collagen deposition at lower concentrations of 
TGF-β1, while samples with immobilized TGF-β1 showed the highest fluorescence 
at high concentrations, as shown in Figure 64. 
However, this difference no longer shows up at 21 days, with samples using soluble 
TGF-β1 now showing the highest collagen in high-concentration groups. Further 
analysis is complicated by the loss of a number of samples before measurements 
could begin on day 21, causing some of the planned data points to be unavailable 
(specifically for the immobilized TGF-β1 samples). 
5.5. Discussion 
A number of interesting trends could be seen in the cell culture experiments 
described in this chapter. Nonetheless, various problems were encountered with cell 
retention and proliferation during the experimental work. 
Most importantly, the experiments saw a major loss of cell activity over the first week 
of culture. As culture prior to seeding on the experimental surfaces showed no 
problems, the most likely cause for this is a large-scale loss of cells, indicating a 
major incompatibility with the cell culture environment. The use of chemically  
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Figure 64: Main Effects on Collagen II deposition of the samples with soluble TGF-β1 (A, B) and 
immobilized TGF-β1 (C, D). Note the difference between sample types on day 14 (A, C) as well as the loss 
of data points for samples with immobilized TGF-β1 on day 21 (D). 
modified Polycaprolactone was tested during chapter 4, which indicated that cells 
successfully attached after seeding, without substantial cell loss as seen here. 
Furthermore, as microscopy analysis of the used well plates did not show any 
substantial cell attachment on the bottom of the plate, this suggests that cells were 
not ‘washed off’ the cell culture surface with the addition of the full medium after 3 
hours. This is in line with other work that has shown that cells will attach onto 
surfaces in <3 hours on numerous different material types, with attachment times as 
low as <1 hour total showing good attachment285,286,293. Consequently, the effects 
seen during this experiment are considered to be due to cell behaviour following cell 
seeding and attachment (including responses to the culture environment such as 
surface material), rather than consequences of the seeding protocol itself. 
However, one difference between the two situations was that the experiment in 
chapter 4 was not intended for further culture; cell seeding density was higher during 
the previous experiment since cells reaching confluence prior to measurements was 
not a consideration. The number of cells seeded during this experiment was only 
10,000 cells per square centimetre of surface area, compared to the previously used 
A        B 
 
 
 
 
C        D 
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20,000 cells per square centimetre. Consequently, a potential cause for the losses in 
this experiment is the lower seeding density – though all cells were seeded in a 
single droplet, differences in initial cell density, spreading and cell-to-cell interaction 
may have negatively affected cells during the experiments described in this chapter. 
Cell-to-cell signalling has been shown to have a substantial impact on both 
proliferation and differentiation of cells, with higher cell densities resulting in both 
increased paracrine signalling294 and effects from direct cell-to-cell physical 
contact295. As mesenchymal stem cells have been shown to rapidly spread across 
stiff substrates after seeding296, an insufficiently high initial seeding density may have 
resulted in cells spreading until a loss of necessary signalling effects occurs. This 
may also explain why the center-point samples had such unusual results – although 
cells were seeded onto surfaces using the same method regardless of sample type, 
it is possible that the initial cell suspension was not sufficiently mixed. 
Consequently, these samples could then have been seeded with a lower 
concentration of cells, which may have further complicated attachment and survival 
beyond the effects seen with the rest of the experiment. Likewise, the outliers seen 
in the samples using TGF-β1-free flat surfaces may be caused by this process – if 
these samples were seeded with an above average number of cells, this may have 
been introduced additional signalling effects and partially prevented the cell loss 
seen in the other samples. 
While the cellular environment was evidently unsuitable for the performed 
experiments, noticeable differences could be seen across the used values for both 
the patterning types and the concentrations of TGF-β1 used during these 
experiments. As such, further work with this type of environment may be able to use 
these parameters provided a solution is found for the cell loss seen during this 
experiment. 
Despite the difficulties with acquiring suitably robust data, some interesting trends 
could be identified by looking at the gathered data. The increased cell survival and 
ECM production depending on patterning for samples with immobilized TGF-β1 
compared to samples using soluble TGF-β1 suggest a relationship between 
immobilized growth factors, surface topology and cell response exists. 
159 
 
The immobilization of TGF- β1 showed an increased influence of pattern on cell 
behaviour across all samples using immobilized TGF-β1. This strongly suggests that 
the measured differences are due to a real effect; despite the fact each sample 
individually did not reach statistical significance. Regression modelling for showed 
0.1 < p < 0.25 for pattern and immobilized concentrations, with only Lactate on day 
12 having p=0.045. 
In particular, the topology of the cellular environment will have an impact on the 
cytoskeleton through both cell deformation and altered availability of focal adhesion 
sites18,222. The cytoskeleton has previously been shown to be involved in numerous 
cell processes, including differentiation of hMSCs18,283. Modifying the structure and 
behaviour of the cytoskeleton through altered cell deformation and attachment 
processes could therefore create both a direct influence on cell behaviour and 
modify responsiveness to other influences such as mechanical effects or exposure to 
growth factors18,297 such as the TGF-β1 used during this project. Combined with the 
involvement of the cytoskeleton in chondrogenic differentiation284, this presents a 
potential process through which the patterning and immobilized growth factors may 
interact as seen in these results.  
Large-scale patterning showed the greatest advantage both in terms of early marker 
expression and total Collagen II expression. As the 49.1µm patterns are 
considerably larger than the cells themselves, this may have resulted in cells 
remaining in closer contact to each other within the confines of each ‘well’ in the 
pattern – a possibility which ties in closely with the potential impact of cell seeding 
density mentioned above. Smaller feature sizes may instead have a greater impact 
on cell deformation through sub-cellular topology.  
While statistical analysis of these results was, by necessity, very limited due to both 
a limited number of samples and unexpected cell loss during culture, this still 
provides a tentative answer to the initial hypothesis suggested in chapter 1. The 
increased relevance of patterning when combined with immobilized proteins 
suggests this type of environment may form a useful tool for further improving cell 
culture processes. However, additional work will be needed to overcome the 
difficulties encountered during this chapter and ensure sufficiently robust data on this 
process.  
160 
 
          Chapter 6: Discussion and conclusion  
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6.1. Discussion 
Regenerative medicine provides a promising field for improving current methods and 
therapeutics in medical care. However, recent years have seen rapidly rising costs in 
healthcare services, driven by an aging population and an increased need for long-
term care, making the cost-effectiveness of new treatments a major priority in 
medical research. 
Regenerative medicine offers a potential avenue for the creation of long-lasting 
therapeutic results without the need for extensive follow-up or long-term care. 
However, the cost of regenerative medicine is comparatively high, owing to the need 
for high quality materials (including living tissues) and often lengthy processes to 
prepare such materials for the desired medical intervention. Consequently, 
improvements to cost-effectiveness, efficiency and overall level of control of the 
processes used for regenerative medicine treatments may greatly improve the 
effectiveness of these processes and allow them to meet society’s current and future 
needs. In particular, the complexity of the cellular environment stem cells are found 
in in vivo is a major challenge to accurately recreate; with the shape and mechanical 
properties of surrounding tissue, level of exposure to numerous bioactive 
compounds, and direct cell-to-cell contact all combining to form a unique stem cell 
niche that is difficult to artificially replicate15,16. 
To tackle these challenges, the work described in this thesis focused on potential 
improvements to the efficiency and level of control over cell culture environments 
using a combination of topology and immobilized growth factors. Only a 
chondrocyte-based proof of concept was investigated, though similar methods may 
be applicable for other cell types, environments, or potential therapies as well. 
The new insights gained from this experimental work should be suitable for 
modifying existing cell culture methods without the need for large-scale changes to 
implementation or the addition of costly resources or process steps. Ideally, any 
discovered improvements can be implemented during the preparation of the cell 
culture environment, adding appropriate surface topologies and/or immobilized 
proteins suitable for specific cell types without any changes to the cell culture 
process itself. 
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Initially, a review of published literature was used to determine suitable options for 
the work to be performed. Various options for creating micrometre-scale patterning, 
cell culture materials, chemical modification of such materials for the immobilization 
of proteins, as well as cell types and growth factors or growth factor combinations 
were identified. Based on both the project’s needs and appropriate complexity and 
practical considerations, the available options were evaluated and a combination of 
mould-based patterning with chemically modified Poly (Ethylene Glycol) was chosen 
for the initial experiments. 
First, experimental work focused on the creation of highly-defined micrometre scale 
patterning based on moulds formed using uniformly distributed microparticles. 
Different patterns with feature sizes ranging from 1 to 50 µm diameter were 
successfully created by embedding microparticles in silicone, as seen in chapter 2. 
Following the creation of the initial patterns, surface topology was successfully 
transferred onto other materials for later cell culture, including Poly (Ethylene Glycol), 
Polystyrene and Polycaprolactone. Further improvements to this process were 
developed by adjusting the methods used during the copying process, including the 
use of specific concentrations of the polymer blend for Poly (Ethylene Glycol) to 
ensure the features are duplicated in detail, as seen in Figures 13-15. Furthermore, 
pattern transfer was notably improved by modifying the deposition process so that 
the initially created topology is transferred from the silicone mould under a vacuum 
when using Polystyrene and Polycaprolactone, as seen in Figures 12 and 21. The 
developed process allowed for large-scale creation of patterned surfaces suitable for 
later experiments without the need to repeat the lengthier process used to create 
new patterns from microparticles. 
Further work focused on the immobilization of relevant proteins onto the surface of 
created materials. Numerous immobilization processes are described in literature, 
including the impact on cells cultured on modified adherent cell culture surfaces or 
three-dimensional hydrogel matrices. However, the wide spectrum of differing 
environments and processes used meant that comparison of published results is 
exceedingly difficult and immobilized concentrations were primarily useful only as 
guidelines for the current work. Therefore, experimental work was undertaken to 
verify and quantify the immobilization of selected proteins on cell culture materials. 
163 
 
The initial attempts to quantify immobilization of proteins onto functionalized surfaces 
using newly-created Poly (Ethylene Glycol) microparticles was not successful, as 
seen in chapter 3. Further work using flat Poly (Ethylene Glycol) surfaces showed 
further difficulties in reliably immobilizing proteins, and the decision was made to 
focus on different materials rather than fully investigate the cause of the 
immobilization problems. 
Following further review of literature and the selection of alternate material choices, 
continued experimental work resulted in the creation of functionalized surfaces on 
newly created Polycaprolactone and Polystyrene samples. Surface treatment with 
Sodium Hydroxide solutions was used to create oxygen-rich functional groups. 
These groups were then used to further functionalize the surface using a 
Carbodiimide crosslinking process, creating covalent bonds between the oxygen 
groups on the material surface and exposed primary amines on TGF-β1 added to the 
surface in solution. 
Using this process, these surfaces allowed for the immobilization of varying TGF-β1 
concentrations up to 4 pMol/cm2, with the exact values dependent on the TGF-β1 
concentration used during the immobilization process. 
Finally, the previously developed patterning methods and TGF-β1 immobilization 
process were combined to create surfaces for a larger scale cell culture experiment. 
hMSCs were cultured for three weeks on modified Polycaprolactone surfaces with 
highly regular patterns using feature sizes from 1.93 to 49.1 µm, using either soluble 
or immobilized TGF-β1 at concentrations of 0.04 to 0.04 pmol/mL or 0.02 to 0.2 
pmol/cm2. 
Analysis of metabolic activity, expression of cellular markers CD90 and CD105 and 
the deposition of Collagen II showed noticeable differences between samples 
cultured with immobilized TGF-β1 and samples exposed to TGF-β1 in solution. 
Samples cultured on surfaces with immobilized TGF-β1 repeatedly showed a higher 
influence of pattern on cell behaviour with increased cell viability, reduced 
expression of CD90 and CD105 as well as increased Collagen-II deposition on 
samples with both large-scale patterns and immobilized TGF-β1. By contrast, 
surface patterning had a substantially smaller effect on samples cultured with soluble 
TGF-β1. These results suggest the existence of a link between the local topology of 
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the cell culture surface and the impact of immobilization on growth factors on such 
surfaces. 
The completed experiments did not include any investigation into the underlying 
mechanisms due to practical limitations. Nonetheless, the greater impact of large-
scale patterning on immobilized growth factor influence suggests that underlying 
mechanisms are more likely to involve larger scale processes such as cell 
deformation and cytoskeletal structure rather than effects on micrometre or smaller 
scales such as localized membrane deformation. 
Few of the measured differences reached statistical significance at any single 
measurement point. Nonetheless, effects occurred in a large proportion of sample 
groups, suggesting these effects are real but the current experiment did not have 
enough statistical power to confirm them. Further work is required to both verify 
these results and, if appropriate, determine strategies to apply any gained insights 
for the improvement of current cell culture practices. 
The initial expectations when starting this project underwent substantial changes as 
work progressed. Notably, early plans included more extensive cell culture tests 
including anisotropic and other non-spherical patterns. Instead, additional time was 
required to adjust the selected processes for the needs of the project. The 
differences compared to literature that were experienced when modifying Poly 
(ethylene glycol) and Polycaprolactone surfaces for cell culture highlights the need to 
verify published results and confirm if planned processes are suitable. 
Consequently, the focus of this project shifted away from the minimum of surface 
modification and further cell culture work towards increased efforts on creating and 
modifying the necessary surfaces. Due to the increasing importance of verifying the 
used chemical modification processes, a number of choices that were made during 
the early parts of the project were, in retrospect, not the best options available. 
Most importantly, the decision to quantify growth factor immobilization and 
accessibility in the selected PEG-based material before verifying the material’s 
effects on cell culture resulted in a substantial amount of time and resources being 
spent on creating suitable PEG-based microparticles for analysis. Not only did these 
particles fail to provide the desired information in terms of protein immobilization, the 
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selected material itself ultimately proved to be unsuitable for the desired cell culture 
experiments, potentially due to the need for increased UV exposure compared to 
literature. Consequently, the experimental work described in chapter 3 did not result 
in a suitable strategy for further cell culture experiments. In contrast, PEG-based 
surfaces have been successfully used in published research108,109,118,119,122,123,296,298, 
further highlighting the need to verify even comparatively basic assumptions used 
during cell culture work. Although similar, the changes made to the experimental 
process during this project were evidently too different from published work to ensure 
successful cell culture. 
Likewise, Polycaprolactone has been used for (adherent) cell culture in published 
research and initial attachment tests were positive as seen in chapter 4, yet the 
experimental work in chapter 5 showed substantial difficulties with maintaining cell 
attachment and survival.  
Polycaprolactone has been used for cell culture in various different forms, including 
fibrous scaffolds299,300, porous scaffolds301 as well as continuous surfaces134,147. 
Published work shows that chemical modification of the surface material can have 
substantial effects on cell attachment and viability. While culture using 
Polycaprolactone fibrous meshes functions with little changes to the polymer299,300, 
inclusion of additional cell attachment proteins such as RGD is often required for 
effective implementation of solid surfaces135. Compared to the experiments 
completed during this project, the work by Drevelle and Marletta suggest that the 
chemical modification employed during this project may have resulted in a surface 
with too high hydrophilicity134,135. Consequently, the unexpected issues encountered 
with cell culture during the final experiment may be explained by this difference in 
surface chemistry. The inclusion of additional cell attachment proteins alongside the 
immobilized TGF-β1 may have been a suitable step to prevent this effect, but this 
was not tested. Likewise, using a different immobilization technique than the Sodium 
Hydroxide and Carbodiimide crosslinking technique used here may provide better 
results.  
In addition, the work by Pok147 indicates that the underlying nano-scale polymer 
structure of created Polycaprolactone surfaces may have an impact on cell 
behaviour for adherent culture. Although the oven-based process used here was not 
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considered in that publication, the fact that the initial method of creating the polymer 
surface itself may be a factor of interest suggests that different manufacturing 
techniques may yield better results.  
Further work will have to solve these problems, either by further modification of the 
surfaces in question or by switching to a more reliable cell culture material (such as 
Polystyrene) at the cost of an increase in non-specific binding. 
The experimental results were in line with published work in the context of TGF-β1 
influence. Work during this project showed a higher Collagen II deposition in 
samples with higher concentrations of TGF-β1, matching results seen in literature 
both when used as a soluble component50–52 and when immobilized onto the 
surface20,56. Still, further work on alternate immobilization techniques may be 
appropriate, as internalization or consumption of TGF-β1 was not verified during this 
experiment and this may have further effects on cultured cells53,302. 
6.2. Future work 
The work completed during this project provided a number of important insights, but 
further improvements are required to verify the results and provide means to improve 
existing cell culture processes. 
Most importantly, the concluding experiment could not provide robust data due to 
large-scale cell loss early in culture. Any future work should prioritize the creation of 
a more suitable cell culture environment to prevent such losses. It is unclear what 
the exact cause was for the cell loss seen during the experiments in chapter 5, 
though a number of potential improvements are nonetheless promising opportunities 
to pursue. First of all, this project focused substantially on the creation of a surface 
with a controlled, quantifiable amount of immobilized protein, not only in terms of 
immobilized TGF-β1 but also in terms of limiting the adsorption of other proteins out 
of solution. Despite the initial tests at the end of chapter 4, the used surface material, 
(chemically modified) Polycaprolactone, remains the most immediately likely cause 
of the problems encountered during the last experiments. Alternative materials or 
surface treatments may be preferable, and while these experiments could not be 
performed during this project, additional investigations into the use of other types of 
polymers may lead to substantial improvements. 
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Furthermore, testing the impact of non-specifically bound proteins adsorbed out of 
solution on the influence (or lack thereof) of specifically bound proteins such as 
growth factors may further increase the number of options available for surface 
materials. Treated Polystyrene was included in a number of tests as a ‘back-up’ 
option, but was not used for the final experiments due to its higher propensity for 
non-specific adsorption of proteins. Should future work indicate that non-specific 
adsorption of medium components do not have any adverse effects on immobilized 
proteins, the use of materials with higher adsorption such as Polystyrene might have 
a substantial beneficial impact on further cell culture. 
Alternative material compositions may also solve some of the challenges 
encountered during the earlier work involving microparticle analysis. The lack of 
suitable filtering techniques for the particles created during this project severely 
limited the amount of potential processing and analysis methods that could be used 
for the project. For further work using particles for quantification of surface 
immobilization, establishing an effective collection process should be considered a 
priority. The use of modified particles may allow for additional collection strategies 
such as centrifugation (with suitable density differences), magnetic capture (with the 
inclusion of trace amounts of iron or other magnetic metals), or temperature- or 
solvent-based drying (provided immobilized proteins do not degrade during the 
process)303. Likewise, the use of filters or semi-permeable membranes may provide 
another way to remove excess suspension liquid304. 
The initial seeding density of the cells at the start of culture was also noted to be a 
potential factor in terms of cell survival and activity during the remainder of the 
culture period. Additional experiments focusing on the impact of different seeding 
densities should be used to verify if alternate seeding densities can serve to prevent 
the cell loss seen during the experimental work in chapter 5. In addition, the used 
drop-wise deposition method may be improved to allow for more equally distributed 
cell seeding, though this may depend in part on the use of different creation and 
functionalization processes available133,134,305,306. 
This project initially attempted to quantify the amount of immobilized protein that was 
accessible by cells during culture using flow cytometry, which was not successful. 
Later work estimated the immobilization of TGF-β1 by measuring fluorescent marker 
168 
 
binding using a plate reader, which provided the approximation of surface 
concentrations used during the experiments in chapter 5. The substantial level of 
variation in the measured results further supports the need for a more thorough 
understanding of the cellular environment, including potential effects of immobilized 
protein densities. Consequently, while a practical estimate was used during these 
experiments, gaining more accurate information on the level of exposure of cells to 
immobilized proteins in culture remains an important aspect of cell culture to 
consider. 
Furthermore, only a very limited number of concentrations of TGF-β1 were used 
during this project due to practical considerations. Including additional growth factor 
concentrations in further work may provide additional insight into the effects of 
growth factor concentrations on cells during culture. Information on minimum 
concentrations of proteins and other chemical aspects required for specific 
responses, potential non-linear relationships between surface concentrations and 
cellular impact, and varying concentrations by location on the cell culture surfaces 
may all provide further means to improve current cell culture techniques 
43,73,223,273,307,308. 
Another limitation of this project is that only a single cell and tissue type were used 
for experiments. The increasing need for viable long-term treatments of damaged or 
poorly functional cartilage means that a greater degree of control over chondrocyte 
differentiation and extracellular matrix production is highly relevant. Nonetheless, a 
large number of other cell types and therapeutic purposes may benefit from further 
work using methods such as those developed during this project. Cells with a highly 
structured environment such as neurons, muscle cells and the cells constituting the 
tissues in arterial walls may show a larger impact of adjusting the local cellular 
environment, and further investigation of such cells and tissues may improve 
culturing techniques as well as short- and long-term biocompatibility of various 
medical devices such as stents15,199,309,310. Likewise, the relevant topology and 
growth factor presentation methods will almost certainly need adjustment to make 
them suitable for these different cell types. 
Additionally, while the effectiveness of functionalized surfaces with specific 
topologies is likely substantially less effective in suspension-based cell culture, 
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functionalized particles are already used in other forms of cell culture for both short 
and long-term exposure7,112. Adapting this type of environment for the use of 
patterned particles might provide further insight into shorter-duration transient 
exposure on cells. 
Another aspect of the recently completed experiments was the investigated variation 
during cell culture based on the patterning of the underlying cell culture surface. 
Initially, a larger number of different patterning scales were considered, but these 
options were not included in the final experiments due to practical limitations. 
Furthermore, the patterning types used during this project were exclusively spherical 
convex in shape, with no further variation in topology other than the scale of the 
constituent features. Both convex and anisotropic shapes were considered for 
inclusion, but were not included due to time constraints and practical limitations. As 
such, further work focusing on the most effective shape of the features making up 
the used patterns may provide additional methods to enhance the cell culture 
environment. Convex shapes may result in a higher effective cell density due to 
grouping of cells in each ‘well’ shape, as well as different biomechanical cues due to 
altered deformation of cells compared to concave shapes. Anisotropic shapes such 
as grooves and ridges may be of particular interest for the manipulation of cells 
normally found in highly anisotropic environments such as muscle cells and nerve 
cells. Likewise, different shapes may present varying curvature and ‘sharpness’ of 
features in contact with cells, which may present additional options to investigate 
potential effects of cell membrane deformation and cytoskeletal activity216,223,224. 
Finally, the use of different surface topology might allow for the inclusion of new 
gradients or other location-dependent exposure to immobilized growth factors. The 
use of rod-shaped features has been widespread in cell culture based research, 
predominantly in fields investigating the mechanical properties of cultured cells such 
as contractive force. However, such shapes also allow for the deposition of growth 
factors on only specific parts of the surface, creating a potential method for varying 
the growth factor exposure of cells along different stages of differentiation and 
morphology89,215. 
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6.3. Conclusion 
To conclude, the work performed during this project could not provide a definite 
answer to the initial research questions posed in chapter 1; the offered hypothesis 
remains unverified without additional, more robust experiments. 
Nonetheless, the results from the experimental work shown in chapter 5 provided a 
number of important insights. While none of the measured effects reached statistical 
significance over the full experiment, trends across multiple measurements showed 
a noticeable effect of varying pattern feature sizes that only occurred on surfaces 
using immobilized TGF-β1. Most notably, the relative Pareto Effects of patterning 
and TGF-β1 concentration in the analysed samples show that pattern is consistently 
the more influential (though still non-significant) effect in all samples with immobilized 
TGF-β1, while the TGF-β1 concentration is consistently more important than 
patterning in samples using soluble TGF-β1. Immobilization of TGF-β1 non-
significantly improved early differentiation as measured by expression of CD90 and 
CD105, as well as Collagen II deposition after two weeks of culture. Both of these 
effects were most pronounced on surfaces with patterning using large features 
(49.1µm diameter).  
Together, these results suggest that immobilization of growth factors enhances the 
impact of a cell culture surface’s topology on cells during culture. These results have 
not been confirmed and will require additional verification before these potential 
effects should be considered for implementation in clinical research, but they 
nonetheless provide preliminary evidence that the principle works as a proof-of-
concept.  
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